{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T20:27:56Z","timestamp":1795120076611,"version":"4.10.3"},"reference-count":1289,"publisher":"BMJ","issue":"Suppl 3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:p>Ulcerative colitis and Crohn\u2019s disease are the principal forms of inflammatory bowel disease. Both represent chronic inflammation of the gastrointestinal tract, which displays heterogeneity in inflammatory and symptomatic burden between patients and within individuals over time. Optimal management relies on understanding and tailoring evidence-based interventions by clinicians in partnership with patients. This guideline for management of inflammatory bowel disease in adults over 16 years of age was developed by Stakeholders representing UK physicians (British Society of Gastroenterology), surgeons (Association of Coloproctology of Great Britain and Ireland), specialist nurses (Royal College of Nursing), paediatricians (British Society of Paediatric Gastroenterology, Hepatology and Nutrition), dietitians (British Dietetic Association), radiologists (British Society of Gastrointestinal and Abdominal Radiology), general practitioners (Primary Care Society for Gastroenterology) and patients (Crohn\u2019s and Colitis UK). A systematic review of 88\u2009247 publications and a Delphi consensus process involving 81 multidisciplinary clinicians and patients was undertaken to develop 168 evidence- and expert opinion-based recommendations for pharmacological, non-pharmacological and surgical interventions, as well as optimal service delivery in the management of both ulcerative colitis and Crohn\u2019s disease. Comprehensive up-to-date guidance is provided regarding indications for, initiation and monitoring of immunosuppressive therapies, nutrition interventions, pre-, peri- and postoperative management, as well as structure and function of the multidisciplinary team and integration between primary and secondary care. Twenty research priorities to inform future clinical management are presented, alongside objective measurement of priority importance, determined by 2379 electronic survey responses from individuals living with ulcerative colitis and Crohn\u2019s disease, including patients, their families and friends.<\/jats:p>","DOI":"10.1136\/gutjnl-2019-318484","type":"journal-article","created":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T11:24:15Z","timestamp":1569583455000},"page":"s1-s106","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2157,"title":["British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults"],"prefix":"10.1136","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7271-4956","authenticated-orcid":false,"given":"Christopher Andrew","family":"Lamb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4368-1961","authenticated-orcid":false,"given":"Nicholas A","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5855-9873","authenticated-orcid":false,"given":"Tim","family":"Raine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1377-7172","authenticated-orcid":false,"given":"Philip Anthony","family":"Hendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1568-3978","authenticated-orcid":false,"given":"Philip J","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1039-6251","authenticated-orcid":false,"given":"Jimmy K","family":"Limdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1670-8815","authenticated-orcid":false,"given":"Bu\u2019Hussain","family":"Hayee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9369-8115","authenticated-orcid":false,"given":"Miranda C E","family":"Lomer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5285-7714","authenticated-orcid":false,"given":"Gareth C","family":"Parkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2022-5859","authenticated-orcid":false,"given":"Christian","family":"Selinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0785-1815","authenticated-orcid":false,"given":"Kevin J","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6904-1255","authenticated-orcid":false,"given":"R Justin","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9112-5698","authenticated-orcid":false,"given":"Cathy","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7137-5799","authenticated-orcid":false,"given":"Stuart","family":"Gittens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3033-5851","authenticated-orcid":false,"given":"Malcolm G","family":"Dunlop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1117-1588","authenticated-orcid":false,"given":"Omar","family":"Faiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6462-5091","authenticated-orcid":false,"given":"Aileen","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8643-8617","authenticated-orcid":false,"given":"Vikki","family":"Garrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4192-6526","authenticated-orcid":false,"given":"Paul D","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6467-0631","authenticated-orcid":false,"given":"Miles","family":"Parkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0556-6965","authenticated-orcid":false,"given":"Jeremy","family":"Sanderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8920-5752","authenticated-orcid":false,"given":"Helen","family":"Terry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"IBD guidelines eDelphi consensus group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1942-7568","authenticated-orcid":false,"given":"Daniel R","family":"Gaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6681-9882","authenticated-orcid":false,"given":"Tariq H","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6765-8806","authenticated-orcid":false,"given":"Stuart A","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7442-6093","authenticated-orcid":false,"given":"Melissa","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8782-0292","authenticated-orcid":false,"given":"Matthew","family":"Brookes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3944-6646","authenticated-orcid":false,"given":"Richard","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8768-4550","authenticated-orcid":false,"given":"A Barney","family":"Hawthorne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,9,27]]},"reference":[{"key":"2020050721381611000_68.Suppl_3.s1.1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.224154"},{"key":"2020050721381611000_68.Suppl_3.s1.2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39489.470347.AD"},{"key":"2020050721381611000_68.Suppl_3.s1.3","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.090449"},{"key":"2020050721381611000_68.Suppl_3.s1.4","unstructured":"BSG Guidelines Advice Document. British Society of Gastroenterology. 2018. https:\/\/www.bsg.org.uk\/clinical\/bsg-guidelines\/guideline-development-within-the-bsg-cssc-policies.html (Accessed 1 Feb 2019)."},{"issue":"Suppl 8","key":"2020050721381611000_68.Suppl_3.s1.5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/codi.14448","article-title":"The Association of Coloproctology of Great Britain and Ireland consensus guidelines in surgery for inflammatory bowel disease","volume":"20","author":"Brown","year":"2018","journal-title":"Colorectal Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"2020050721381611000_68.Suppl_3.s1.7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01265.x"},{"key":"2020050721381611000_68.Suppl_3.s1.8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0016-5085(94)90054-X","article-title":"Course of ulcerative colitis: analysis of changes in disease activity over years","volume":"107","author":"Langholz","year":"1994","journal-title":"Gastroenterology"},{"key":"2020050721381611000_68.Suppl_3.s1.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2006.02.005"},{"key":"2020050721381611000_68.Suppl_3.s1.10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1155\/2014\/834512","article-title":"Atypical distribution of inflammation in newly diagnosed ulcerative colitis is not rare","volume":"28","author":"Park","year":"2014","journal-title":"Can J Gastroenterol Hepatol"},{"key":"2020050721381611000_68.Suppl_3.s1.11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.01533.x"},{"key":"2020050721381611000_68.Suppl_3.s1.12","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199309000-00002"},{"key":"2020050721381611000_68.Suppl_3.s1.13","doi-asserted-by":"publisher","DOI":"10.1007\/s10350-005-0160-3"},{"key":"2020050721381611000_68.Suppl_3.s1.14","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2013-201885"},{"key":"2020050721381611000_68.Suppl_3.s1.15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2036.2006.03159.x","article-title":"Review article: Indeterminate colitis-definition, diagnosis and management","volume":"25","author":"Tremaine","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"2020050721381611000_68.Suppl_3.s1.16","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.31.6.567"},{"key":"2020050721381611000_68.Suppl_3.s1.17","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2003.015214"},{"key":"2020050721381611000_68.Suppl_3.s1.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2009.07.001"},{"key":"2020050721381611000_68.Suppl_3.s1.19","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2008.38"},{"key":"2020050721381611000_68.Suppl_3.s1.20","doi-asserted-by":"publisher","DOI":"10.1080\/003655200453610"},{"key":"2020050721381611000_68.Suppl_3.s1.21","doi-asserted-by":"publisher","DOI":"10.1136\/gut.40.3.328"},{"key":"2020050721381611000_68.Suppl_3.s1.22","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.082909"},{"key":"2020050721381611000_68.Suppl_3.s1.23","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21493"},{"key":"2020050721381611000_68.Suppl_3.s1.24","doi-asserted-by":"crossref","first-page":"15374","DOI":"10.3748\/wjg.v20.i41.15374","article-title":"Performance of the Montreal classification for inflammatory bowel diseases","volume":"20","author":"Spekhorst","year":"2014","journal-title":"World J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.25","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.177"},{"key":"2020050721381611000_68.Suppl_3.s1.26","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.cgh.2017.06.016","article-title":"Natural history of adult ulcerative colitis in population-based cohorts: a systematic review","volume":"16","author":"Fumery","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2020050721381611000_68.Suppl_3.s1.27","doi-asserted-by":"publisher","DOI":"10.1159\/000104731"},{"key":"2020050721381611000_68.Suppl_3.s1.28","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.038505"},{"key":"2020050721381611000_68.Suppl_3.s1.29","doi-asserted-by":"publisher","DOI":"10.1155\/2005\/269076"},{"key":"2020050721381611000_68.Suppl_3.s1.30","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3109\/00365529609004876","article-title":"Changes in extent of ulcerative colitis: a study on the course and prognostic factors","volume":"31","author":"Langholz","year":"1996","journal-title":"Scand J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.31","doi-asserted-by":"publisher","DOI":"10.1097\/01.MIB.0000225339.91484.fc"},{"key":"2020050721381611000_68.Suppl_3.s1.32","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198712243172603"},{"key":"2020050721381611000_68.Suppl_3.s1.33","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20520"},{"key":"2020050721381611000_68.Suppl_3.s1.34","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21480"},{"key":"2020050721381611000_68.Suppl_3.s1.35","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-300486"},{"key":"2020050721381611000_68.Suppl_3.s1.36","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.07.024"},{"key":"2020050721381611000_68.Suppl_3.s1.37","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjv111"},{"key":"2020050721381611000_68.Suppl_3.s1.38","doi-asserted-by":"crossref","first-page":"129","DOI":"10.5946\/ce.2018.042","article-title":"Chronological review of endoscopic indices in inflammatory bowel disease","volume":"52","author":"Lee","year":"2019","journal-title":"Clin Endosc"},{"key":"2020050721381611000_68.Suppl_3.s1.39","first-page":"CD011450","article-title":"Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis","volume":"1","author":"Mohammed Vashist","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"2020050721381611000_68.Suppl_3.s1.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2015.06.001"},{"key":"2020050721381611000_68.Suppl_3.s1.41","doi-asserted-by":"publisher","DOI":"10.1097\/01.MIB.0000164024.10848.0a"},{"issue":"Suppl 2","key":"2020050721381611000_68.Suppl_3.s1.42","first-page":"S576","article-title":"Patient Reported Outcome Measures (PROMs) in inflammatory bowel disease: new data","volume":"11","author":"Bojic","year":"2017","journal-title":"J Crohns Colitis"},{"key":"2020050721381611000_68.Suppl_3.s1.43","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.056358"},{"key":"2020050721381611000_68.Suppl_3.s1.44","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11894-015-0477-6","article-title":"Understanding endoscopic disease activity in IBD: how to incorporate it into practice","volume":"18","author":"Christensen","year":"2016","journal-title":"Curr Gastroenterol Rep"},{"key":"2020050721381611000_68.Suppl_3.s1.45","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000046"},{"key":"2020050721381611000_68.Suppl_3.s1.46","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-302830"},{"key":"2020050721381611000_68.Suppl_3.s1.47","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/jgh.13923","article-title":"Limited uptake of ulcerative colitis \"treat-to-target\" recommendations in real-world practice","volume":"33","author":"Bryant","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"2020050721381611000_68.Suppl_3.s1.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2014.08.011"},{"key":"2020050721381611000_68.Suppl_3.s1.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2013.06.010"},{"key":"2020050721381611000_68.Suppl_3.s1.50","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.05.051"},{"key":"2020050721381611000_68.Suppl_3.s1.51","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21838"},{"key":"2020050721381611000_68.Suppl_3.s1.52","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2010.12.028"},{"key":"2020050721381611000_68.Suppl_3.s1.53","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.06.054"},{"key":"2020050721381611000_68.Suppl_3.s1.54","doi-asserted-by":"publisher","DOI":"10.1016\/j.giec.2014.03.005"},{"key":"2020050721381611000_68.Suppl_3.s1.55","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.gie.2017.08.029","article-title":"Zeroing in on endoscopic and histologic mucosal healing to reduce the risk of colorectal neoplasia in inflammatory bowel disease","volume":"86","author":"Saxena","year":"2017","journal-title":"Gastrointest Endosc"},{"key":"2020050721381611000_68.Suppl_3.s1.56","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2015.233"},{"key":"2020050721381611000_68.Suppl_3.s1.57","first-page":"CD000543","article-title":"Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis","volume":"10","author":"Feagan","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2020050721381611000_68.Suppl_3.s1.58","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.71"},{"key":"2020050721381611000_68.Suppl_3.s1.59","first-page":"CD000543","article-title":"Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis","volume":"4","author":"Wang","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2020050721381611000_68.Suppl_3.s1.60","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.67"},{"key":"2020050721381611000_68.Suppl_3.s1.61","doi-asserted-by":"publisher","DOI":"10.1155\/2007\/862917"},{"key":"2020050721381611000_68.Suppl_3.s1.62","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.00248.x"},{"key":"2020050721381611000_68.Suppl_3.s1.63","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.08.069"},{"key":"2020050721381611000_68.Suppl_3.s1.64","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04620.x"},{"key":"2020050721381611000_68.Suppl_3.s1.65","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2010.04575.x"},{"key":"2020050721381611000_68.Suppl_3.s1.66","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20580"},{"key":"2020050721381611000_68.Suppl_3.s1.67","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2014.03.035"},{"key":"2020050721381611000_68.Suppl_3.s1.68","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.07103.x"},{"key":"2020050721381611000_68.Suppl_3.s1.69","first-page":"1398","article-title":"A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis","volume":"97","author":"Levine","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.70","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.10.025"},{"key":"2020050721381611000_68.Suppl_3.s1.71","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2002.01151.x"},{"key":"2020050721381611000_68.Suppl_3.s1.72","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2013.08.007"},{"key":"2020050721381611000_68.Suppl_3.s1.73","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.060103"},{"key":"2020050721381611000_68.Suppl_3.s1.74","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.410"},{"key":"2020050721381611000_68.Suppl_3.s1.75","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2004.09.017"},{"key":"2020050721381611000_68.Suppl_3.s1.76","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21468"},{"key":"2020050721381611000_68.Suppl_3.s1.77","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1155\/2009\/501345","article-title":"Renal effects of long-term treatment with 5-aminosalicylic acid","volume":"23","author":"Patel","year":"2009","journal-title":"Can J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.78","doi-asserted-by":"publisher","DOI":"10.1159\/000326682"},{"key":"2020050721381611000_68.Suppl_3.s1.79","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21049"},{"key":"2020050721381611000_68.Suppl_3.s1.80","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/00004836-198812000-00012","article-title":"Adverse effects with oral 5-aminosalicyclic acid","volume":"10","author":"Fardy","year":"1988","journal-title":"J Clin Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.81","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjv219"},{"key":"2020050721381611000_68.Suppl_3.s1.82","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02462.x"},{"key":"2020050721381611000_68.Suppl_3.s1.83","doi-asserted-by":"publisher","DOI":"10.1157\/13127088"},{"key":"2020050721381611000_68.Suppl_3.s1.84","doi-asserted-by":"publisher","DOI":"10.1136\/gut.1.3.217"},{"key":"2020050721381611000_68.Suppl_3.s1.85","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.5321.1708"},{"key":"2020050721381611000_68.Suppl_3.s1.86","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2009.09.007"},{"key":"2020050721381611000_68.Suppl_3.s1.87","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.08.003"},{"key":"2020050721381611000_68.Suppl_3.s1.88","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-304258"},{"key":"2020050721381611000_68.Suppl_3.s1.89","doi-asserted-by":"crossref","unstructured":"Sherlock ME , MacDonald JK , Griffiths AM , et al . Oral budesonide for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 2015:CD007698.doi:10.1002\/14651858.CD007698.pub3","DOI":"10.1002\/14651858.CD007698.pub3"},{"key":"2020050721381611000_68.Suppl_3.s1.90","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13076"},{"key":"2020050721381611000_68.Suppl_3.s1.91","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jju027.011"},{"key":"2020050721381611000_68.Suppl_3.s1.92","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12712"},{"key":"2020050721381611000_68.Suppl_3.s1.93","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1996.v110.pm8964395"},{"key":"2020050721381611000_68.Suppl_3.s1.94","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-3565(04)00662-7"},{"key":"2020050721381611000_68.Suppl_3.s1.95","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2010.11.006"},{"key":"2020050721381611000_68.Suppl_3.s1.96","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/ajg.2015.114","article-title":"Oral prolonged release beclomethasone dipropionate and prednisone in the treatment of active ulcerative colitis: results from a double-blind, randomized, parallel group study","volume":"110","author":"Van Assche","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.97","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01609.x"},{"key":"2020050721381611000_68.Suppl_3.s1.98","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2002.01298.x"},{"key":"2020050721381611000_68.Suppl_3.s1.99","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.70"},{"key":"2020050721381611000_68.Suppl_3.s1.100","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.5302.441"},{"key":"2020050721381611000_68.Suppl_3.s1.101","doi-asserted-by":"publisher","DOI":"10.3109\/00365527809182199"},{"key":"2020050721381611000_68.Suppl_3.s1.102","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.4947.1041"},{"key":"2020050721381611000_68.Suppl_3.s1.103","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.26279"},{"key":"2020050721381611000_68.Suppl_3.s1.104","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39345.714039.55"},{"key":"2020050721381611000_68.Suppl_3.s1.105","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.6874"},{"key":"2020050721381611000_68.Suppl_3.s1.106","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.09.033"},{"key":"2020050721381611000_68.Suppl_3.s1.107","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1365-2036.2007.03569.x","article-title":"Clinical trial: oral prednisolone metasulfobenzoate (Predocol) vs. oral prednisolone for active ulcerative colitis","volume":"27","author":"Rhodes","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"2020050721381611000_68.Suppl_3.s1.108","doi-asserted-by":"crossref","unstructured":"Wang Y , Parker CE , Feagan BG , et al . Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev 2016:CD000544.doi:10.1002\/14651858.CD000544.pub4","DOI":"10.1002\/14651858.CD000544.pub4"},{"key":"2020050721381611000_68.Suppl_3.s1.109","first-page":"CD004118","article-title":"Rectal 5-aminosalicylic acid for maintenance of remission in ulcerative colitis","volume":"11","author":"Marshall","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2020050721381611000_68.Suppl_3.s1.110","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2011.10.043"},{"key":"2020050721381611000_68.Suppl_3.s1.111","doi-asserted-by":"crossref","first-page":"O214","DOI":"10.1111\/codi.13393","article-title":"Once daily vs multiple daily mesalamine therapy for mild to moderate ulcerative colitis: a meta-analysis","volume":"18","author":"Li","year":"2016","journal-title":"Colorectal Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.112","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.23024"},{"key":"2020050721381611000_68.Suppl_3.s1.113","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1751-2980.2012.00576.x","article-title":"Once-daily versus multiple-daily mesalamine for patients with ulcerative colitis: a meta-analysis","volume":"13","author":"Tong","year":"2012","journal-title":"J Dig Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.114","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.296"},{"key":"2020050721381611000_68.Suppl_3.s1.115","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.04683.x"},{"key":"2020050721381611000_68.Suppl_3.s1.116","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.22997"},{"key":"2020050721381611000_68.Suppl_3.s1.117","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1111\/j.1572-0241.2002.07092.x","article-title":"Rational selection of oral 5-aminosalicylate formulations and prodrugs for the treatment of ulcerative colitis","volume":"97","author":"Sandborn","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.118","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.64"},{"key":"2020050721381611000_68.Suppl_3.s1.119","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.04023.x"},{"key":"2020050721381611000_68.Suppl_3.s1.120","doi-asserted-by":"crossref","unstructured":"Timmer A , Patton PH , Chande N , et al . Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev 2016:CD000478.doi:10.1002\/14651858.CD000478.pub4","DOI":"10.1002\/14651858.CD000478.pub4"},{"key":"2020050721381611000_68.Suppl_3.s1.121","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1056\/NEJMoa050516","article-title":"Infliximab for induction and maintenance therapy for ulcerative colitis","volume":"353","author":"Rutgeerts","year":"2005","journal-title":"N Engl J Med Overseas Ed"},{"key":"2020050721381611000_68.Suppl_3.s1.122","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.10.052"},{"key":"2020050721381611000_68.Suppl_3.s1.123","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0b013e3182802909"},{"key":"2020050721381611000_68.Suppl_3.s1.124","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000115"},{"key":"2020050721381611000_68.Suppl_3.s1.125","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2008.03.004"},{"key":"2020050721381611000_68.Suppl_3.s1.126","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2010.345"},{"key":"2020050721381611000_68.Suppl_3.s1.127","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.221127"},{"key":"2020050721381611000_68.Suppl_3.s1.128","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.10.032"},{"key":"2020050721381611000_68.Suppl_3.s1.129","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2014.242"},{"key":"2020050721381611000_68.Suppl_3.s1.130","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1185\/03007995.2016.1168290","article-title":"Comparison of real-world outcomes of adalimumab and infliximab for patients with ulcerative colitis in the United States","volume":"32","author":"Sandborn","year":"2016","journal-title":"Curr Med Res Opin"},{"key":"2020050721381611000_68.Suppl_3.s1.131","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw019.483"},{"key":"2020050721381611000_68.Suppl_3.s1.132","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.05.048"},{"key":"2020050721381611000_68.Suppl_3.s1.133","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2017-100895"},{"key":"2020050721381611000_68.Suppl_3.s1.134","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1586\/17474124.2015.1024657","article-title":"Comparative efficacy of golimumab, infliximab, and adalimumab for moderately to severely active ulcerative colitis: a network meta-analysis accounting for differences in trial designs","volume":"9","author":"Thorlund","year":"2015","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"2020050721381611000_68.Suppl_3.s1.135","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1097\/01.MIB.0000456723.80943.9a","article-title":"P-026 Applying probabilistic rank ordering methodology to existing network meta-analysis of adalimumab, golimumab and infliximab for moderate-to-severe ulcerative colitis","volume":"20","author":"Kristian","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.136","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.5114\/aoms.2016.58682","article-title":"An indirect comparison of infliximab versus adalimumab or golimumab for active ulcerative colitis","volume":"5","author":"Kawalec","year":"2016","journal-title":"Arch Med Sci"},{"key":"2020050721381611000_68.Suppl_3.s1.137","unstructured":"Technology appraisal guidance [TA329] Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy. National Institute for Health and Care Excellence. 2015. https:\/\/www.nice.org.uk\/guidance\/ta329 (Accessed 12 Dec 2018)."},{"key":"2020050721381611000_68.Suppl_3.s1.138","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1215734","article-title":"Vedolizumab as induction and maintenance therapy for ulcerative colitis","volume":"369","author":"Feagan","year":"2013","journal-title":"N Engl J Med Overseas Ed"},{"key":"2020050721381611000_68.Suppl_3.s1.139","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.cgh.2016.08.044","article-title":"Efficacy of vedolizumab induction and maintenance therapy in patients with ulcerative colitis, regardless of prior exposure to tumor necrosis factor antagonists","volume":"15","author":"Feagan","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2020050721381611000_68.Suppl_3.s1.140","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/s41395-018-0162-0","article-title":"Open: Vedolizumab for ulcerative colitis: treatment outcomes from the VICTORY consortium","volume":"113","author":"Narula","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.141","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1093\/ibd\/izy155","article-title":"Effectiveness and safety of vedolizumab in anti-TNF-naive patients with inflammatory bowel disease-a multicenter retrospective European study","volume":"24","author":"Kopylov","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.142","doi-asserted-by":"crossref","first-page":"S-81","DOI":"10.1016\/S0016-5085(19)36989-6","article-title":"416a \u2013 Vedolizumab shows superior efficacy versus adalimumab: results of Varsity\u2014the first head-to-head study of biologic therapy for moderate-to-severe ulcerative colitis","volume":"156","author":"Sands","year":"2019","journal-title":"Gastroenterology"},{"key":"2020050721381611000_68.Suppl_3.s1.143","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1056\/NEJMoa1112168","article-title":"Tofacitinib, an oral Janus kinase inhibitor, in active ulcerative colitis","volume":"367","author":"Sandborn","year":"2012","journal-title":"N Engl J Med Overseas Ed"},{"key":"2020050721381611000_68.Suppl_3.s1.144","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1606910","article-title":"Tofacitinib as induction and maintenance therapy for ulcerative colitis","volume":"376","author":"Sandborn","year":"2017","journal-title":"N Engl J Med Overseas Ed"},{"issue":"Suppl 1","key":"2020050721381611000_68.Suppl_3.s1.145","doi-asserted-by":"crossref","first-page":"S366","DOI":"10.1093\/ecco-jcc\/jjx180.643","article-title":"P516 Efficacy and safety of tofacitinib retreatment for ulcerative colitis after treatment interruption: Results from the OCTAVE clinical trials","volume":"12","author":"Pan\u00e9s","year":"2018","journal-title":"J Crohn\u2019s Colitis"},{"issue":"supplement_1","key":"2020050721381611000_68.Suppl_3.s1.146","doi-asserted-by":"crossref","first-page":"S049","DOI":"10.1093\/ecco-jcc\/jjx180.063","article-title":"DOP026 Efficacy and safety of dose escalation to tofacitinib 10 mg BID for patients with ulcerative colitis following loss of response on tofacitinib 5 mg BID maintenance therapy: results from OCTAVE open","volume":"12","author":"Sands","year":"2018","journal-title":"J Crohns Colitis"},{"key":"2020050721381611000_68.Suppl_3.s1.147","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)62113-9"},{"key":"2020050721381611000_68.Suppl_3.s1.148","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210457"},{"key":"2020050721381611000_68.Suppl_3.s1.149","unstructured":"ClinicalTrials.gov. Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis. 2019. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02092467 [Accessed 19 May 2019]."},{"key":"2020050721381611000_68.Suppl_3.s1.150","unstructured":"XELJANZ (tofacitinib): Increased risk of pulmonary embolism and mortality in rheumatoid arthritis patients receiving 10mg twice daily in a clinical trial. Pfizer. 2019. https:\/\/assets.publishing.service.gov.uk\/media\/5cb5a218ed915d3f4da780e6\/Xeljanz-March-2019.pdf [Accessed 19 May 2019]."},{"key":"2020050721381611000_68.Suppl_3.s1.151","unstructured":"European Medicines Agency. Restrictions in use of Xeljanz while EMA reviews risk of blood clots in lungs. 2019. https:\/\/www.ema.europa.eu\/en\/news\/restrictions-use-xeljanz-while-ema-reviews-risk-blood-clots-lungs [Accessed 19 May 2019]."},{"key":"2020050721381611000_68.Suppl_3.s1.152","unstructured":"National Institute for Health and Care Excellence.Technology appraisal guidance [TA547] Tofacitinib for moderately to severely active ulcerative colitis. 2018. https:\/\/www.nice.org.uk\/guidance\/ta547 [Accessed 14 Dec 2018]."},{"key":"2020050721381611000_68.Suppl_3.s1.153","first-page":"1586","article-title":"LB01 Safety and efficacy of ustekinumab induction therapy in patients with moderate to severe ulcerative colitis: results from the Phase 3 UNIFI study","volume":"6","author":"Sands","year":"2018","journal-title":"United Eur Gastroenterol J"},{"issue":"Suppl 1","key":"2020050721381611000_68.Suppl_3.s1.154","doi-asserted-by":"crossref","first-page":"S025","DOI":"10.1093\/ecco-jcc\/jjy222.034","article-title":"OP37 Efficacy and safety of ustekinumab as maintenance therapy in ulcerative colitis: Week 44 results from UNIFI","volume":"13","author":"Sandborn","year":"2019","journal-title":"J Crohns Colitis"},{"key":"2020050721381611000_68.Suppl_3.s1.155","doi-asserted-by":"crossref","unstructured":"Wang Y , MacDonald JK , Vandermeer B , et al . Methotrexate for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev 2015:CD007560.doi:10.1002\/14651858.CD007560.pub3","DOI":"10.1002\/14651858.CD007560.pub3"},{"key":"2020050721381611000_68.Suppl_3.s1.156","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1053\/j.gastro.2015.10.050","article-title":"Methotrexate is not superior to placebo for inducing steroid-free remission, but induces steroid-free clinical remission in a larger proportion of patients with ulcerative colitis","volume":"150","author":"Carbonnel","year":"2016","journal-title":"Gastroenterology"},{"key":"2020050721381611000_68.Suppl_3.s1.157","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1053\/j.gastro.2018.06.046","article-title":"Methotrexate is not superior to placebo in maintaining steroid-free response or remission in ulcerative colitis","volume":"155","author":"Herfarth","year":"2018","journal-title":"Gastroenterology"},{"key":"2020050721381611000_68.Suppl_3.s1.158","doi-asserted-by":"publisher","DOI":"10.7326\/M13-2403"},{"key":"2020050721381611000_68.Suppl_3.s1.159","doi-asserted-by":"crossref","unstructured":"Vickers AD , Ainsworth C , Mody R , et al . Systematic review with network meta-analysis: comparative efficacy of biologics in the treatment of moderately to severely active ulcerative colitis. PLoS One 2016;11:e0165435.doi:10.1371\/journal.pone.0165435","DOI":"10.1371\/journal.pone.0165435"},{"key":"2020050721381611000_68.Suppl_3.s1.160","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/phar.1785","article-title":"Safety profile of biologic drugs in the therapy of ulcerative colitis: a systematic review and network meta-analysis","volume":"36","author":"Mo\u0107ko","year":"2016","journal-title":"Pharmacotherapy"},{"key":"2020050721381611000_68.Suppl_3.s1.161","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14449"},{"issue":"Suppl","key":"2020050721381611000_68.Suppl_3.s1.162","doi-asserted-by":"crossref","first-page":"S402","DOI":"10.14309\/00000434-201810001-00718","article-title":"Efficacy of tofacitinib and biologics as induction and maintenance therapy for moderately-to-severely active ulcerative colitis: a systematic review and network meta-analysis: Presidential Poster Award","volume":"113","author":"Rubin","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"Suppl1","key":"2020050721381611000_68.Suppl_3.s1.163","doi-asserted-by":"crossref","first-page":"S018","DOI":"10.1093\/ecco-jcc\/jjy222.025","article-title":"OP26 Long-term safety of vedolizumab in ulcerative colitis and Crohn\u2019s disease: final results from the GEMINI LTS study","volume":"13","author":"Vermeire","year":"2019","journal-title":"J Crohn\u2019s Colitis"},{"key":"2020050721381611000_68.Suppl_3.s1.164","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.cgh.2016.02.016","article-title":"Effectiveness and safety of vedolizumab induction therapy for patients with inflammatory bowel disease","volume":"14","author":"Amiot","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2020050721381611000_68.Suppl_3.s1.165","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-311079"},{"issue":"Suppl 1","key":"2020050721381611000_68.Suppl_3.s1.166","doi-asserted-by":"crossref","first-page":"S354","DOI":"10.14309\/00000434-201710001-00640","article-title":"Efficacy of tofacitinib in patients with ulcerative colitis by prior tumor necrosis factor inhibitor treatment status: Results from octave induction and maintenance studies","volume":"112","author":"Dubinsky","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.167","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/j.1365-2036.2011.04619.x","article-title":"Review article: delivery and efficacy of topical 5-aminosalicylic acid (mesalazine) therapy in the treatment of ulcerative colitis","volume":"33","author":"Harris","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"2020050721381611000_68.Suppl_3.s1.168","first-page":"1867","article-title":"A double-blind comparison of oral versus rectal mesalamine versus combination therapy in the treatment of distal ulcerative colitis","volume":"92","author":"Safdi","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.169","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3109\/00365529509093256","article-title":"Mesalazine suppositories versus hydrocortisone foam in patients with distal ulcerative colitis. A comparison of the efficacy and practicality of two topical treatment regimens","volume":"30","author":"Farup","year":"1995","journal-title":"Scand J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.170","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.01940.x"},{"key":"2020050721381611000_68.Suppl_3.s1.171","doi-asserted-by":"crossref","unstructured":"Marshall JK , Thabane M , Steinhart AH , et al . Rectal 5-aminosalicylic acid for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 2010:CD004115.doi:10.1002\/14651858.CD004115.pub2","DOI":"10.1002\/14651858.CD004115.pub2"},{"key":"2020050721381611000_68.Suppl_3.s1.172","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.22939"},{"key":"2020050721381611000_68.Suppl_3.s1.173","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21258"},{"key":"2020050721381611000_68.Suppl_3.s1.174","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-010-1334-y"},{"key":"2020050721381611000_68.Suppl_3.s1.175","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.02185.x"},{"key":"2020050721381611000_68.Suppl_3.s1.176","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1097\/MIB.0000000000000379","article-title":"Systematic Review: Rectal therapies for the treatment of distal forms of ulcerative colitis","volume":"21","author":"Cohen","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.177","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.cgh.2018.04.027","article-title":"Budesonide suppositories are effective and safe for treating acute ulcerative proctitis","volume":"17","author":"Kruis","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2020050721381611000_68.Suppl_3.s1.178","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2012-100274"},{"key":"2020050721381611000_68.Suppl_3.s1.179","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.dld.2016.12.001","article-title":"Azathioprine for refractory ulcerative proctitis: A retrospective multicenter study","volume":"49","author":"Mallet","year":"2017","journal-title":"Dig Liver Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.180","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1159\/000358149","article-title":"Managing intractable proctitis and the problematic pouch","volume":"32","author":"Kent","year":"2014","journal-title":"Dig Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.181","first-page":"3204","article-title":"Current treatment of ulcerative colitis","volume":"17","author":"Meier","year":"2011","journal-title":"World J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.182","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/MIB.0000000000000227","article-title":"Pathogenesis, diagnosis, and management of ulcerative proctitis, chronic radiation proctopathy, and diversion proctitis","volume":"21","author":"Wu","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.183","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2010.04293.x"},{"key":"2020050721381611000_68.Suppl_3.s1.184","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.cgh.2017.02.027","article-title":"Efficacy of rectal tacrolimus for induction therapy in patients with resistant ulcerative proctitis","volume":"15","author":"Lawrance","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2020050721381611000_68.Suppl_3.s1.185","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.305.6844.20"},{"key":"2020050721381611000_68.Suppl_3.s1.186","doi-asserted-by":"publisher","DOI":"10.1136\/gut.35.9.1282"},{"key":"2020050721381611000_68.Suppl_3.s1.187","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199511000-00003"},{"key":"2020050721381611000_68.Suppl_3.s1.188","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00473.x"},{"key":"2020050721381611000_68.Suppl_3.s1.189","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200209000-00007"},{"key":"2020050721381611000_68.Suppl_3.s1.190","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.gie.2017.07.028","article-title":"Impact of mucosal inflammation on risk of colorectal neoplasia in patients with ulcerative colitis: a systematic review and meta-analysis","volume":"86","author":"Flores","year":"2017","journal-title":"Gastrointest Endosc"},{"key":"2020050721381611000_68.Suppl_3.s1.191","doi-asserted-by":"crossref","first-page":"7561","DOI":"10.3748\/wjg.v19.i43.7561","article-title":"Has the risk of colorectal cancer in inflammatory bowel disease decreased?","volume":"19","author":"Andersen","year":"2013","journal-title":"World J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.192","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.08.055"},{"key":"2020050721381611000_68.Suppl_3.s1.193","doi-asserted-by":"publisher","DOI":"10.1016\/S1873-9946(14)60490-6"},{"key":"2020050721381611000_68.Suppl_3.s1.194","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12980"},{"key":"2020050721381611000_68.Suppl_3.s1.195","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.410"},{"key":"2020050721381611000_68.Suppl_3.s1.196","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/apt.13491","article-title":"Review article: the practical management of acute severe ulcerative colitis","volume":"43","author":"Seah","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"2020050721381611000_68.Suppl_3.s1.197","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.05.029"},{"key":"2020050721381611000_68.Suppl_3.s1.198","doi-asserted-by":"publisher","DOI":"10.1080\/10245330701340734"},{"key":"2020050721381611000_68.Suppl_3.s1.199","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2010.02.001"},{"key":"2020050721381611000_68.Suppl_3.s1.200","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S2468-1253(16)30003-6","article-title":"Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial","volume":"1","author":"Williams","year":"2016","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2020050721381611000_68.Suppl_3.s1.201","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2008.03.014"},{"key":"2020050721381611000_68.Suppl_3.s1.202","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/apt.13614","article-title":"Predicting outcome in acute severe ulcerative colitis: comparison of the Travis and Ho scores using UK IBD audit data","volume":"43","author":"Lynch","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"2020050721381611000_68.Suppl_3.s1.203","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199002000-00011"},{"key":"2020050721381611000_68.Suppl_3.s1.204","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/apt.13670","article-title":"Review article: acute severe ulcerative colitis - evidence-based consensus statements","volume":"44","author":"Chen","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"2020050721381611000_68.Suppl_3.s1.205","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2012-100211"},{"key":"2020050721381611000_68.Suppl_3.s1.206","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2011.239301.471"},{"key":"2020050721381611000_68.Suppl_3.s1.207","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.01007.x"},{"key":"2020050721381611000_68.Suppl_3.s1.208","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/MPG.0000000000001079","article-title":"Corticosteroid dosing in pediatric acute severe ulcerative colitis: a propensity score analysis","volume":"63","author":"Choshen","year":"2016","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2020050721381611000_68.Suppl_3.s1.209","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0140-6736(74)90552-2","article-title":"Intensive intravenous regimen for severe attacks of ulcerative colitis","volume":"1","author":"Truelove","year":"1974","journal-title":"Lancet"},{"key":"2020050721381611000_68.Suppl_3.s1.210","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2036.2010.04392.x","article-title":"Review article: the optimal medical management of acute severe ulcerative colitis","volume":"32","author":"Hart","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"2020050721381611000_68.Suppl_3.s1.211","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61963-2"},{"key":"2020050721381611000_68.Suppl_3.s1.212","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2008.02052.x"},{"key":"2020050721381611000_68.Suppl_3.s1.213","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2007.03418.x"},{"key":"2020050721381611000_68.Suppl_3.s1.214","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.12.028"},{"key":"2020050721381611000_68.Suppl_3.s1.215","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01780.x"},{"key":"2020050721381611000_68.Suppl_3.s1.216","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12073"},{"key":"2020050721381611000_68.Suppl_3.s1.217","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2011.09.005"},{"key":"2020050721381611000_68.Suppl_3.s1.218","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1155\/2014\/914303","article-title":"Clostridium difficile infection worsens the prognosis of ulcerative colitis","volume":"28","author":"Negr\u00f3n","year":"2014","journal-title":"Can J Gastroenterol Hepatol"},{"key":"2020050721381611000_68.Suppl_3.s1.219","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02606-13"},{"key":"2020050721381611000_68.Suppl_3.s1.220","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2007.03383.x"},{"issue":"Suppl 1","key":"2020050721381611000_68.Suppl_3.s1.221","doi-asserted-by":"crossref","first-page":"S358","DOI":"10.1016\/S0016-5085(12)61351-1","article-title":"Sa1916 A combination of serum albumin and band neutrophil count is predictive of short-term colectomy following infliximab treatment for severe steroid refractory ulcerative colitis","volume":"142","author":"Kaur","year":"2012","journal-title":"Gastroenterology"},{"key":"2020050721381611000_68.Suppl_3.s1.222","first-page":"20","article-title":"Predictors of emergency colectomy in patients admitted with acute severe ulcerative colitis","volume":"55","author":"Mokhele","year":"2017","journal-title":"S Afr J Surg"},{"key":"2020050721381611000_68.Suppl_3.s1.223","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1097\/MCG.0000000000000884","article-title":"CRP\/Albumin Ratio: An early predictor of steroid responsiveness in acute severe ulcerative colitis","volume":"52","author":"Gibson","year":"2018","journal-title":"J Clin Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.224","doi-asserted-by":"publisher","DOI":"10.1007\/BF02088063"},{"key":"2020050721381611000_68.Suppl_3.s1.225","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2003.04.001"},{"key":"2020050721381611000_68.Suppl_3.s1.226","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01653.x"},{"key":"2020050721381611000_68.Suppl_3.s1.227","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2014.01.006"},{"key":"2020050721381611000_68.Suppl_3.s1.228","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjv047"},{"key":"2020050721381611000_68.Suppl_3.s1.229","doi-asserted-by":"crossref","first-page":"697","DOI":"10.17235\/reed.2016.4470\/2016","article-title":"The use of a segmental endoscopic score may improve the prediction of clinical outcomes in acute severe ulcerative colitis","volume":"108","author":"Fernandes","year":"2016","journal-title":"Rev Esp Enferm Dig"},{"key":"2020050721381611000_68.Suppl_3.s1.230","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199406303302601"},{"key":"2020050721381611000_68.Suppl_3.s1.231","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(03)01214-9"},{"key":"2020050721381611000_68.Suppl_3.s1.232","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.23983"},{"key":"2020050721381611000_68.Suppl_3.s1.233","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.04.001"},{"key":"2020050721381611000_68.Suppl_3.s1.234","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1038\/ajg.2017.180","article-title":"Long-term efficacy and safety of cyclosporine in a cohort of steroid-refractory acute severe ulcerative colitis patients from the ENEIDA Registry (1989-2013): a nationwide multicenter study","volume":"112","author":"Ord\u00e1s","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.235","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.01149.x"},{"key":"2020050721381611000_68.Suppl_3.s1.236","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e3181e883dd"},{"key":"2020050721381611000_68.Suppl_3.s1.237","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200501000-00016"},{"key":"2020050721381611000_68.Suppl_3.s1.238","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01718.x"},{"key":"2020050721381611000_68.Suppl_3.s1.239","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.03.003"},{"key":"2020050721381611000_68.Suppl_3.s1.240","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12387"},{"key":"2020050721381611000_68.Suppl_3.s1.241","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2010.04435.x"},{"key":"2020050721381611000_68.Suppl_3.s1.242","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/jgh.12517","article-title":"Comparison of efficacy, pharmacokinetics, and immunogenicity between infliximab mono- versus combination therapy in ulcerative colitis","volume":"29","author":"Hayes","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"2020050721381611000_68.Suppl_3.s1.243","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61084-8"},{"key":"2020050721381611000_68.Suppl_3.s1.244","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-313060"},{"key":"2020050721381611000_68.Suppl_3.s1.245","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/ajg.2016.7","article-title":"Systematic review and meta-analysis: infliximab or cyclosporine as rescue therapy in patients with severe ulcerative colitis refractory to steroids","volume":"111","author":"Narula","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.246","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04934.x"},{"key":"2020050721381611000_68.Suppl_3.s1.247","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2008.04.035"},{"key":"2020050721381611000_68.Suppl_3.s1.248","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1097\/MIB.0000000000000350","article-title":"Systematic review: Sequential rescue therapy in severe ulcerative colitis: do the benefits outweigh the risks?","volume":"21","author":"Narula","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.249","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2009.183095"},{"key":"2020050721381611000_68.Suppl_3.s1.250","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.08.035"},{"key":"2020050721381611000_68.Suppl_3.s1.251","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/apt.13913","article-title":"Review article: dose optimisation of infliximab for acute severe ulcerative colitis","volume":"45","author":"Hindryckx","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"2020050721381611000_68.Suppl_3.s1.252","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-308099"},{"key":"2020050721381611000_68.Suppl_3.s1.253","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2015.10.029"},{"key":"2020050721381611000_68.Suppl_3.s1.254","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2014.07.041"},{"key":"2020050721381611000_68.Suppl_3.s1.255","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/ibd\/izy383","article-title":"Systematic review and meta-analysis: optimal salvage therapy in acute severe ulcerative colitis","volume":"25","author":"Choy","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.256","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0140-6736(50)90550-2","article-title":"Ulcerative colitis course and prognosis","volume":"255","author":"Rice-Oxley","year":"1950","journal-title":"The Lancet"},{"key":"2020050721381611000_68.Suppl_3.s1.257","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2013.01.014"},{"key":"2020050721381611000_68.Suppl_3.s1.258","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/SLA.0000000000002275","article-title":"Higher surgical morbidity for ulcerative colitis patients in the era of biologics","volume":"268","author":"Abelson","year":"2018","journal-title":"Ann Surg"},{"key":"2020050721381611000_68.Suppl_3.s1.259","doi-asserted-by":"publisher","DOI":"10.1007\/s10350-004-0750-5"},{"key":"2020050721381611000_68.Suppl_3.s1.260","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1463-1318.2012.03188.x","article-title":"Surgical outcomes in steroid refractory acute severe ulcerative colitis: the impact of rescue therapy","volume":"15","author":"Powar","year":"2013","journal-title":"Colorectal Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.261","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2012.08.002"},{"key":"2020050721381611000_68.Suppl_3.s1.262","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.01.004"},{"key":"2020050721381611000_68.Suppl_3.s1.263","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/1751-2980.12278","article-title":"Surgical and medical treatment in patients with acute severe ulcerative colitis","volume":"16","author":"Fornaro","year":"2015","journal-title":"J Dig Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.264","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.727"},{"key":"2020050721381611000_68.Suppl_3.s1.265","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.386"},{"key":"2020050721381611000_68.Suppl_3.s1.266","doi-asserted-by":"publisher","DOI":"10.1016\/S1072-7515(03)00434-4"},{"key":"2020050721381611000_68.Suppl_3.s1.267","doi-asserted-by":"publisher","DOI":"10.1007\/DCR.0b013e31819a5cc1"},{"key":"2020050721381611000_68.Suppl_3.s1.268","doi-asserted-by":"crossref","first-page":"O153","DOI":"10.1111\/codi.13658","article-title":"Subtotal colectomy for ulcerative colitis: lessons learned from a tertiary centre","volume":"19","author":"Buchs","year":"2017","journal-title":"Colorectal Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.269","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2014.08.012"},{"key":"2020050721381611000_68.Suppl_3.s1.270","doi-asserted-by":"publisher","DOI":"10.1111\/codi.12978"},{"key":"2020050721381611000_68.Suppl_3.s1.271","doi-asserted-by":"publisher","DOI":"10.1097\/DCR.0000000000000418"},{"key":"2020050721381611000_68.Suppl_3.s1.272","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00384-013-1814-6","article-title":"Quality of life after proctocolectomy and ileal pouch-anal anastomosis in patients with ulcerative colitis","volume":"29","author":"Koerdt","year":"2014","journal-title":"Int J Colorectal Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.273","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e31827d99a2"},{"key":"2020050721381611000_68.Suppl_3.s1.274","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1318.2010.02538.x"},{"key":"2020050721381611000_68.Suppl_3.s1.275","doi-asserted-by":"publisher","DOI":"10.1007\/DCR.0b013e3181d98d66"},{"key":"2020050721381611000_68.Suppl_3.s1.276","doi-asserted-by":"publisher","DOI":"10.1007\/BF02234458"},{"key":"2020050721381611000_68.Suppl_3.s1.277","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.7312"},{"key":"2020050721381611000_68.Suppl_3.s1.278","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000152018.99541.f1"},{"key":"2020050721381611000_68.Suppl_3.s1.279","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e31814539b1"},{"key":"2020050721381611000_68.Suppl_3.s1.280","doi-asserted-by":"publisher","DOI":"10.1007\/DCR.0b013e318217eea7"},{"key":"2020050721381611000_68.Suppl_3.s1.281","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2013.12.007"},{"key":"2020050721381611000_68.Suppl_3.s1.282","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00384-011-1140-9","article-title":"The clinical impact of primary sclerosing cholangitis in patients with an ileal pouch-anal anastomosis for ulcerative colitis","volume":"26","author":"Rahman","year":"2011","journal-title":"Int J Colorectal Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.283","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s11605-010-1223-x","article-title":"Primary sclerosing cholangitis and extraintestinal manifestations in patients with ulcerative colitis and ileal pouch-anal anastomosis","volume":"14","author":"Wasmuth","year":"2010","journal-title":"J Gastrointest Surg"},{"key":"2020050721381611000_68.Suppl_3.s1.284","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/apt.14828","article-title":"The impact of ileal pouch-anal anastomosis on graft survival following liver transplantation for primary sclerosing cholangitis","volume":"48","author":"Trivedi","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"2020050721381611000_68.Suppl_3.s1.285","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12478"},{"key":"2020050721381611000_68.Suppl_3.s1.286","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-011-1274-9"},{"key":"2020050721381611000_68.Suppl_3.s1.287","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.090316"},{"key":"2020050721381611000_68.Suppl_3.s1.288","doi-asserted-by":"publisher","DOI":"10.1111\/codi.12171"},{"key":"2020050721381611000_68.Suppl_3.s1.289","doi-asserted-by":"publisher","DOI":"10.1016\/S0399-8320(06)73233-X"},{"key":"2020050721381611000_68.Suppl_3.s1.290","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-008-0139-y"},{"key":"2020050721381611000_68.Suppl_3.s1.291","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e318250caa9"},{"key":"2020050721381611000_68.Suppl_3.s1.292","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e3182813741"},{"key":"2020050721381611000_68.Suppl_3.s1.293","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/codi.13536","article-title":"The prevalence of chronic peri-pouch sepsis in patients treated for antibiotic-dependent or refractory primary idiopathic pouchitis","volume":"19","author":"van der Ploeg","year":"2017","journal-title":"Colorectal Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.294","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03643.x"},{"key":"2020050721381611000_68.Suppl_3.s1.295","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/MIB.0000000000001057","article-title":"Frequency and risk factors of Clostridium difficile infection in hospitalized patients with pouchitis: a population-based study","volume":"23","author":"Kistangari","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.296","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-010-0143-y"},{"key":"2020050721381611000_68.Suppl_3.s1.297","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s11894-012-0282-4","article-title":"Diagnosis and differential diagnosis of Crohn\u2019s disease of the ileal pouch","volume":"14","author":"Li","year":"2012","journal-title":"Curr Gastroenterol Rep"},{"key":"2020050721381611000_68.Suppl_3.s1.298","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/0016-5085(94)90832-X","article-title":"Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment","volume":"107","author":"Sandborn","year":"1994","journal-title":"Gastroenterology"},{"key":"2020050721381611000_68.Suppl_3.s1.299","doi-asserted-by":"publisher","DOI":"10.1007\/s10350-004-6652-8"},{"key":"2020050721381611000_68.Suppl_3.s1.300","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20874"},{"key":"2020050721381611000_68.Suppl_3.s1.301","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/apt.13905","article-title":"Systematic review with meta-analysis: the management of chronic refractory pouchitis with an evidence-based treatment algorithm","volume":"45","author":"Segal","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"2020050721381611000_68.Suppl_3.s1.302","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1996.01430170043007"},{"key":"2020050721381611000_68.Suppl_3.s1.303","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200111000-00004"},{"key":"2020050721381611000_68.Suppl_3.s1.304","first-page":"CD001176","article-title":"Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis","volume":"11","author":"Singh","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2020050721381611000_68.Suppl_3.s1.305","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(03)00171-9"},{"key":"2020050721381611000_68.Suppl_3.s1.306","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1007\/s10620-017-4454-9","article-title":"Sulfasalazine in prevention of pouchitis after proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis","volume":"62","author":"Scaioli","year":"2017","journal-title":"Dig Dis Sci"},{"key":"2020050721381611000_68.Suppl_3.s1.307","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2000.9370"},{"key":"2020050721381611000_68.Suppl_3.s1.308","doi-asserted-by":"publisher","DOI":"10.1136\/gut.53.1.108"},{"key":"2020050721381611000_68.Suppl_3.s1.309","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20369"},{"key":"2020050721381611000_68.Suppl_3.s1.310","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01465.x"},{"key":"2020050721381611000_68.Suppl_3.s1.311","doi-asserted-by":"publisher","DOI":"10.1097\/01.MIB.0000437495.30052.be"},{"key":"2020050721381611000_68.Suppl_3.s1.312","doi-asserted-by":"publisher","DOI":"10.1080\/00365520410004668"},{"key":"2020050721381611000_68.Suppl_3.s1.313","doi-asserted-by":"publisher","DOI":"10.1136\/gut.38.2.234"},{"key":"2020050721381611000_68.Suppl_3.s1.314","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-309398"},{"key":"2020050721381611000_68.Suppl_3.s1.315","doi-asserted-by":"crossref","first-page":"12955","DOI":"10.1038\/srep12955","article-title":"Variable alterations of the microbiota, without metabolic or immunological change, following faecal microbiota transplantation in patients with chronic pouchitis","volume":"5","author":"Landy","year":"2015","journal-title":"Sci Rep"},{"key":"2020050721381611000_68.Suppl_3.s1.316","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-316818"},{"key":"2020050721381611000_68.Suppl_3.s1.317","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2007.03306.x"},{"key":"2020050721381611000_68.Suppl_3.s1.318","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2013.12.001"},{"key":"2020050721381611000_68.Suppl_3.s1.319","doi-asserted-by":"publisher","DOI":"10.1177\/1756283X10370611"},{"key":"2020050721381611000_68.Suppl_3.s1.320","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/MIB.0000000000000593","article-title":"Incidence and severity of prepouch ileitis: a distinct disease entity or a manifestation of refractory pouchitis?","volume":"22","author":"Samaan","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.321","doi-asserted-by":"crossref","first-page":"AB269","DOI":"10.1080\/00365521.2019.1569718","article-title":"Adalimumab in the treatment of chronic pouchitis. A randomized double-blind, placebo-controlled trial","volume":"54","author":"Kj\u00e6r","year":"2019","journal-title":"Scand J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.322","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/apt.14479","article-title":"Vedolizumab in the treatment of chronic, antibiotic-dependent or refractory pouchitis","volume":"47","author":"B\u00e4r","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"2020050721381611000_68.Suppl_3.s1.323","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1097\/DCR.0b013e31829ebd83","article-title":"Topical tacrolimus therapy for antibiotic-refractory pouchitis","volume":"56","author":"Uchino","year":"2013","journal-title":"Dis Colon Rectum"},{"key":"2020050721381611000_68.Suppl_3.s1.324","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1318.2009.01816.x"},{"key":"2020050721381611000_68.Suppl_3.s1.325","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20430"},{"key":"2020050721381611000_68.Suppl_3.s1.326","unstructured":"Ileoanal Pouch Report. Association of Coloprotoctology of Great Britain and Ireland, https:\/\/www.acpgbi.org.uk\/content\/uploads\/2016\/07\/Ileoanal-Pouch-Report-2017-FINAL.compressed.pdf [Accessed 14 Dec 2018]."},{"key":"2020050721381611000_68.Suppl_3.s1.327","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000026"},{"key":"2020050721381611000_68.Suppl_3.s1.328","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3109\/00365521.2015.1004364","article-title":"Neoplasia in the colorectal specimens of patients with ulcerative colitis and ileal pouch-anal anastomosis - need for routine surveillance?","volume":"50","author":"Block","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.329","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.5811"},{"key":"2020050721381611000_68.Suppl_3.s1.330","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.05.085"},{"key":"2020050721381611000_68.Suppl_3.s1.331","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1318.2006.01148.x"},{"key":"2020050721381611000_68.Suppl_3.s1.332","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1318.2011.02669.x"},{"key":"2020050721381611000_68.Suppl_3.s1.333","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000152"},{"key":"2020050721381611000_68.Suppl_3.s1.334","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-013-3054-9"},{"key":"2020050721381611000_68.Suppl_3.s1.335","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1318.2004.00716.x"},{"key":"2020050721381611000_68.Suppl_3.s1.336","doi-asserted-by":"publisher","DOI":"10.3109\/00365528909091339"},{"key":"2020050721381611000_68.Suppl_3.s1.337","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.117"},{"key":"2020050721381611000_68.Suppl_3.s1.338","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1159\/000358133","article-title":"Standardized recording of parameters related to the natural history of inflammatory bowel disease: from Montreal to Paris","volume":"32","author":"Hyams","year":"2014","journal-title":"Dig Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.339","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/MPG.0000000000001729","article-title":"Endoscopic and histological assessment of paediatric inflammatory bowel disease over a 3-year follow-up period","volume":"66","author":"Ashton","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2020050721381611000_68.Suppl_3.s1.340","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/MPG.0000000000001032","article-title":"Endoscopic versus histological disease extent at presentation of paediatric inflammatory bowel disease","volume":"62","author":"Ashton","year":"2016","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2020050721381611000_68.Suppl_3.s1.341","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/MPG.0000000000000967","article-title":"Addition of histology to the Paris classification of pediatric Crohn disease alters classification of disease location","volume":"62","author":"Fernandes","year":"2016","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2020050721381611000_68.Suppl_3.s1.342","doi-asserted-by":"publisher","DOI":"10.1136\/gut.21.4.279"},{"key":"2020050721381611000_68.Suppl_3.s1.343","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.31072"},{"key":"2020050721381611000_68.Suppl_3.s1.344","unstructured":"European Medicines Agency. Guideline on the development of new medicinal products for the treatment of Crohn\u2019s Disease. June 2018 https:\/\/www.ema.europa.eu\/documents\/scientific-guideline\/guideline-development-new-medicinal-products-treatment-crohns-disease-revision-2_en.pdf (Accessed 14 Dec 2018)."},{"key":"2020050721381611000_68.Suppl_3.s1.345","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(80)92767-1","article-title":"A simple index of Crohn\u2019s-disease activity","volume":"1","author":"Harvey","year":"1980","journal-title":"Lancet"},{"key":"2020050721381611000_68.Suppl_3.s1.346","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/ecco-jcc\/jjx161","article-title":"Developing a standard set of patient-centred outcomes for inflammatory bowel disease: an international, cross-disciplinary consensus","volume":"12","author":"Kim","year":"2018","journal-title":"J Crohns Colitis"},{"key":"2020050721381611000_68.Suppl_3.s1.347","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-305600"},{"key":"2020050721381611000_68.Suppl_3.s1.348","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/ajg.2016.59","article-title":"Poor correlation between clinical disease activity and mucosal inflammation, and the role of psychological comorbidity in inflammatory bowel disease","volume":"111","author":"Gracie","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.349","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21506"},{"key":"2020050721381611000_68.Suppl_3.s1.350","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/apt.13995","article-title":"Review article: moving towards common therapeutic goals in Crohn\u2019s disease and rheumatoid arthritis","volume":"45","author":"Allen","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"2020050721381611000_68.Suppl_3.s1.351","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrgastro.2013.233","article-title":"IBD: Measuring what counts--endoscopic assessment in IBD","volume":"11","author":"Khanna","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2020050721381611000_68.Suppl_3.s1.352","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000131"},{"key":"2020050721381611000_68.Suppl_3.s1.353","doi-asserted-by":"publisher","DOI":"10.1136\/gut.30.7.983"},{"key":"2020050721381611000_68.Suppl_3.s1.354","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5107(04)01878-4"},{"key":"2020050721381611000_68.Suppl_3.s1.355","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/ajg.2016.580","article-title":"Responsiveness of endoscopic indices of disease activity for Crohn\u2019s disease","volume":"112","author":"Khanna","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.356","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1038\/ajg.2017.229","article-title":"Editorial: Endoscopic scoring systems in Crohn\u2019s disease for evaluation of responsiveness to treatment: are we ready for the prime time of endoscopic assessment?","volume":"112","author":"Buchner","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.357","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.10.055"},{"key":"2020050721381611000_68.Suppl_3.s1.358","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2011.07.013"},{"key":"2020050721381611000_68.Suppl_3.s1.359","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(90)90613-6"},{"key":"2020050721381611000_68.Suppl_3.s1.360","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1016\/S0140-6736(17)32641-7","article-title":"Effect of tight control management on Crohn\u2019s disease (CALM): a multicentre, randomised, controlled phase 3 trial","volume":"390","author":"Colombel","year":"2018","journal-title":"Lancet"},{"issue":"Suppl","key":"2020050721381611000_68.Suppl_3.s1.361","first-page":"A8","article-title":"OP017 Treat to target for Crohn\u2019s disease with adalimumab treatment is cost effective over 48 weeks: An economic assessment of the CALM trial","volume":"5","author":"Panaccione","year":"2017","journal-title":"United Eur Gastroenterol J"},{"key":"2020050721381611000_68.Suppl_3.s1.362","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2012.03.026"},{"key":"2020050721381611000_68.Suppl_3.s1.363","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2004.30499.x"},{"key":"2020050721381611000_68.Suppl_3.s1.364","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00004836-199810000-00008","article-title":"Terminal ileal imaging with ileoscopy versus small-bowel meal with pneumocolon","volume":"27","author":"Marshall","year":"1998","journal-title":"J Clin Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.365","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.00201.x"},{"key":"2020050721381611000_68.Suppl_3.s1.366","doi-asserted-by":"publisher","DOI":"10.1080\/003655298750027308"},{"key":"2020050721381611000_68.Suppl_3.s1.367","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-012-2072-0"},{"key":"2020050721381611000_68.Suppl_3.s1.368","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1021762"},{"key":"2020050721381611000_68.Suppl_3.s1.369","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3181c0a5ab"},{"key":"2020050721381611000_68.Suppl_3.s1.370","doi-asserted-by":"crossref","first-page":"62","DOI":"10.5009\/gnl16015","article-title":"Effectiveness of capsule endoscopy compared with other diagnostic modalities in patients with small bowel Crohn\u2019s disease: a meta-analysis","volume":"11","author":"Choi","year":"2017","journal-title":"Gut Liver"},{"key":"2020050721381611000_68.Suppl_3.s1.371","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1007\/s00330-016-4615-9","article-title":"The first joint ESGAR\/ ESPR consensus statement on the technical performance of cross-sectional small bowel and colonic imaging","volume":"27","author":"Taylor","year":"2017","journal-title":"Eur Radiol"},{"key":"2020050721381611000_68.Suppl_3.s1.372","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-007-0763-2"},{"key":"2020050721381611000_68.Suppl_3.s1.373","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2471070611"},{"key":"2020050721381611000_68.Suppl_3.s1.374","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-013-2973-0"},{"key":"2020050721381611000_68.Suppl_3.s1.375","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.acra.2017.04.013","article-title":"A diagnostic accuracy meta-analysis of CT and MRI for the evaluation of small bowel Crohn disease","volume":"24","author":"Liu","year":"2017","journal-title":"Acad Radiol"},{"key":"2020050721381611000_68.Suppl_3.s1.376","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04710.x"},{"key":"2020050721381611000_68.Suppl_3.s1.377","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1097\/MIB.0000000000000727","article-title":"Medical imaging in small bowel Crohn\u2019s disease-computer tomography enterography, magnetic resonance enterography, and ultrasound: \"Which One Is the Best for What?\"","volume":"22","author":"Greenup","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.378","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S2468-1253(18)30161-4","article-title":"Diagnostic accuracy of magnetic resonance enterography and small bowel ultrasound for the extent and activity of newly diagnosed and relapsed Crohn\u2019s disease (METRIC): a multicentre trial","volume":"3","author":"Taylor","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2020050721381611000_68.Suppl_3.s1.379","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-008-1287-0"},{"key":"2020050721381611000_68.Suppl_3.s1.380","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1007\/s00330-015-3737-9","article-title":"Grading of Crohn\u2019s disease activity using CT, MRI, US and scintigraphy: a meta-analysis","volume":"25","author":"Puylaert","year":"2015","journal-title":"Eur Radiol"},{"key":"2020050721381611000_68.Suppl_3.s1.381","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21551"},{"key":"2020050721381611000_68.Suppl_3.s1.382","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjv196"},{"key":"2020050721381611000_68.Suppl_3.s1.383","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw055"},{"key":"2020050721381611000_68.Suppl_3.s1.384","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.24815"},{"key":"2020050721381611000_68.Suppl_3.s1.385","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2014.424"},{"key":"2020050721381611000_68.Suppl_3.s1.386","doi-asserted-by":"publisher","DOI":"10.1016\/j.ultrasmedbio.2014.09.013"},{"key":"2020050721381611000_68.Suppl_3.s1.387","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.13121775"},{"key":"2020050721381611000_68.Suppl_3.s1.388","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.00287.x"},{"key":"2020050721381611000_68.Suppl_3.s1.389","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-010-1402-9"},{"key":"2020050721381611000_68.Suppl_3.s1.390","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2015.04.185"},{"key":"2020050721381611000_68.Suppl_3.s1.391","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.3748\/wjg.v22.i7.2165","article-title":"Diagnostic imaging and radiation exposure in inflammatory bowel disease","volume":"22","author":"Zakeri","year":"2016","journal-title":"World J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.392","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2008.151415"},{"key":"2020050721381611000_68.Suppl_3.s1.393","first-page":"385","article-title":"Radiation exposure in Crohn\u2019s disease patients","volume":"94","author":"Bousorra","year":"2016","journal-title":"Tunis Med"},{"key":"2020050721381611000_68.Suppl_3.s1.394","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60815-0"},{"key":"2020050721381611000_68.Suppl_3.s1.395","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2008.01920.x"},{"key":"2020050721381611000_68.Suppl_3.s1.396","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1148\/radiol.2016151281","article-title":"Diagnostic accuracy of CT enterography for active inflammatory terminal ileal Crohn disease: comparison of full-dose and half-dose images reconstructed with FBP and half-dose images with SAFIRE","volume":"280","author":"Gandhi","year":"2016","journal-title":"Radiology"},{"key":"2020050721381611000_68.Suppl_3.s1.397","doi-asserted-by":"crossref","first-page":"20160612","DOI":"10.1259\/bjr.20160612","article-title":"Diagnostic efficacy of single-pass abdominal multidetector-row CT: prospective evaluation of a low dose protocol","volume":"90","author":"Camera","year":"2017","journal-title":"Br J Radiol"},{"key":"2020050721381611000_68.Suppl_3.s1.398","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1214790"},{"key":"2020050721381611000_68.Suppl_3.s1.399","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.gie.2016.07.028","article-title":"Lack of benefit of active preparation compared with a clear fluid-only diet in small-bowel visualization for video capsule endoscopy: results of a randomized, blinded, controlled trial","volume":"85","author":"Hookey","year":"2017","journal-title":"Gastrointest Endosc"},{"key":"2020050721381611000_68.Suppl_3.s1.400","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1080\/17474124.2017.1359540","article-title":"Systematic review and meta-analysis: is bowel preparation still necessary in small bowel capsule endoscopy?","volume":"11","author":"Yung","year":"2017","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"2020050721381611000_68.Suppl_3.s1.401","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1055\/a-0576-0566","article-title":"Small-bowel capsule endoscopy and device-assisted enteroscopy for diagnosis and treatment of small-bowel disorders: European Society of Gastrointestinal Endoscopy (ESGE) Technical Review","volume":"50","author":"Rondonotti","year":"2018","journal-title":"Endoscopy"},{"key":"2020050721381611000_68.Suppl_3.s1.402","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.713"},{"key":"2020050721381611000_68.Suppl_3.s1.403","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1038\/ajg.2010.203","article-title":"Capsule endoscopy in suspected Crohn\u2019s disease: \"yield\" does not equal \"diagnosis\"","volume":"105","author":"Doherty","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.404","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2008.02.017"},{"key":"2020050721381611000_68.Suppl_3.s1.405","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1391855"},{"key":"2020050721381611000_68.Suppl_3.s1.406","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.gie.2016.12.024","article-title":"Retention associated with video capsule endoscopy: systematic review and meta-analysis","volume":"85","author":"Rezapour","year":"2017","journal-title":"Gastrointest Endosc"},{"key":"2020050721381611000_68.Suppl_3.s1.407","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1053\/j.gastro.2016.12.032","article-title":"Clinical practice guidelines for the use of video capsule\u00a0endoscopy","volume":"152","author":"Enns","year":"2017","journal-title":"Gastroenterology"},{"key":"2020050721381611000_68.Suppl_3.s1.408","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2011.03.1239"},{"key":"2020050721381611000_68.Suppl_3.s1.409","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.04.008"},{"key":"2020050721381611000_68.Suppl_3.s1.410","doi-asserted-by":"crossref","first-page":"8999","DOI":"10.3748\/wjg.v22.i40.8999","article-title":"Systematic review: Safety of balloon assisted enteroscopy in Crohn\u2019s disease","volume":"22","author":"Arulanandan","year":"2016","journal-title":"World J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.411","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2009.05.005"},{"key":"2020050721381611000_68.Suppl_3.s1.412","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70254-9"},{"key":"2020050721381611000_68.Suppl_3.s1.413","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13190"},{"key":"2020050721381611000_68.Suppl_3.s1.414","doi-asserted-by":"crossref","unstructured":"Rezaie A , Kuenzig ME , Benchimol EI , et al . Budesonide for induction of remission in Crohn\u2019s disease. Cochrane Database Syst Rev 2015(6):CD000296.doi:10.1002\/14651858.CD000296.pub4","DOI":"10.1002\/14651858.CD000296.pub4"},{"key":"2020050721381611000_68.Suppl_3.s1.415","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/MIB.0000000000001023","article-title":"Comparative effectiveness of mesalamine, sulfasalazine, corticosteroids, and budesonide for the induction of remission in Crohn\u2019s disease: a Bayesian network meta-analysis","volume":"23","author":"Coward","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.416","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2014.01.021"},{"key":"2020050721381611000_68.Suppl_3.s1.417","doi-asserted-by":"crossref","unstructured":"Benchimol EI , Seow CH , Steinhart AH , et al . Traditional corticosteroids for induction of remission in Crohn\u2019s disease. Cochrane Database Syst Rev 2008:CD006792.doi:10.1002\/14651858.CD006792.pub2","DOI":"10.1002\/14651858.CD006792.pub2"},{"key":"2020050721381611000_68.Suppl_3.s1.418","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/0016-5085(79)90385-8","article-title":"National Cooperative Crohn\u2019s Disease Study: results of drug treatment","volume":"77","author":"Summers","year":"1979","journal-title":"Gastroenterology"},{"key":"2020050721381611000_68.Suppl_3.s1.419","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0016-5085(84)90409-8","article-title":"European Cooperative Crohn\u2019s Disease Study (ECCDS): results of drug treatment","volume":"86","author":"Malchow","year":"1984","journal-title":"Gastroenterology"},{"key":"2020050721381611000_68.Suppl_3.s1.420","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2007.03431.x"},{"key":"2020050721381611000_68.Suppl_3.s1.421","first-page":"CD000542","article-title":"Enteral nutritional therapy for induction of remission in Crohn\u2019s disease","volume":"4","author":"Narula","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"2020050721381611000_68.Suppl_3.s1.422","doi-asserted-by":"publisher","DOI":"10.1136\/gut.32.12.1492"},{"key":"2020050721381611000_68.Suppl_3.s1.423","doi-asserted-by":"publisher","DOI":"10.1136\/gut.35.6.783"},{"key":"2020050721381611000_68.Suppl_3.s1.424","doi-asserted-by":"publisher","DOI":"10.1111\/jhn.12176"},{"key":"2020050721381611000_68.Suppl_3.s1.425","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000489630","article-title":"Treatment of active crohn\u2019s disease with exclusive and partial enteral nutrition: a pilot study in adults","volume":"2","author":"Wall","year":"2018","journal-title":"Inflamm Intest Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.426","first-page":"995","article-title":"Efficacy of exclusive enteral nutrition in complicated Crohn\u2019s disease","volume":"52","author":"Yang","year":"2017","journal-title":"Scand J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.427","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3390\/nu9080832","article-title":"Effects of the exclusive enteral nutrition on the microbiota profile of patients with Crohn\u2019s disease: a systematic review","volume":"9","author":"Gatti","year":"2017","journal-title":"Nutrients"},{"key":"2020050721381611000_68.Suppl_3.s1.428","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/ecco-jcc\/jjx109","article-title":"Research gaps in diet and nutrition in inflammatory bowel disease. A Topical Review by D-ECCO Working Group [Dietitians of ECCO]","volume":"11","author":"Sigall-Boneh","year":"2017","journal-title":"J Crohns Colitis"},{"key":"2020050721381611000_68.Suppl_3.s1.429","doi-asserted-by":"publisher","DOI":"10.1111\/jhn.12133"},{"key":"2020050721381611000_68.Suppl_3.s1.430","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.04035.x"},{"key":"2020050721381611000_68.Suppl_3.s1.431","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2036.1994.tb00338.x","article-title":"Polymeric nutrition as the primary therapy in children with small bowel Crohn\u2019s disease","volume":"8","author":"Beattie","year":"1994","journal-title":"Aliment Pharmacol Ther"},{"key":"2020050721381611000_68.Suppl_3.s1.432","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00707.x"},{"key":"2020050721381611000_68.Suppl_3.s1.433","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.03.010"},{"key":"2020050721381611000_68.Suppl_3.s1.434","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i43.7652"},{"key":"2020050721381611000_68.Suppl_3.s1.435","doi-asserted-by":"crossref","unstructured":"Zachos M , Tondeur M , Griffiths AM . Enteral nutritional therapy for induction of remission in Crohn\u2019s disease. Cochrane Database Syst Rev 2007:CD000542.doi:10.1002\/14651858.CD000542.pub2","DOI":"10.1002\/14651858.CD000542.pub2"},{"key":"2020050721381611000_68.Suppl_3.s1.436","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.clnu.2016.12.027","article-title":"ESPEN guideline: Clinical nutrition in inflammatory bowel disease","volume":"36","author":"Forbes","year":"2017","journal-title":"Clin Nutr"},{"key":"2020050721381611000_68.Suppl_3.s1.437","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-277X.1998.00075.x"},{"key":"2020050721381611000_68.Suppl_3.s1.438","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/MEG.0000000000000027","article-title":"Standard versus rapid food reintroduction after exclusive enteral nutritional therapy in paediatric Crohn\u2019s disease","volume":"26","author":"Faiman","year":"2014","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2020050721381611000_68.Suppl_3.s1.439","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1053\/j.gastro.2018.12.002","article-title":"Treatment of active Crohn\u2019s disease with an ordinary food-based diet that replicates exclusive enteral nutrition","volume":"156","author":"Svolos","year":"2019","journal-title":"Gastroenterology"},{"key":"2020050721381611000_68.Suppl_3.s1.440","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.72"},{"key":"2020050721381611000_68.Suppl_3.s1.441","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.11.032"},{"key":"2020050721381611000_68.Suppl_3.s1.442","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2174\/1389557515666150722104230","article-title":"Role of Rifaximin in inflammatory bowel disease treatment","volume":"16","author":"Scribano","year":"2015","journal-title":"Mini Rev Med Chem"},{"key":"2020050721381611000_68.Suppl_3.s1.443","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-315199"},{"key":"2020050721381611000_68.Suppl_3.s1.444","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.03.031"},{"key":"2020050721381611000_68.Suppl_3.s1.445","unstructured":"Graham DY , Hardi R , Welton T , et al . LB06 - A phase III randomized, double blind, placebo-controlled, multicenter, parallel group study to assess the efficacy and safety of fixed-dose combination RHB-104 in subjects with moderately to severely active Crohn\u2019s disease. United Eur Gastroenterol J 2018;6(Suppl)."},{"key":"2020050721381611000_68.Suppl_3.s1.446","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S2468-1253(17)30248-0","article-title":"Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn\u2019s disease: a randomised controlled, open-label, multicentre trial","volume":"2","author":"Ponsioen","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2020050721381611000_68.Suppl_3.s1.447","doi-asserted-by":"crossref","unstructured":"de Groof EJ , Stevens TW , Eshuis EJ , et al . Cost-effectiveness of laparoscopic ileocaecal resection versus infliximab treatment of terminal ileitis in Crohn\u2019s disease: the LIR!C Trial. Gut 2019. doi: 10.1136\/gutjnl-2018-317539 [Epub ahead of print 11 Feb 2019].doi:10.1136\/gutjnl-2018-317539","DOI":"10.1136\/gutjnl-2018-317539"},{"key":"2020050721381611000_68.Suppl_3.s1.448","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/apt.14334","article-title":"A multi-centre audit of excess steroid use in 1176 patients with inflammatory bowel disease","volume":"46","author":"Selinger","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"2020050721381611000_68.Suppl_3.s1.449","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.12.019"},{"key":"2020050721381611000_68.Suppl_3.s1.450","doi-asserted-by":"publisher","DOI":"10.1080\/00365520801957149"},{"key":"2020050721381611000_68.Suppl_3.s1.451","doi-asserted-by":"publisher","DOI":"10.1172\/JCI59255"},{"key":"2020050721381611000_68.Suppl_3.s1.452","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02338.x"},{"key":"2020050721381611000_68.Suppl_3.s1.453","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.41992.x"},{"key":"2020050721381611000_68.Suppl_3.s1.454","first-page":"CD002913","article-title":"Budesonide for maintenance of remission in Crohn\u2019s disease","volume":"8","author":"Kuenzig","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2020050721381611000_68.Suppl_3.s1.455","first-page":"CD000067","article-title":"Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn\u2019s disease","volume":"10","author":"Chande","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2020050721381611000_68.Suppl_3.s1.456","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.10.011"},{"key":"2020050721381611000_68.Suppl_3.s1.457","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199502023320503"},{"key":"2020050721381611000_68.Suppl_3.s1.458","first-page":"CD003459","article-title":"Methotrexate for induction of remission in refractory Crohn\u2019s disease","volume":"8","author":"McDonald","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2020050721381611000_68.Suppl_3.s1.459","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200006013422202"},{"key":"2020050721381611000_68.Suppl_3.s1.460","first-page":"CD006884","article-title":"Methotrexate for maintenance of remission in Crohn\u2019s disease","volume":"8","author":"Patel","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2020050721381611000_68.Suppl_3.s1.461","doi-asserted-by":"publisher","DOI":"10.1002\/art.23144"},{"key":"2020050721381611000_68.Suppl_3.s1.462","doi-asserted-by":"publisher","DOI":"10.1136\/ard.61.8.756"},{"key":"2020050721381611000_68.Suppl_3.s1.463","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/MEG.0000000000000609","article-title":"European experience with methotrexate treatment in Crohn\u2019s disease: a multicenter retrospective analysis","volume":"28","author":"Kopylov","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2020050721381611000_68.Suppl_3.s1.464","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-307964"},{"key":"2020050721381611000_68.Suppl_3.s1.465","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01614.x"},{"key":"2020050721381611000_68.Suppl_3.s1.466","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12161"},{"key":"2020050721381611000_68.Suppl_3.s1.467","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780330112"},{"key":"2020050721381611000_68.Suppl_3.s1.468","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/apt.13700","article-title":"Steroid dependency and trends in prescribing for inflammatory bowel disease - a 20-year national population-based study","volume":"44","author":"Chhaya","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"2020050721381611000_68.Suppl_3.s1.469","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12929"},{"key":"2020050721381611000_68.Suppl_3.s1.470","first-page":"CD003715","article-title":"Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn\u2019s disease","volume":"9","author":"Akobeng","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2020050721381611000_68.Suppl_3.s1.471","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008870.pub2"},{"key":"2020050721381611000_68.Suppl_3.s1.472","first-page":"CD008870","article-title":"Aminosalicylates for induction of remission or response in Crohn\u2019s disease","volume":"12","author":"Lim","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"2020050721381611000_68.Suppl_3.s1.473","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-312673"},{"key":"2020050721381611000_68.Suppl_3.s1.474","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08512-4"},{"key":"2020050721381611000_68.Suppl_3.s1.475","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2008.155812"},{"key":"2020050721381611000_68.Suppl_3.s1.476","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2003.11.014"},{"key":"2020050721381611000_68.Suppl_3.s1.477","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0904492"},{"key":"2020050721381611000_68.Suppl_3.s1.478","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjv126"},{"key":"2020050721381611000_68.Suppl_3.s1.479","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20845"},{"key":"2020050721381611000_68.Suppl_3.s1.480","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.212712"},{"key":"2020050721381611000_68.Suppl_3.s1.481","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S2468-1253(19)30012-3","article-title":"Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn\u2019s disease: a prospective, multicentre, cohort study","volume":"4","author":"Kennedy","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2020050721381611000_68.Suppl_3.s1.482","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.11.024"},{"key":"2020050721381611000_68.Suppl_3.s1.483","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200601000-00003"},{"key":"2020050721381611000_68.Suppl_3.s1.484","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2015.04.010"},{"key":"2020050721381611000_68.Suppl_3.s1.485","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.11.030"},{"key":"2020050721381611000_68.Suppl_3.s1.486","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.11.041"},{"key":"2020050721381611000_68.Suppl_3.s1.487","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-12-200706190-00159"},{"key":"2020050721381611000_68.Suppl_3.s1.488","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.01.035"},{"key":"2020050721381611000_68.Suppl_3.s1.489","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2013.06.019"},{"key":"2020050721381611000_68.Suppl_3.s1.490","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2014.07.003"},{"key":"2020050721381611000_68.Suppl_3.s1.491","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw152"},{"key":"2020050721381611000_68.Suppl_3.s1.492","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/ecco-jcc\/jjy050","article-title":"Clinical benefit of long-term adalimumab treatment in patients with Crohn\u2019s disease following loss of response or intolerance to infliximab: 96-week efficacy data from GAIN\/ADHERE Trials","volume":"12","author":"Panaccione","year":"2018","journal-title":"J Crohns Colitis"},{"key":"2020050721381611000_68.Suppl_3.s1.493","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1080\/00365521.2016.1245777","article-title":"Concurrent immunomodulator therapy is associated with higher adalimumab trough levels during scheduled maintenance therapy","volume":"52","author":"Bond","year":"2017","journal-title":"Scand J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.494","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.cgh.2017.10.036","article-title":"Clinical and pharmacokinetic factors associated with adalimumab-induced mucosal healing in patients with Crohn\u2019s\u00a0disease","volume":"16","author":"Watanabe","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2020050721381611000_68.Suppl_3.s1.495","doi-asserted-by":"crossref","unstructured":"Sazonovs A , Kennedy NA , Bewshea C , et al . OTU-002 HLA-DQA1 contributes to the development of antibodies to anti-TNF therapy in Crohn\u2019s disease. Gut 2018;67(Suppl 1):A52.","DOI":"10.1093\/ecco-jcc\/jjx180.012"},{"key":"2020050721381611000_68.Suppl_3.s1.496","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1111\/apt.13994","article-title":"Suppression of anti-drug antibodies to infliximab or adalimumab with the addition of an immunomodulator in patients with inflammatory bowel disease","volume":"45","author":"Strik","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"2020050721381611000_68.Suppl_3.s1.497","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1215739"},{"key":"2020050721381611000_68.Suppl_3.s1.498","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/MIB.0000000000000979","article-title":"Vedolizumab as induction and maintenance therapy for Crohn\u2019s disease in patients na\u00efve to or who have failed tumor necrosis factor antagonist therapy","volume":"23","author":"Sands","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.499","doi-asserted-by":"crossref","unstructured":"Wang MC , Zhang LY , Han W , et al . PRISMA--efficacy and safety of vedolizumab for inflammatory bowel diseases: a systematic review and meta-analysis of randomized controlled trials. Medicine 2014;93:e326.doi:10.1097\/MD.0000000000000326","DOI":"10.1097\/MD.0000000000000326"},{"key":"2020050721381611000_68.Suppl_3.s1.500","first-page":"412","article-title":"Long-term efficacy of vedolizumab for Crohn\u2019s disease","volume":"11","author":"Vermeire","year":"2017","journal-title":"J Crohns Colitis"},{"issue":"Suppl 1","key":"2020050721381611000_68.Suppl_3.s1.501","first-page":"A89","article-title":"PWE-045 Vedolizumab results in reduced hospitalisation and steroid use over 1-year: Results from the Scottish Vedolizumab Cohort","volume":"67","author":"Plevris","year":"2018","journal-title":"Gut"},{"key":"2020050721381611000_68.Suppl_3.s1.502","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1080\/00365521.2017.1304987","article-title":"Long-term effectiveness of vedolizumab in inflammatory bowel disease: a national study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG)","volume":"52","author":"Eriksson","year":"2017","journal-title":"Scand J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.503","doi-asserted-by":"crossref","unstructured":"Faleck DM , Winters A , Chablaney S , et al . Shorter disease duration is associated with higher rates of response to vedolizumab in patients with Crohn\u2019s disease but not ulcerative colitis. Clin Gastroenterol Hepatol 2019. doi: 10.1016\/j.cgh.2018.12.040. [Epub ahead of print 6 Jan 2019].doi:10.1016\/j.cgh.2018.12.040","DOI":"10.1016\/j.cgh.2018.12.040"},{"key":"2020050721381611000_68.Suppl_3.s1.504","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/apt.14090","article-title":"Editorial: biologics in inflammatory bowel disease-time for direct comparisons","volume":"46","author":"Ungaro","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"2020050721381611000_68.Suppl_3.s1.505","doi-asserted-by":"crossref","first-page":"S-369","DOI":"10.1016\/S0016-5085(18)31547-6","article-title":"Sa1723 - Comparative effectiveness of vedolizumab and tumor necrosis factor-antagonist therapy in Crohn\u2019s disease: a multicenter consortium propensity score-matched analysis","volume":"154","author":"Bohm","year":"2018","journal-title":"Gastroenterology"},{"key":"2020050721381611000_68.Suppl_3.s1.506","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1056\/NEJMoa1602773","article-title":"Ustekinumab as induction and maintenance therapy for Crohn\u2019s disease","volume":"375","author":"Feagan","year":"2016","journal-title":"N Engl J Med"},{"key":"2020050721381611000_68.Suppl_3.s1.507","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2015.09.018"},{"key":"2020050721381611000_68.Suppl_3.s1.508","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1097\/MIB.0000000000000842","article-title":"Ustekinumab for the Treatment of Refractory Crohn\u2019s Disease: The Spanish Experience in a Large Multicentre Open-label Cohort","volume":"22","author":"Khorrami","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.509","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2014.06.005"},{"key":"2020050721381611000_68.Suppl_3.s1.510","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1080\/00365521.2017.1373847","article-title":"Ustekinumab use in Crohn\u2019s disease: a Canadian tertiary care centre experience","volume":"52","author":"Greenup","year":"2017","journal-title":"Scand J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.511","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/MIB.0000000000000624","article-title":"Patients with refractory Crohn\u2019s disease successfully treated with ustekinumab","volume":"22","author":"Harris","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.512","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1111\/apt.14016","article-title":"Clinical, endoscopic and radiographic outcomes with ustekinumab in medically-refractory Crohn\u2019s disease: real world experience from a multicentre cohort","volume":"45","author":"Ma","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"2020050721381611000_68.Suppl_3.s1.513","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2217\/cer-2017-0041","article-title":"An indirect comparison of ustekinumab and vedolizumab in the therapy of TNF-failure Crohn\u2019s disease patients","volume":"7","author":"Kawalec","year":"2018","journal-title":"J Comp Eff Res"},{"key":"2020050721381611000_68.Suppl_3.s1.514","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13139"},{"key":"2020050721381611000_68.Suppl_3.s1.515","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2012.05.015"},{"key":"2020050721381611000_68.Suppl_3.s1.516","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.218"},{"key":"2020050721381611000_68.Suppl_3.s1.517","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.16700"},{"key":"2020050721381611000_68.Suppl_3.s1.518","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/ecco-jcc\/jjx184","article-title":"Autologous haematopoietic stem cell transplantation (AHSCT) in severe Crohn\u2019s disease: a review on behalf of ECCO and EBMT","volume":"12","author":"Snowden","year":"2018","journal-title":"J Crohns Colitis"},{"key":"2020050721381611000_68.Suppl_3.s1.519","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-300995"},{"key":"2020050721381611000_68.Suppl_3.s1.520","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.389"},{"key":"2020050721381611000_68.Suppl_3.s1.521","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0b013e31828133c1"},{"key":"2020050721381611000_68.Suppl_3.s1.522","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1463-1318.2005.00766.x","article-title":"Jejunal Crohn\u2019s disease is associated with a higher postoperative recurrence rate than ileocaecal Crohn\u2019s disease","volume":"7","author":"Keh","year":"2005","journal-title":"Colorectal Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.523","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2009.03.008"},{"key":"2020050721381611000_68.Suppl_3.s1.524","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200105000-00006"},{"key":"2020050721381611000_68.Suppl_3.s1.525","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.mayocp.2017.03.015","article-title":"A diagnostic approach to recurrent orofacial swelling: a retrospective study of 104 patients","volume":"92","author":"Miest","year":"2017","journal-title":"Mayo Clin Proc"},{"key":"2020050721381611000_68.Suppl_3.s1.526","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-3565(05)00424-6"},{"key":"2020050721381611000_68.Suppl_3.s1.527","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200606000-00011"},{"key":"2020050721381611000_68.Suppl_3.s1.528","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s12519-016-0045-7","article-title":"The role of exclusive enteral nutrition in the management of orofacial granulomatosis in children","volume":"12","author":"Mutalib","year":"2016","journal-title":"World J Pediatr"},{"key":"2020050721381611000_68.Suppl_3.s1.529","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/bjd.12655","article-title":"Long-term effectiveness of intralesional triamcinolone acetonide therapy in orofacial granulomatosis: an observational cohort study","volume":"170","author":"Fedele","year":"2014","journal-title":"Br J Dermatol"},{"key":"2020050721381611000_68.Suppl_3.s1.530","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/jop.12379","article-title":"Azathioprine is effective for oral involvement in Crohn\u2019s disease but not for orofacial granulomatosis alone","volume":"45","author":"Mentzer","year":"2016","journal-title":"J Oral Pathol Med"},{"key":"2020050721381611000_68.Suppl_3.s1.531","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.2010.00976.x"},{"key":"2020050721381611000_68.Suppl_3.s1.532","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-312581"},{"key":"2020050721381611000_68.Suppl_3.s1.533","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.3109\/00365521.2015.1050691","article-title":"Glucose breath test and Crohn\u2019s disease: Diagnosis of small intestinal bacterial overgrowth and evaluation of therapeutic response","volume":"50","author":"Greco","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.534","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01800.x"},{"key":"2020050721381611000_68.Suppl_3.s1.535","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1185\/0300799009117003","article-title":"Effect of rifaximin on intestinal bacterial overgrowth in Crohn\u2019s disease as assessed by the H2-glucose breath Test","volume":"16","author":"Biancone","year":"2000","journal-title":"Current Med Res Opin"},{"key":"2020050721381611000_68.Suppl_3.s1.536","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.07.041"},{"key":"2020050721381611000_68.Suppl_3.s1.537","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/MOG.0000000000000078","article-title":"Complications and surgery in the inflammatory bowel diseases biological era","volume":"30","author":"Sokol","year":"2014","journal-title":"Curr Opin Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.538","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-304353"},{"key":"2020050721381611000_68.Suppl_3.s1.539","doi-asserted-by":"publisher","DOI":"10.1159\/000367824"},{"key":"2020050721381611000_68.Suppl_3.s1.540","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2009.180182"},{"key":"2020050721381611000_68.Suppl_3.s1.541","doi-asserted-by":"crossref","first-page":"5434","DOI":"10.1007\/s00464-016-4902-1","article-title":"Endoscopic balloon dilation in the management of strictures in Crohn\u2019s disease: a systematic review and meta-analysis of non-randomized trials","volume":"30","author":"Navaneethan","year":"2016","journal-title":"Surg Endosc"},{"key":"2020050721381611000_68.Suppl_3.s1.542","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1111\/apt.13388","article-title":"Systematic review with meta-analysis: endoscopic balloon dilatation for Crohn\u2019s disease strictures","volume":"42","author":"Morar","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"2020050721381611000_68.Suppl_3.s1.543","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.4804"},{"key":"2020050721381611000_68.Suppl_3.s1.544","doi-asserted-by":"publisher","DOI":"10.1007\/BF02053938"},{"key":"2020050721381611000_68.Suppl_3.s1.545","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v11.i26.3971"},{"key":"2020050721381611000_68.Suppl_3.s1.546","doi-asserted-by":"publisher","DOI":"10.1007\/BF02055108"},{"key":"2020050721381611000_68.Suppl_3.s1.547","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2006.07.011"},{"key":"2020050721381611000_68.Suppl_3.s1.548","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1318.2006.01114.x"},{"key":"2020050721381611000_68.Suppl_3.s1.549","doi-asserted-by":"publisher","DOI":"10.1007\/s10350-006-0804-y"},{"key":"2020050721381611000_68.Suppl_3.s1.550","doi-asserted-by":"publisher","DOI":"10.1097\/DCR.0b013e31824f875a"},{"key":"2020050721381611000_68.Suppl_3.s1.551","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1007\/s00268-005-0284-6","article-title":"Intervention-free interval following strictureplasty for Crohn\u2019s Disease","volume":"30","author":"Roy","year":"2006","journal-title":"World J Surg"},{"key":"2020050721381611000_68.Suppl_3.s1.552","doi-asserted-by":"publisher","DOI":"10.1055\/s-2003-38145"},{"key":"2020050721381611000_68.Suppl_3.s1.553","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2007.04.013"},{"key":"2020050721381611000_68.Suppl_3.s1.554","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2013.10.001"},{"key":"2020050721381611000_68.Suppl_3.s1.555","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00247-015-3533-3","article-title":"Role of percutaneous abscess drainage in the management of young patients with Crohn disease","volume":"46","author":"Pugmire","year":"2016","journal-title":"Pediatr Radiol"},{"key":"2020050721381611000_68.Suppl_3.s1.556","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-200105000-00010"},{"key":"2020050721381611000_68.Suppl_3.s1.557","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2223010554"},{"key":"2020050721381611000_68.Suppl_3.s1.558","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1097\/MCG.0000000000000607","article-title":"A systematic review assessing medical treatment for rectovaginal and enterovesical fistulae in Crohn\u2019s disease","volume":"50","author":"Kaimakliotis","year":"2016","journal-title":"J Clin Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.559","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000000040"},{"key":"2020050721381611000_68.Suppl_3.s1.560","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2011.08.015"},{"key":"2020050721381611000_68.Suppl_3.s1.561","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw169"},{"key":"2020050721381611000_68.Suppl_3.s1.562","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/codi.12473","article-title":"Definitive surgical closure of enterocutaneous fistula: outcome and factors predictive of increased postoperative morbidity","volume":"16","author":"Ravindran","year":"2014","journal-title":"Colorectal Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.563","doi-asserted-by":"crossref","first-page":"10380","DOI":"10.3748\/wjg.v22.i47.10380","article-title":"Factors associated with surgery in patients with intra-abdominal fistulizing Crohn\u2019s disease","volume":"22","author":"Yaari","year":"2016","journal-title":"World J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.564","doi-asserted-by":"publisher","DOI":"10.1177\/2050640613487194"},{"key":"2020050721381611000_68.Suppl_3.s1.565","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2014.183"},{"key":"2020050721381611000_68.Suppl_3.s1.566","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03819.x"},{"key":"2020050721381611000_68.Suppl_3.s1.567","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030815"},{"key":"2020050721381611000_68.Suppl_3.s1.568","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2168.1999.01020.x"},{"key":"2020050721381611000_68.Suppl_3.s1.569","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.28676"},{"key":"2020050721381611000_68.Suppl_3.s1.570","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2333031724"},{"key":"2020050721381611000_68.Suppl_3.s1.571","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.dld.2014.08.003","article-title":"Magnetic resonance imaging and clinical assessments for perianal Crohn\u2019s disease: gain and limits","volume":"46","author":"Garros","year":"2014","journal-title":"Dig Liver Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.572","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.3748\/wjg.v21.i5.1394","article-title":"Management of perianal fistulas in Crohn\u2019s disease: an up-to-date review","volume":"21","author":"Marzo","year":"2015","journal-title":"World J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.573","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-135-10-200111200-00011"},{"key":"2020050721381611000_68.Suppl_3.s1.574","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1586\/17474124.2015.1031110","article-title":"Imaging of perianal fistulizing Crohn\u2019s disease","volume":"9","author":"Chidi","year":"2015","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"2020050721381611000_68.Suppl_3.s1.575","doi-asserted-by":"publisher","DOI":"10.1016\/S1052-5157(02)00013-2"},{"key":"2020050721381611000_68.Suppl_3.s1.576","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01561.x"},{"key":"2020050721381611000_68.Suppl_3.s1.577","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200303000-00003"},{"key":"2020050721381611000_68.Suppl_3.s1.578","doi-asserted-by":"publisher","DOI":"10.1007\/s10350-004-6611-4"},{"key":"2020050721381611000_68.Suppl_3.s1.579","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1318.2004.00749.x"},{"key":"2020050721381611000_68.Suppl_3.s1.580","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12906"},{"key":"2020050721381611000_68.Suppl_3.s1.581","doi-asserted-by":"publisher","DOI":"10.1007\/s10350-006-0656-5"},{"key":"2020050721381611000_68.Suppl_3.s1.582","first-page":"3","article-title":"Clinical advantages of combined seton placement and infliximab maintenance therapy for perianal fistulizing Crohn\u2019s disease: When and how were the seton drains removed?","volume":"57","author":"Tanaka","year":"2010","journal-title":"Hepatogastroenterology"},{"key":"2020050721381611000_68.Suppl_3.s1.583","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/codi.13311","article-title":"Treatment of perianal fistula in Crohn\u2019s disease: a systematic review and meta-analysis comparing seton drainage and anti-tumour necrosis factor treatment","volume":"18","author":"de Groof","year":"2016","journal-title":"Colorectal Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.584","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-015-0831-x"},{"key":"2020050721381611000_68.Suppl_3.s1.585","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199905063401804"},{"key":"2020050721381611000_68.Suppl_3.s1.586","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/apt.13970","article-title":"Higher infliximab trough levels are associated with perianal fistula healing in patients with Crohn\u2019s disease","volume":"45","author":"Yarur","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"2020050721381611000_68.Suppl_3.s1.587","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2008.159251"},{"key":"2020050721381611000_68.Suppl_3.s1.588","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-304488"},{"key":"2020050721381611000_68.Suppl_3.s1.589","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31203-X"},{"key":"2020050721381611000_68.Suppl_3.s1.590","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/apt.14814","article-title":"Review article: pathogenesis of Crohn\u2019s perianal fistula-understanding factors impacting on success and failure of treatment strategies","volume":"48","author":"Tozer","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"2020050721381611000_68.Suppl_3.s1.591","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1016\/S0016-5085(17)30930-7","article-title":"Fistula healing in pivotal studies of ustekinumab in Crohn\u2019s disease","volume":"152","author":"Sands","year":"2017","journal-title":"Gastroenterology"},{"issue":"Suppl","key":"2020050721381611000_68.Suppl_3.s1.592","doi-asserted-by":"crossref","first-page":"S361","DOI":"10.14309\/00000434-201710001-00651","article-title":"Real-life data on the use of ustekinumab for the treatment of fistulas in patients with Crohn\u02bcs\u00a0disease","volume":"112","author":"Tsistrakis","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.593","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/codi.13462","article-title":"Surgical management of fistulating perianal Crohn\u2019s disease: a UK survey","volume":"19","author":"Lee","year":"2017","journal-title":"Colorectal Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.594","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000000479"},{"key":"2020050721381611000_68.Suppl_3.s1.595","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-005-0072-7"},{"key":"2020050721381611000_68.Suppl_3.s1.596","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10151-012-0921-7","article-title":"Video-assisted anal fistula treatment (VAAFT) combined with advancement flap repair in Crohn\u2019s disease","volume":"17","author":"Schwandner","year":"2013","journal-title":"Tech Coloproctol"},{"key":"2020050721381611000_68.Suppl_3.s1.597","doi-asserted-by":"publisher","DOI":"10.1097\/DCR.0b013e318239d1e4"},{"key":"2020050721381611000_68.Suppl_3.s1.598","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.02.013"},{"key":"2020050721381611000_68.Suppl_3.s1.599","doi-asserted-by":"publisher","DOI":"10.1007\/DCR.0b013e3181973487"},{"key":"2020050721381611000_68.Suppl_3.s1.600","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-012-1581-9"},{"key":"2020050721381611000_68.Suppl_3.s1.601","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1053\/j.gastro.2017.12.020","article-title":"Long-term efficacy and safety of stem cell therapy (cx601) for complex perianal fistulas in patients with crohn\u2019s disease","volume":"154","author":"Pan\u00e9s","year":"2018","journal-title":"Gastroenterology"},{"key":"2020050721381611000_68.Suppl_3.s1.602","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/DCR.0000000000001093","article-title":"A systematic review and meta-analysis of mesenchymal stem cell injections for the treatment of perianal crohn\u2019s disease: Progress made and future directions","volume":"61","author":"Lightner","year":"2018","journal-title":"Dis Colon Rectum"},{"key":"2020050721381611000_68.Suppl_3.s1.603","doi-asserted-by":"publisher","DOI":"10.1136\/gut.26.3.279"},{"key":"2020050721381611000_68.Suppl_3.s1.604","doi-asserted-by":"publisher","DOI":"10.1007\/s002680010250"},{"key":"2020050721381611000_68.Suppl_3.s1.605","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1177\/000313480907500814","article-title":"Fecal diversion in perirectal fistulizing Crohn\u2019s disease is an underutilized and potentially temporary means of successful treatment","volume":"75","author":"Rehg","year":"2009","journal-title":"Am Surg"},{"key":"2020050721381611000_68.Suppl_3.s1.606","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2168.2000.01467.x"},{"key":"2020050721381611000_68.Suppl_3.s1.607","doi-asserted-by":"crossref","first-page":"O119","DOI":"10.1111\/codi.13286","article-title":"Systematic review of evidence and consensus on perianal fistula: an analysis of national and international guidelines","volume":"18","author":"de Groof","year":"2016","journal-title":"Colorectal Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.608","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1007\/s10620-017-4618-7","article-title":"The use of temporary fecal diversion in colonic and perianal crohn\u2019s disease does not improve outcomes","volume":"62","author":"Bafford","year":"2017","journal-title":"Dig Dis Sci"},{"key":"2020050721381611000_68.Suppl_3.s1.609","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000216"},{"key":"2020050721381611000_68.Suppl_3.s1.610","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13356"},{"key":"2020050721381611000_68.Suppl_3.s1.611","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-008-1034-6"},{"key":"2020050721381611000_68.Suppl_3.s1.612","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2009.12.010"},{"key":"2020050721381611000_68.Suppl_3.s1.613","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20469"},{"key":"2020050721381611000_68.Suppl_3.s1.614","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20199"},{"key":"2020050721381611000_68.Suppl_3.s1.615","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20948"},{"key":"2020050721381611000_68.Suppl_3.s1.616","doi-asserted-by":"crossref","first-page":"e434","DOI":"10.1016\/j.ejrad.2013.04.033","article-title":"Crohn\u2019s disease recurrence in patients with ileocolic anastomosis: value of computed tomography enterography with water enema","volume":"82","author":"Paparo","year":"2013","journal-title":"Eur J Radiol"},{"key":"2020050721381611000_68.Suppl_3.s1.617","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.09091165"},{"key":"2020050721381611000_68.Suppl_3.s1.618","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.6593"},{"key":"2020050721381611000_68.Suppl_3.s1.619","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.01.026"},{"key":"2020050721381611000_68.Suppl_3.s1.620","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2015.30"},{"key":"2020050721381611000_68.Suppl_3.s1.621","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S2468-1253(16)30078-4","article-title":"Mercaptopurine versus placebo to prevent recurrence of Crohn\u2019s disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial","volume":"1","author":"Mowat","year":"2016","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2020050721381611000_68.Suppl_3.s1.622","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/apt.13570","article-title":"Review article: bile acid diarrhoea - pathogenesis, diagnosis and management","volume":"43","author":"Mottacki","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"2020050721381611000_68.Suppl_3.s1.623","doi-asserted-by":"publisher","DOI":"10.1136\/gut.35.1.90"},{"key":"2020050721381611000_68.Suppl_3.s1.624","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2011.574728"},{"key":"2020050721381611000_68.Suppl_3.s1.625","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2012.01953.x"},{"key":"2020050721381611000_68.Suppl_3.s1.626","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.290.6478.1315"},{"key":"2020050721381611000_68.Suppl_3.s1.627","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/BF02285463","article-title":"Effect of loperamide and delay of bowel motility on bile acid malabsorption caused by late radiation damage and ileal resection","volume":"18","author":"Vald\u00e9s Olmos","year":"1991","journal-title":"Eur J Nucl Med"},{"key":"2020050721381611000_68.Suppl_3.s1.628","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/MOG.0000000000000344","article-title":"Bile acid disease: the emerging epidemic","volume":"33","author":"Oduyebo","year":"2017","journal-title":"Curr Opin Gastroenterol"},{"issue":"Suppl 1","key":"2020050721381611000_68.Suppl_3.s1.629","doi-asserted-by":"crossref","first-page":"A130.1","DOI":"10.1136\/gutjnl-2013-304907.288","article-title":"PTU-198\u2005Serum FGF19 Levels are Related to Disease Activity in Ileal Crohn\u2019S Disease","volume":"62","author":"Nolan","year":"2013","journal-title":"Gut"},{"key":"2020050721381611000_68.Suppl_3.s1.630","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12466"},{"key":"2020050721381611000_68.Suppl_3.s1.631","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/701287"},{"key":"2020050721381611000_68.Suppl_3.s1.632","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-9-61"},{"key":"2020050721381611000_68.Suppl_3.s1.633","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-200007000-00015"},{"key":"2020050721381611000_68.Suppl_3.s1.634","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v16.i24.2978"},{"key":"2020050721381611000_68.Suppl_3.s1.635","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12479"},{"key":"2020050721381611000_68.Suppl_3.s1.636","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02314.x"},{"key":"2020050721381611000_68.Suppl_3.s1.637","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-008-0542-9"},{"key":"2020050721381611000_68.Suppl_3.s1.638","doi-asserted-by":"publisher","DOI":"10.1136\/gut.25.6.665"},{"key":"2020050721381611000_68.Suppl_3.s1.639","doi-asserted-by":"publisher","DOI":"10.1136\/gut.33.3.331"},{"key":"2020050721381611000_68.Suppl_3.s1.640","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61908-5"},{"key":"2020050721381611000_68.Suppl_3.s1.641","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2014.02.010"},{"key":"2020050721381611000_68.Suppl_3.s1.642","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1018188"},{"key":"2020050721381611000_68.Suppl_3.s1.643","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03774.x"},{"key":"2020050721381611000_68.Suppl_3.s1.644","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2012.05002.x"},{"key":"2020050721381611000_68.Suppl_3.s1.645","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4240\/wjgs.v9.i7.167","article-title":"Analysis of risk factors - especially different types of plexitis - for postoperative relapse in Crohn\u2019s disease","volume":"9","author":"Milassin","year":"2017","journal-title":"World J Gastrointest Surg"},{"key":"2020050721381611000_68.Suppl_3.s1.646","doi-asserted-by":"publisher","DOI":"10.1007\/DCR.0b013e3181b7bfb0"},{"key":"2020050721381611000_68.Suppl_3.s1.647","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.dld.2016.01.009","article-title":"Post-operative recurrence of Crohn\u2019s disease: A prospective study at 5 years","volume":"48","author":"Onali","year":"2016","journal-title":"Dig Liver Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.648","first-page":"CD010233","article-title":"Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn\u2019s disease","volume":"8","author":"Gordon","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2020050721381611000_68.Suppl_3.s1.649","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.10.051"},{"key":"2020050721381611000_68.Suppl_3.s1.650","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21928"},{"key":"2020050721381611000_68.Suppl_3.s1.651","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.167.16.1804"},{"key":"2020050721381611000_68.Suppl_3.s1.652","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2010.01.016"},{"key":"2020050721381611000_68.Suppl_3.s1.653","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1053\/j.gastro.2016.02.072","article-title":"Infliximab reduces endoscopic, but not clinical, recurrence of Crohn\u2019s disease after ileocolonic resection","volume":"150","author":"Regueiro","year":"2016","journal-title":"Gastroenterology"},{"key":"2020050721381611000_68.Suppl_3.s1.654","first-page":"281","article-title":"Previous exposure to multiple anti-TNF is associated with decreased efficiency in preventing postoperative Crohn\u2019s disease recurrence","volume":"11","author":"Collins","year":"2017","journal-title":"J Crohns Colitis"},{"key":"2020050721381611000_68.Suppl_3.s1.655","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2013.287"},{"key":"2020050721381611000_68.Suppl_3.s1.656","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.09.031"},{"key":"2020050721381611000_68.Suppl_3.s1.657","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3748\/wjg.v19.i5.648","article-title":"Use of antibiotics in the treatment of Crohn\u2019s disease","volume":"19","author":"Scribano","year":"2013","journal-title":"World J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.658","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)90121-3"},{"key":"2020050721381611000_68.Suppl_3.s1.659","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.01.010"},{"key":"2020050721381611000_68.Suppl_3.s1.660","doi-asserted-by":"publisher","DOI":"10.1097\/01.MIB.0000428910.36091.10"},{"key":"2020050721381611000_68.Suppl_3.s1.661","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1159\/000358141","article-title":"Is rifaximin effective in maintaining remission in Crohn\u2019s disease?","volume":"32","author":"Jigaranu","year":"2014","journal-title":"Dig Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.662","doi-asserted-by":"crossref","unstructured":"Doherty G , Bennett G , Patil S , et al . Interventions for prevention of post-operative recurrence of Crohn\u2019s disease. Cochrane Database Syst Rev 2009:CD006873.doi:10.1002\/14651858.CD006873.pub2","DOI":"10.1002\/14651858.CD006873.pub2"},{"key":"2020050721381611000_68.Suppl_3.s1.663","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i5.1147"},{"key":"2020050721381611000_68.Suppl_3.s1.664","doi-asserted-by":"publisher","DOI":"10.1159\/000335431"},{"key":"2020050721381611000_68.Suppl_3.s1.665","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.585"},{"key":"2020050721381611000_68.Suppl_3.s1.666","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2005.032383"},{"key":"2020050721381611000_68.Suppl_3.s1.667","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1097\/MIB.0000000000001162","article-title":"Development and validation of a novel prediction model for differential diagnosis between Crohn\u2019s disease and intestinal tuberculosis","volume":"23","author":"Bae","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.668","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05686.x"},{"key":"2020050721381611000_68.Suppl_3.s1.669","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2010.04548.x"},{"key":"2020050721381611000_68.Suppl_3.s1.670","doi-asserted-by":"publisher","DOI":"10.1097\/01.meg.0000131040.38607.09"},{"key":"2020050721381611000_68.Suppl_3.s1.671","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.cgh.2017.10.008","article-title":"Non-Clostridium difficile bacterial infections are rare in patients with flares of inflammatory bowel disease","volume":"16","author":"Hanada","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2020050721381611000_68.Suppl_3.s1.672","doi-asserted-by":"publisher","DOI":"10.1038\/s41395-018-0211-8"},{"key":"2020050721381611000_68.Suppl_3.s1.673","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000219"},{"key":"2020050721381611000_68.Suppl_3.s1.674","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0b013e318297d222"},{"key":"2020050721381611000_68.Suppl_3.s1.675","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1097\/MIB.0000000000000205","article-title":"Risk factors and management of refractory or recurrent clostridium difficile infection in ileal pouch patients","volume":"20","author":"Seril","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.676","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-009-0749-9"},{"key":"2020050721381611000_68.Suppl_3.s1.677","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2007.128231"},{"key":"2020050721381611000_68.Suppl_3.s1.678","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21457"},{"key":"2020050721381611000_68.Suppl_3.s1.679","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/apt.13972","article-title":"Systematic review with meta-analysis: the impact of Clostridium difficile infection on the short- and long-term risks of colectomy in inflammatory bowel disease","volume":"45","author":"Law","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"2020050721381611000_68.Suppl_3.s1.680","doi-asserted-by":"publisher","DOI":"10.1086\/519265"},{"key":"2020050721381611000_68.Suppl_3.s1.681","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.cgh.2016.10.024","article-title":"Management of Clostridium difficile infection in inflammatory bowel disease: expert review from the Clinical Practice Updates Committee of the AGA Institute","volume":"15","author":"Khanna","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2020050721381611000_68.Suppl_3.s1.682","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/MIB.0000000000001073","article-title":"Diagnostic accuracy of blood-based tests and histopathology for cytomegalovirus reactivation in inflammatory bowel disease: a systematic review and meta-analysis","volume":"23","author":"Tandon","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.683","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2014.05.026"},{"key":"2020050721381611000_68.Suppl_3.s1.684","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2005.01.011"},{"key":"2020050721381611000_68.Suppl_3.s1.685","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20498"},{"key":"2020050721381611000_68.Suppl_3.s1.686","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2147\/IDR.S149784","article-title":"Is cytomegalovirus infection related to inflammatory bowel disease, especially steroid-resistant inflammatory bowel disease? A meta-analysis","volume":"10","author":"Lv","year":"2017","journal-title":"Infect Drug Resist"},{"key":"2020050721381611000_68.Suppl_3.s1.687","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000000361"},{"key":"2020050721381611000_68.Suppl_3.s1.688","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2013.12.014"},{"key":"2020050721381611000_68.Suppl_3.s1.689","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20253"},{"key":"2020050721381611000_68.Suppl_3.s1.690","doi-asserted-by":"crossref","first-page":"4813","DOI":"10.3748\/wjg.v12.i30.4813","article-title":"Cytomegalovirus and inflammatory bowel disease: is there a link?","volume":"12","author":"Criscuoli","year":"2006","journal-title":"World J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.691","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.01013.x"},{"key":"2020050721381611000_68.Suppl_3.s1.692","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200305000-00002"},{"key":"2020050721381611000_68.Suppl_3.s1.693","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.3748\/wjg.v22.i3.1321","article-title":"Cytomegalovirus in inflammatory bowel disease: A systematic review","volume":"22","author":"R\u00f6mkens","year":"2016","journal-title":"World J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.694","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00989.x"},{"key":"2020050721381611000_68.Suppl_3.s1.695","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e3182160c9c"},{"key":"2020050721381611000_68.Suppl_3.s1.696","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.202"},{"key":"2020050721381611000_68.Suppl_3.s1.697","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/MIB.0000000000001160","article-title":"Impact of infliximab and cyclosporine on the risk of colectomy in hospitalized patients with ulcerative colitis complicated by cytomegalovirus: a multicenter retrospective study","volume":"23","author":"Kopylov","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.698","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2014.09.042"},{"key":"2020050721381611000_68.Suppl_3.s1.699","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13124"},{"key":"2020050721381611000_68.Suppl_3.s1.700","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2013.12.013"},{"key":"2020050721381611000_68.Suppl_3.s1.701","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/MEG.0000000000001025","article-title":"Patients' beliefs about medicine are associated with early thiopurine discontinuation in patients with inflammatory bowel diseases","volume":"30","author":"Broekman","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2020050721381611000_68.Suppl_3.s1.702","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/apt.13831","article-title":"The relationship between different information sources and disease-related patient knowledge and anxiety in patients with inflammatory bowel disease","volume":"45","author":"Selinger","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"2020050721381611000_68.Suppl_3.s1.703","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21147"},{"key":"2020050721381611000_68.Suppl_3.s1.704","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.dld.2014.07.006","article-title":"Screening prior to biological therapy in Crohn\u2019s disease: adherence to guidelines and prevalence of infections. Results from a multicentre retrospective study","volume":"46","author":"van der Have","year":"2014","journal-title":"Dig Liver Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.705","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/apt.14933","article-title":"Impact of Epstein-Barr virus serological status on clinical outcomes in adult patients with inflammatory bowel disease","volume":"48","author":"de Francisco","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"2020050721381611000_68.Suppl_3.s1.706","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1053\/j.gastro.2017.02.004","article-title":"Infliximab is not associated with increased risk of malignancy or hemophagocytic lymphohistiocytosis in pediatric patients with inflammatory bowel disease","volume":"152","author":"Hyams","year":"2017","journal-title":"Gastroenterology"},{"key":"2020050721381611000_68.Suppl_3.s1.707","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1053\/j.gastro.2017.04.055","article-title":"The usefulness of serologic testing for Epstein-Barr virus before initiation of therapy for inflammatory bowel disease","volume":"153","author":"Barnes","year":"2017","journal-title":"Gastroenterology"},{"key":"2020050721381611000_68.Suppl_3.s1.708","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2013.138"},{"key":"2020050721381611000_68.Suppl_3.s1.709","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1038\/ajg.2016.433","article-title":"Crohn\u2019s disease activity and concomitant immunosuppressants affect the risk of serious and opportunistic infections in patients treated with adalimumab","volume":"111","author":"Osterman","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.710","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-012-0686-9"},{"key":"2020050721381611000_68.Suppl_3.s1.711","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.01.012"},{"key":"2020050721381611000_68.Suppl_3.s1.712","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-3565(04)00060-6"},{"key":"2020050721381611000_68.Suppl_3.s1.713","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21329"},{"key":"2020050721381611000_68.Suppl_3.s1.714","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2012.08.010"},{"key":"2020050721381611000_68.Suppl_3.s1.715","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2005.046797"},{"key":"2020050721381611000_68.Suppl_3.s1.716","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3109\/00365521.2014.1000960","article-title":"Risks for opportunistic tuberculosis infection in a cohort of 873 patients with inflammatory bowel disease receiving a tumor necrosis factor-\u03b1 inhibitor","volume":"50","author":"Byun","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.717","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-013-2820-9"},{"key":"2020050721381611000_68.Suppl_3.s1.718","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002288"},{"key":"2020050721381611000_68.Suppl_3.s1.719","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.17.1.208-217.2004"},{"key":"2020050721381611000_68.Suppl_3.s1.720","doi-asserted-by":"crossref","first-page":"749","DOI":"10.4269\/ajtmh.2002.66.749","article-title":"Serology and eosinophil count in the diagnosis and management of strongyloidiasis in a non-endemic area","volume":"66","author":"Loutfy","year":"2002","journal-title":"Am J Trop Med Hyg"},{"key":"2020050721381611000_68.Suppl_3.s1.721","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/ibd\/izy243","article-title":"Increased risk of influenza and influenza-related complications among 140,480 patients with inflammatory bowel disease","volume":"25","author":"Tinsley","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.722","unstructured":"Department of Health. Influenza: The Green Book, Chapter 19. 2018. https:\/\/www.gov.uk\/government\/publications\/influenza-the-green-book-chapter-19 (Accessed 7 Feb 2019)."},{"key":"2020050721381611000_68.Suppl_3.s1.723","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/MIB.0000000000000615","article-title":"Immunogenicity of influenza vaccine for patients with inflammatory bowel disease on maintenance infliximab therapy: a randomized trial","volume":"22","author":"deBruyn","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.724","unstructured":"Department of Health. Hepatitis B: The Green Book, Chapter 18. July 2017 https:\/\/www.gov.uk\/government\/publications\/hepatitis-b-the-green-book-chapter-18 (Accessed 14 Dec 2018)."},{"key":"2020050721381611000_68.Suppl_3.s1.725","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/MEG.0000000000000370","article-title":"Impact of immunosuppressive therapy on hepatitis B vaccination in inflammatory bowel diseases","volume":"27","author":"Belle","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2020050721381611000_68.Suppl_3.s1.726","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1111\/jgh.13001","article-title":"Treatment with infliximab or azathioprine negatively impact the efficacy of hepatitis B vaccine in inflammatory bowel disease patients","volume":"30","author":"Andrade","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"2020050721381611000_68.Suppl_3.s1.727","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-011-1980-8"},{"key":"2020050721381611000_68.Suppl_3.s1.728","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2012.05110.x"},{"key":"2020050721381611000_68.Suppl_3.s1.729","unstructured":"Department of Health. Pneumococcal: The Green Book, Chapter 25. January 2018 https:\/\/www.gov.uk\/government\/publications\/pneumococcal-the-green-book-chapter-25 (Accessed 14 Dec 2018)."},{"key":"2020050721381611000_68.Suppl_3.s1.730","unstructured":"Department of Health. Contraindications and special considerations: The Green Book, Chapter 6. October 2017 https:\/\/www.gov.uk\/government\/publications\/contraindications-and-special-considerations-the-green-book-chapter-6 (Accessed 14 Dec 2018)."},{"key":"2020050721381611000_68.Suppl_3.s1.731","first-page":"540","article-title":"Vaccinating patients with inflammatory bowel disease","volume":"12","author":"Reich","year":"2016","journal-title":"Gastroenterol Hepatol"},{"key":"2020050721381611000_68.Suppl_3.s1.732","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.3748\/wjg.v21.i11.3184","article-title":"Updates in vaccination: recommendations for adult inflammatory bowel disease patients","volume":"21","author":"Chaudrey","year":"2015","journal-title":"World J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.733","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq183"},{"key":"2020050721381611000_68.Suppl_3.s1.734","first-page":"e44","article-title":"IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"2014","author":"Rubin","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.735","unstructured":"Department of Health. Shingles (herpes zoster): The Green Book, Chapter 28A. 2016. https:\/\/www.gov.uk\/government\/publications\/shingles-herpes-zoster-the-green-book-chapter-28a (Accessed 10 Jan 2019)."},{"key":"2020050721381611000_68.Suppl_3.s1.736","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1097\/MIB.0000000000000743","article-title":"Herpes zoster vaccine response in inflammatory bowel disease patients on low-dose immunosuppression","volume":"22","author":"Wasan","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.737","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.06.002"},{"key":"2020050721381611000_68.Suppl_3.s1.738","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03788.x"},{"key":"2020050721381611000_68.Suppl_3.s1.739","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.02124.x"},{"key":"2020050721381611000_68.Suppl_3.s1.740","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200624080-00004"},{"key":"2020050721381611000_68.Suppl_3.s1.741","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3060"},{"key":"2020050721381611000_68.Suppl_3.s1.742","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/cpt.1304","article-title":"Clinical Pharmacogenetics Implementation Consortium guideline for thiopurine dosing based on TPMT and NUDT15 genotypes: 2018 update","volume":"105","author":"Relling","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"2020050721381611000_68.Suppl_3.s1.743","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20345"},{"key":"2020050721381611000_68.Suppl_3.s1.744","unstructured":"Aronoff GR , Bennett WB , Berns JS , et al . Drug Prescribing in Renal Failure: Dosing Guidelines for Adults and Children: American College of Physicians. 2007."},{"key":"2020050721381611000_68.Suppl_3.s1.745","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2014.07.036"},{"key":"2020050721381611000_68.Suppl_3.s1.746","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204993"},{"key":"2020050721381611000_68.Suppl_3.s1.747","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.10.021"},{"key":"2020050721381611000_68.Suppl_3.s1.748","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20959"},{"key":"2020050721381611000_68.Suppl_3.s1.749","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01582.x"},{"key":"2020050721381611000_68.Suppl_3.s1.750","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000338"},{"key":"2020050721381611000_68.Suppl_3.s1.751","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.12039"},{"key":"2020050721381611000_68.Suppl_3.s1.752","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21458"},{"key":"2020050721381611000_68.Suppl_3.s1.753","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.41900.x"},{"key":"2020050721381611000_68.Suppl_3.s1.754","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.032896"},{"key":"2020050721381611000_68.Suppl_3.s1.755","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)70140-5"},{"key":"2020050721381611000_68.Suppl_3.s1.756","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2007.086215"},{"key":"2020050721381611000_68.Suppl_3.s1.757","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04756.x"},{"key":"2020050721381611000_68.Suppl_3.s1.758","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12555"},{"key":"2020050721381611000_68.Suppl_3.s1.759","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2014.12.026"},{"key":"2020050721381611000_68.Suppl_3.s1.760","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/apt.14106","article-title":"Azathioprine dose reduction in inflammatory bowel disease patients on combination therapy: an open-label, prospective and randomised clinical trial","volume":"46","author":"Roblin","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"2020050721381611000_68.Suppl_3.s1.761","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.32420"},{"key":"2020050721381611000_68.Suppl_3.s1.762","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2013.06.002"},{"key":"2020050721381611000_68.Suppl_3.s1.763","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/apt.14571","article-title":"Randomised clinical trial: efficacy, safety and dosage of adjunctive allopurinol in azathioprine\/mercaptopurine nonresponders (AAA Study)","volume":"47","author":"Friedman","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"2020050721381611000_68.Suppl_3.s1.764","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200406000-00016"},{"key":"2020050721381611000_68.Suppl_3.s1.765","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1080\/00365521.2016.1216589","article-title":"Randomized clinical trial: a pilot study comparing efficacy of low-dose azathioprine and allopurinol to azathioprine on clinical outcomes in inflammatory bowel disease","volume":"51","author":"Kiszka-Kanowitz","year":"2016","journal-title":"Scand J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.766","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2012.02.007"},{"key":"2020050721381611000_68.Suppl_3.s1.767","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03782.x"},{"key":"2020050721381611000_68.Suppl_3.s1.768","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.04221.x"},{"key":"2020050721381611000_68.Suppl_3.s1.769","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.dld.2018.02.001","article-title":"Low-dose thiopurine with allopurinol co-therapy overcomes thiopurine intolerance and allows thiopurine continuation in inflammatory bowel disease","volume":"50","author":"Vasudevan","year":"2018","journal-title":"Dig Liver Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.770","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.11.020"},{"key":"2020050721381611000_68.Suppl_3.s1.771","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2009.02.003"},{"key":"2020050721381611000_68.Suppl_3.s1.772","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/apt.14571","article-title":"Randomised clinical trial: efficacy, safety and dosage of adjunctive allopurinol in azathioprine\/mercaptopurine nonresponders (AAA Study)","volume":"47","author":"Friedman","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"2020050721381611000_68.Suppl_3.s1.773","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)70354-4"},{"key":"2020050721381611000_68.Suppl_3.s1.774","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2009.07.019"},{"key":"2020050721381611000_68.Suppl_3.s1.775","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2008.01848.x"},{"key":"2020050721381611000_68.Suppl_3.s1.776","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0b013e318281f28f"},{"key":"2020050721381611000_68.Suppl_3.s1.777","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3093"},{"key":"2020050721381611000_68.Suppl_3.s1.778","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12511"},{"key":"2020050721381611000_68.Suppl_3.s1.779","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh088"},{"key":"2020050721381611000_68.Suppl_3.s1.780","first-page":"36","article-title":"The efficacy of folic acid and folinic acid in reducing methotrexate gastrointestinal toxicity in rheumatoid arthritis. A metaanalysis of randomized controlled trials","volume":"25","author":"Ortiz","year":"1998","journal-title":"J Rheumatol"},{"key":"2020050721381611000_68.Suppl_3.s1.781","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/MIB.0000000000000589","article-title":"Use of methotrexate in the treatment of inflammatory bowel diseases","volume":"22","author":"Herfarth","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.782","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e3283556db5"},{"key":"2020050721381611000_68.Suppl_3.s1.783","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/ajg.2010.21","article-title":"Changes in liver biochemistry during methotrexate use for inflammatory bowel disease","volume":"105","author":"Fournier","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.784","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.jhep.2010.04.043","article-title":"Assessment of liver fibrosis with transient elastography and FibroTest in patients treated with methotrexate for chronic inflammatory diseases: a case-control study","volume":"53","author":"Laharie","year":"2010","journal-title":"J Hepatol"},{"key":"2020050721381611000_68.Suppl_3.s1.785","doi-asserted-by":"publisher","DOI":"10.1186\/ar1957"},{"issue":"Suppl 2","key":"2020050721381611000_68.Suppl_3.s1.786","doi-asserted-by":"crossref","first-page":"415.2","DOI":"10.1136\/annrheumdis-2014-eular.4289","article-title":"A systematic analysis of the safety of prescribing of anti-rheumatic, immunosuppressive and biologic drugs in men trying to conceive","volume":"73","author":"Panchal","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.787","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket390"},{"key":"2020050721381611000_68.Suppl_3.s1.788","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.reprotox.2017.10.004","article-title":"Birth outcomes after preconception paternal exposure to methotrexate: A nationwide cohort study","volume":"74","author":"Winter","year":"2017","journal-title":"Reprod Toxicol"},{"key":"2020050721381611000_68.Suppl_3.s1.789","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12749"},{"key":"2020050721381611000_68.Suppl_3.s1.790","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1111\/apt.14030","article-title":"Systematic review with meta-analysis: comparative efficacy of biologics for induction and maintenance of mucosal healing in Crohn\u2019s disease and ulcerative colitis controlled trials","volume":"45","author":"Cholapranee","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"2020050721381611000_68.Suppl_3.s1.791","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/apt.13847","article-title":"Systematic review with meta-analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn\u2019s disease and ulcerative colitis","volume":"45","author":"Mao","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"2020050721381611000_68.Suppl_3.s1.792","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.pharep.2016.07.013","article-title":"Safety profile of biologic drugs in the therapy of Crohn disease: A systematic review and network meta-analysis","volume":"68","author":"Mo\u0107ko","year":"2016","journal-title":"Pharmacol Rep"},{"key":"2020050721381611000_68.Suppl_3.s1.793","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.cgh.2015.02.017","article-title":"Effectiveness and safety of immunomodulators with anti-tumor necrosis factor therapy in Crohn\u2019s disease","volume":"13","author":"Osterman","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2020050721381611000_68.Suppl_3.s1.794","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.cgh.2016.03.038","article-title":"Comparative effectiveness and safety of anti\u2013tumor necrosis\u00a0factor agents in biologic-naive patients with Crohn\u2019s disease","volume":"14","author":"Singh","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2020050721381611000_68.Suppl_3.s1.795","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.cgh.2016.11.024","article-title":"Comparison of infliximab and adalimumab in biologic-naive patients with ulcerative colitis: a nationwide Danish cohort\u00a0study","volume":"15","author":"Singh","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2020050721381611000_68.Suppl_3.s1.796","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-300755"},{"key":"2020050721381611000_68.Suppl_3.s1.797","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1002\/ibd.21888","article-title":"Systematic assessment of factors influencing preferences of Crohn\u2019s disease patients in selecting an anti-tumor necrosis factor agent (CHOOSE TNF TRIAL)","volume":"18","author":"Vavricka","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.798","first-page":"391","article-title":"Factors contributing to the preference of Korean patients with Crohn\u2019s disease when selecting an anti-tumor necrosis factor agent (CHOICE Study)","volume":"10","author":"Kim","year":"2016","journal-title":"Gut Liver"},{"key":"2020050721381611000_68.Suppl_3.s1.799","unstructured":"European Medicines Agency. Biosimilars in the EU: Information guide for healthcare professionals. 2017. https:\/\/www.ema.europa.eu\/documents\/leaflet\/biosimilars-eu-information-guide-healthcare-professionals_en.pdf [Accessed 14 Dec 2018]."},{"key":"2020050721381611000_68.Suppl_3.s1.800","unstructured":"Association of the British Pharmaceutical Industry. ABPI position on biologic medicines, including biosimilar medicines. 2015. https:\/\/www.abpi.org.uk\/media\/4568\/abpi-position-on-biosimilar-medicines.pdf [Accessed 14 Dec 2018]."},{"key":"2020050721381611000_68.Suppl_3.s1.801","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11926-017-0658-4","article-title":"Switching between reference biologics and biosimilars for the treatment of rheumatology, gastroenterology, and dermatology inflammatory conditions: considerations for the clinician","volume":"19","author":"Moots","year":"2017","journal-title":"Curr Rheumatol Rep"},{"key":"2020050721381611000_68.Suppl_3.s1.802","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw198"},{"key":"2020050721381611000_68.Suppl_3.s1.803","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1016\/S0140-6736(17)30068-5","article-title":"Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial","volume":"389","author":"J\u00f8rgensen","year":"2017","journal-title":"Lancet"},{"key":"2020050721381611000_68.Suppl_3.s1.804","first-page":"297","article-title":"Switching from Remicade\u00ae to Remsima\u00ae is well tolerated and feasible: a prospective, open-label study","volume":"11","author":"Buer","year":"2017","journal-title":"J Crohns Colitis"},{"key":"2020050721381611000_68.Suppl_3.s1.805","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw087"},{"key":"2020050721381611000_68.Suppl_3.s1.806","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jaad.2016.04.068","article-title":"The infliximab biosimilar in the treatment of moderate to severe plaque psoriasis","volume":"75","author":"Dapavo","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"2020050721381611000_68.Suppl_3.s1.807","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208783"},{"key":"2020050721381611000_68.Suppl_3.s1.808","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208786"},{"key":"2020050721381611000_68.Suppl_3.s1.809","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210742"},{"key":"2020050721381611000_68.Suppl_3.s1.810","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1053\/j.gastro.2018.01.004","article-title":"Increasing infliximab dose based on symptoms, biomarkers, and serum drug concentrations does not increase clinical, endoscopic, and corticosteroid-free remission in patients with\u00a0active luminal Crohn\u2019s disease","volume":"154","author":"D\u2019Haens","year":"2018","journal-title":"Gastroenterology"},{"key":"2020050721381611000_68.Suppl_3.s1.811","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1097\/MIB.0000000000001231","article-title":"Therapeutic drug monitoring during\u00a0induction of anti-tumor necrosis factor therapy in inflammatory bowel disease: defining a therapeutic drug window","volume":"23","author":"Papamichael","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.812","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13445"},{"key":"2020050721381611000_68.Suppl_3.s1.813","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/ajg.2017.21","article-title":"Therapeutic drug monitoring in IBD: the new standard-of-care for anti-TNF therapy","volume":"112","author":"Papamichael","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.814","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000380"},{"key":"2020050721381611000_68.Suppl_3.s1.815","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MIB.0000000000000312","article-title":"Biologic concentration testing in inflammatory bowel disease","volume":"21","author":"Vaughn","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.816","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.02.031"},{"key":"2020050721381611000_68.Suppl_3.s1.817","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2013.07.010"},{"key":"2020050721381611000_68.Suppl_3.s1.818","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-305279"},{"key":"2020050721381611000_68.Suppl_3.s1.819","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2014.07.029"},{"key":"2020050721381611000_68.Suppl_3.s1.820","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2012.12.035"},{"key":"2020050721381611000_68.Suppl_3.s1.821","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0b013e3182a77b41"},{"key":"2020050721381611000_68.Suppl_3.s1.822","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2010.04523.x"},{"key":"2020050721381611000_68.Suppl_3.s1.823","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.22902"},{"key":"2020050721381611000_68.Suppl_3.s1.824","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2013.12"},{"key":"2020050721381611000_68.Suppl_3.s1.825","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-313071"},{"key":"2020050721381611000_68.Suppl_3.s1.826","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2012.10.020"},{"key":"2020050721381611000_68.Suppl_3.s1.827","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.112847"},{"key":"2020050721381611000_68.Suppl_3.s1.828","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000449085","article-title":"Combining therapeutic drug monitoring with biosimilars, a strategy to improve the efficacy of biologicals for treating inflammatory bowel diseases at an affordable cost","volume":"35","author":"Gils","year":"2017","journal-title":"Dig Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.829","unstructured":"National Institute for Health and Care Excellence. Technology appraisal guidance [TA456] Ustekinumab for moderately to severely active Crohn\u2019s disease after previous treatment. https:\/\/www.nice.org.uk\/guidance\/ta456 [Accessed 17 Jan 2019]."},{"key":"2020050721381611000_68.Suppl_3.s1.830","unstructured":"National Institute for Health and Care Excellence. Technology appraisal guidance [TA187] Infliximab and adalimumab for the treatment of Crohn\u2019s disease. 2010. https:\/\/www.nice.org.uk\/guidance\/ta187 [Accessed 15 Dec 2018]."},{"key":"2020050721381611000_68.Suppl_3.s1.831","unstructured":"National Institute for Health and Care Excellence. Technology appraisal guidance [TA342] Vedolizumab for treating moderately to severely active ulcerative colitis. 2015. https:\/\/www.nice.org.uk\/guidance\/ta342 [Accessed 15 Dec 2018]."},{"key":"2020050721381611000_68.Suppl_3.s1.832","unstructured":"National Institute for Health and Care Excellence. Technology appraisal guidance [TA352] Vedolizumab for treating moderately to severely active Crohn\u2019s disease after prior therapy. https:\/\/www.nice.org.uk\/guidance\/ta352 [Accessed 17 Jan 2019]."},{"key":"2020050721381611000_68.Suppl_3.s1.833","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i20.6352"},{"key":"2020050721381611000_68.Suppl_3.s1.834","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/apt.13215","article-title":"Systematic review and meta-analysis: opportunistic infections and malignancies during treatment with anti-integrin antibodies in inflammatory bowel disease","volume":"41","author":"Luthra","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"2020050721381611000_68.Suppl_3.s1.835","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.3748\/wjg.v21.i15.4744","article-title":"Integrin antagonists are effective and safe for Crohn\u2019s disease: a meta-analysis","volume":"21","author":"Ge","year":"2015","journal-title":"World J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.836","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.5114\/aoms.2016.61915","article-title":"Effectiveness and safety of vedolizumab for treatment of Crohn\u2019s disease: a systematic review and meta-analysis","volume":"12","author":"Mo\u0107ko","year":"2016","journal-title":"Arch Med Sci"},{"key":"2020050721381611000_68.Suppl_3.s1.837","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.cgh.2016.04.039","article-title":"Biologic therapies and risk of infection and malignancy in patients with inflammatory bowel disease: a systematic review and network meta-analysis","volume":"14","author":"Bonovas","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2020050721381611000_68.Suppl_3.s1.838","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-307127"},{"key":"2020050721381611000_68.Suppl_3.s1.839","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-316023"},{"key":"2020050721381611000_68.Suppl_3.s1.840","doi-asserted-by":"crossref","first-page":"S-232","DOI":"10.1016\/S0016-5085(15)30763-0","article-title":"Sa1123 Infusion-related reactions with vedolizumab treatment in patients with UC or CD during the GEMINI 1 and GEMINI 2 clinical trials","volume":"148","author":"Sands","year":"2015","journal-title":"Gastroenterology"},{"key":"2020050721381611000_68.Suppl_3.s1.841","first-page":"706","article-title":"Safety surveillance for ustekinumab and other psoriasis treatments from the Psoriasis Longitudinal Assessment and Registry (PSOLAR)","volume":"14","author":"Papp","year":"2015","journal-title":"J Drugs Dermatol"},{"key":"2020050721381611000_68.Suppl_3.s1.842","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1080\/14740338.2017.1323864","article-title":"The safety of ustekinumab for the treatment of psoriatic arthritis","volume":"16","author":"L\u00f3pez-Ferrer","year":"2017","journal-title":"Expert Opin Drug Saf"},{"key":"2020050721381611000_68.Suppl_3.s1.843","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/apt.14419","article-title":"Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohort","volume":"47","author":"Tadbiri","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"2020050721381611000_68.Suppl_3.s1.844","doi-asserted-by":"publisher","DOI":"10.1159\/000449083"},{"key":"2020050721381611000_68.Suppl_3.s1.845","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2015.07.037"},{"key":"2020050721381611000_68.Suppl_3.s1.846","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjv141"},{"key":"2020050721381611000_68.Suppl_3.s1.847","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2008.08.028"},{"key":"2020050721381611000_68.Suppl_3.s1.848","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61302-7"},{"key":"2020050721381611000_68.Suppl_3.s1.849","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/apt.13547","article-title":"Relapse after withdrawal from anti-TNF therapy for inflammatory bowel disease: an observational study, plus systematic review and meta-analysis","volume":"43","author":"Kennedy","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"2020050721381611000_68.Suppl_3.s1.850","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13276"},{"key":"2020050721381611000_68.Suppl_3.s1.851","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1111\/apt.15013","article-title":"Persistent damage on magnetic resonance enterography in patients with Crohn\u2019s disease in endoscopic remission","volume":"48","author":"Rimola","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"2020050721381611000_68.Suppl_3.s1.852","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/ibd\/izx099","article-title":"Exit strategies for biologic therapy in IBD: is it too soon to stop?","volume":"24","author":"Steinhart","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.853","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/ibd\/izx098","article-title":"Stopping biologics in IBD: what is the evidence?","volume":"24","author":"Louis","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.854","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.09.034"},{"key":"2020050721381611000_68.Suppl_3.s1.855","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2014.06.012"},{"key":"2020050721381611000_68.Suppl_3.s1.856","doi-asserted-by":"crossref","first-page":"S-149","DOI":"10.1016\/S0016-5085(12)60560-5","article-title":"864 Close monitoring of CRP and fecal calprotectin is able to predict clinical relapse in patients with crohn\u2019s disease in remission after infliximab withdrawal. a sub-analysis of the stori study","volume":"142","author":"de Suray","year":"2012","journal-title":"Gastroenterology"},{"key":"2020050721381611000_68.Suppl_3.s1.857","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjx002.598"},{"key":"2020050721381611000_68.Suppl_3.s1.858","doi-asserted-by":"crossref","unstructured":"Steinhart AH , Ewe K , Griffiths AM , et al . Corticosteroids for maintenance of remission in Crohn\u2019s disease. Cochrane Database Syst Rev 2003:CD000301.doi:10.1002\/14651858.CD000301","DOI":"10.1002\/14651858.CD000301"},{"key":"2020050721381611000_68.Suppl_3.s1.859","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/ajg.2017.479","article-title":"Increased mortality rates with prolonged corticosteroid therapy when compared with antitumor necrosis factor-\u03b1-directed therapy for inflammatory bowel disease","volume":"113","author":"Lewis","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.860","doi-asserted-by":"publisher","DOI":"10.1097\/01.MIB.0000192325.28168.08"},{"key":"2020050721381611000_68.Suppl_3.s1.861","doi-asserted-by":"crossref","first-page":"14087","DOI":"10.3748\/wjg.v20.i39.14087","article-title":"Managing osteoporosis in ulcerative colitis: something new?","volume":"20","author":"Piodi","year":"2014","journal-title":"World J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.862","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-011-0077-9"},{"key":"2020050721381611000_68.Suppl_3.s1.863","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-200403000-00005"},{"key":"2020050721381611000_68.Suppl_3.s1.864","doi-asserted-by":"publisher","DOI":"10.1097\/MOG.0000000000000037"},{"key":"2020050721381611000_68.Suppl_3.s1.865","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.monrhu.2016.05.003","article-title":"Os et intestin. Prise en charge des ost\u00e9opathies associ\u00e9es aux pathologies intestinales","volume":"83","author":"Briot","year":"2016","journal-title":"Revue du Rhumatisme Monographies"},{"key":"2020050721381611000_68.Suppl_3.s1.866","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-017-4189-7"},{"key":"2020050721381611000_68.Suppl_3.s1.867","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2012-100231"},{"key":"2020050721381611000_68.Suppl_3.s1.868","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/00365521.2016.1233577","article-title":"Vitamin D deficiency in inflammatory bowel disease: prevalence and predictors in a Norwegian outpatient population","volume":"52","author":"Frigstad","year":"2017","journal-title":"Scand J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.869","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.18.2257"},{"key":"2020050721381611000_68.Suppl_3.s1.870","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2012.06.003"},{"key":"2020050721381611000_68.Suppl_3.s1.871","doi-asserted-by":"crossref","unstructured":"Homik J , Suarez-Almazor ME , Shea B , et al . Calcium and vitamin D for corticosteroid-induced osteoporosis. Cochrane Database Syst Rev 2000:CD000952.doi:10.1002\/14651858.CD000952","DOI":"10.1002\/14651858.CD000952"},{"key":"2020050721381611000_68.Suppl_3.s1.872","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f228"},{"key":"2020050721381611000_68.Suppl_3.s1.873","doi-asserted-by":"publisher","DOI":"10.1007\/s001980200108"},{"key":"2020050721381611000_68.Suppl_3.s1.874","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2000.15.6.993"},{"key":"2020050721381611000_68.Suppl_3.s1.875","doi-asserted-by":"publisher","DOI":"10.1186\/1710-1492-9-30"},{"key":"2020050721381611000_68.Suppl_3.s1.876","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-010-1524-7"},{"key":"2020050721381611000_68.Suppl_3.s1.877","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-017-0324-5"},{"key":"2020050721381611000_68.Suppl_3.s1.878","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/art.40137","article-title":"2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis","volume":"69","author":"Buckley","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2020050721381611000_68.Suppl_3.s1.879","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-008-0108-4"},{"key":"2020050721381611000_68.Suppl_3.s1.880","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2013.05.014"},{"key":"2020050721381611000_68.Suppl_3.s1.881","doi-asserted-by":"publisher","DOI":"10.4065\/82.9.1052"},{"key":"2020050721381611000_68.Suppl_3.s1.882","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.cgh.2016.11.037","article-title":"Low risk of pneumonia from Pneumocystis jirovecii infection in patients with inflammatory bowel disease receiving immune suppression","volume":"15","author":"Cotter","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2020050721381611000_68.Suppl_3.s1.883","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.12.036"},{"key":"2020050721381611000_68.Suppl_3.s1.884","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/63.5.741"},{"key":"2020050721381611000_68.Suppl_3.s1.885","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2010.192"},{"key":"2020050721381611000_68.Suppl_3.s1.886","doi-asserted-by":"publisher","DOI":"10.1159\/000358156"},{"key":"2020050721381611000_68.Suppl_3.s1.887","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000638"},{"key":"2020050721381611000_68.Suppl_3.s1.888","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2016.01.020"},{"key":"2020050721381611000_68.Suppl_3.s1.889","doi-asserted-by":"publisher","DOI":"10.1177\/0148607107031004311"},{"key":"2020050721381611000_68.Suppl_3.s1.890","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nrgastro.2016.181","article-title":"Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes","volume":"14","author":"Singh","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2020050721381611000_68.Suppl_3.s1.891","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-015-3629-5"},{"key":"2020050721381611000_68.Suppl_3.s1.892","doi-asserted-by":"publisher","DOI":"10.1177\/0148607110389335"},{"key":"2020050721381611000_68.Suppl_3.s1.893","doi-asserted-by":"publisher","DOI":"10.1177\/0148607114566656"},{"key":"2020050721381611000_68.Suppl_3.s1.894","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(94)90676-9"},{"key":"2020050721381611000_68.Suppl_3.s1.895","doi-asserted-by":"crossref","unstructured":"Sandall AM , Wall CL , Lomer MCE . Nutrition assessment in Crohn\u2019s disease using anthropometric, biochemical, and dietary indexes: A narrative review. J Acad Nutr Diet 2019.\u00a0doi: 10.1016\/j.jand.2019.04.013. [Epub ahead of print 24 Jun 2019].","DOI":"10.1016\/j.jand.2019.04.013"},{"key":"2020050721381611000_68.Suppl_3.s1.896","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.111.023812"},{"key":"2020050721381611000_68.Suppl_3.s1.897","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejcn.1601049"},{"key":"2020050721381611000_68.Suppl_3.s1.898","doi-asserted-by":"publisher","DOI":"10.1080\/07315724.1989.10720330"},{"key":"2020050721381611000_68.Suppl_3.s1.899","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jju009"},{"key":"2020050721381611000_68.Suppl_3.s1.900","doi-asserted-by":"crossref","unstructured":"Lu C , Yang J , Yu W , et al . Association between 25(OH)D level, ultraviolet exposure, geographical location, and inflammatory bowel disease activity: a systematic review and meta-analysis. PLoS One 2015;10:e0132036.doi:10.1371\/journal.pone.0132036","DOI":"10.1371\/journal.pone.0132036"},{"key":"2020050721381611000_68.Suppl_3.s1.901","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000546"},{"key":"2020050721381611000_68.Suppl_3.s1.902","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2012.05181.x"},{"key":"2020050721381611000_68.Suppl_3.s1.903","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1017\/S0029665114001621","article-title":"Vitamin D as a novel therapy in inflammatory bowel disease: new hope or false dawn?","volume":"74","author":"O\u2019Sullivan","year":"2015","journal-title":"Proc Nutr Soc"},{"key":"2020050721381611000_68.Suppl_3.s1.904","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/apt.13936","article-title":"Higher 25-hydroxyvitamin D levels are associated with greater odds of remission with anti-tumour necrosis factor-\u03b1 medications among patients with inflammatory bowel diseases","volume":"45","author":"Winter","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"2020050721381611000_68.Suppl_3.s1.905","doi-asserted-by":"publisher","DOI":"10.1177\/0148607113504002"},{"key":"2020050721381611000_68.Suppl_3.s1.906","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000697"},{"key":"2020050721381611000_68.Suppl_3.s1.907","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2010.04355.x"},{"key":"2020050721381611000_68.Suppl_3.s1.908","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20947"},{"key":"2020050721381611000_68.Suppl_3.s1.909","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1038\/ctg.2013.1","article-title":"Therapeutic effect of vitamin d supplementation in a pilot study of Crohn\u2019s patients","volume":"4","author":"Yang","year":"2013","journal-title":"Clin Transl Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.910","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.260"},{"key":"2020050721381611000_68.Suppl_3.s1.911","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2011.04.016"},{"key":"2020050721381611000_68.Suppl_3.s1.912","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000708"},{"key":"2020050721381611000_68.Suppl_3.s1.913","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1093\/ecco-jcc\/jjx073","article-title":"Fermentable carbohydrates [FODMAPs] exacerbate functional gastrointestinal symptoms in patients with inflammatory bowel disease: a randomised, double-blind, placebo-controlled, cross-over, re-challenge trial","volume":"11","author":"Cox","year":"2017","journal-title":"J Crohns Colitis"},{"key":"2020050721381611000_68.Suppl_3.s1.914","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.3748\/wjg.v23.i18.3356","article-title":"Low-FODMAP diet reduces irritable bowel symptoms in patients with inflammatory bowel disease","volume":"23","author":"Pedersen","year":"2017","journal-title":"World J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.915","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.234617"},{"key":"2020050721381611000_68.Suppl_3.s1.916","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-307983"},{"key":"2020050721381611000_68.Suppl_3.s1.917","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12372"},{"key":"2020050721381611000_68.Suppl_3.s1.918","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/MCO.0000000000000226","article-title":"Micronutrient deficiencies in inflammatory bowel disease","volume":"18","author":"Weisshof","year":"2015","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"2020050721381611000_68.Suppl_3.s1.919","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0025-6196(12)60849-0","article-title":"Preoperative nutritional status and other factors that influence surgical outcome in patients with Crohn\u2019s disease","volume":"60","author":"Lindor","year":"1985","journal-title":"Mayo Clin Proc"},{"key":"2020050721381611000_68.Suppl_3.s1.920","doi-asserted-by":"publisher","DOI":"10.1080\/07315724.2004.10719365"},{"key":"2020050721381611000_68.Suppl_3.s1.921","doi-asserted-by":"publisher","DOI":"10.1007\/s10350-006-0782-0"},{"key":"2020050721381611000_68.Suppl_3.s1.922","first-page":"CD008879","article-title":"Pre-operative nutrition support in patients undergoing gastrointestinal surgery","volume":"11","author":"Burden","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2020050721381611000_68.Suppl_3.s1.923","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3390\/nu9060562","article-title":"Preoperative nutritional conditioning of Crohn\u2019s patients-systematic review of current evidence and practice","volume":"9","author":"Grass","year":"2017","journal-title":"Nutrients"},{"key":"2020050721381611000_68.Suppl_3.s1.924","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.clnu.2017.02.013","article-title":"ESPEN guideline: Clinical nutrition in surgery","volume":"36","author":"Weimann","year":"2017","journal-title":"Clin Nutr"},{"key":"2020050721381611000_68.Suppl_3.s1.925","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjv051"},{"key":"2020050721381611000_68.Suppl_3.s1.926","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2010.04369.x"},{"key":"2020050721381611000_68.Suppl_3.s1.927","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2011.648954"},{"key":"2020050721381611000_68.Suppl_3.s1.928","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.dld.2012.03.010","article-title":"Risk factors and outcome of acute severe lower gastrointestinal bleeding in Crohn\u2019s disease","volume":"44","author":"Kim","year":"2012","journal-title":"Dig Liver Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.929","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1007\/s11605-015-2893-1","article-title":"Perioperative blood transfusion and postoperative outcome in patients with Crohn\u2019s disease undergoing primary ileocolonic resection in the \"biological era\"","volume":"19","author":"Li","year":"2015","journal-title":"J Gastrointest Surg"},{"key":"2020050721381611000_68.Suppl_3.s1.930","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/apt.12947","article-title":"Review article: optimal preparation for surgery in Crohn\u2019s disease","volume":"40","author":"Spinelli","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"2020050721381611000_68.Suppl_3.s1.931","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2008.01942.x"},{"key":"2020050721381611000_68.Suppl_3.s1.932","doi-asserted-by":"publisher","DOI":"10.1097\/DCR.0000000000000099"},{"key":"2020050721381611000_68.Suppl_3.s1.933","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(03)00883-7"},{"key":"2020050721381611000_68.Suppl_3.s1.934","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1097\/MIB.0000000000000919","article-title":"Preoperative anti-tumor necrosis factor therapy in patients with ulcerative colitis is not associated with an increased risk of infectious and noninfectious complications after\u00a0ileal pouch-anal anastomosis","volume":"22","author":"Zittan","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.935","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000381033","article-title":"Safety of proctocolectomy for ulcerative colitis under elective and non-elective circumstances: preoperative corticosteroid treatment worsens outcome","volume":"32","author":"Balachandran","year":"2015","journal-title":"Dig Surg"},{"key":"2020050721381611000_68.Suppl_3.s1.936","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/SLA.0b013e318297adca","article-title":"A prospective, randomized, noninferiority trial of steroid dosing after major colorectal surgery","volume":"259","author":"Zaghiyan","year":"2014","journal-title":"Ann Surg"},{"key":"2020050721381611000_68.Suppl_3.s1.937","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1097\/DCR.0b013e3182a180b7","article-title":"Impact of stress dose steroids on the outcomes of restorative proctocolectomy in patients with ulcerative colitis","volume":"56","author":"Aytac","year":"2013","journal-title":"Dis Colon Rectum"},{"key":"2020050721381611000_68.Suppl_3.s1.938","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/gastro\/gow046","article-title":"Perioperative use of immunosuppressive medications in patients with Crohn\u2019s disease in the new \"biological era\"","volume":"5","author":"Lightner","year":"2017","journal-title":"Gastroenterol Rep"},{"key":"2020050721381611000_68.Suppl_3.s1.939","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.143.12.1222"},{"key":"2020050721381611000_68.Suppl_3.s1.940","doi-asserted-by":"publisher","DOI":"10.1007\/DCR.0b013e3181a7ba96"},{"key":"2020050721381611000_68.Suppl_3.s1.941","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.5375"},{"key":"2020050721381611000_68.Suppl_3.s1.942","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4240\/wjgs.v8.i3.274","article-title":"Post-operative abdominal complications in Crohn\u2019s disease in the biological era: Systematic review and meta-analysis","volume":"8","author":"Waterland","year":"2016","journal-title":"World J Gastrointest Surg"},{"key":"2020050721381611000_68.Suppl_3.s1.943","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.22954"},{"key":"2020050721381611000_68.Suppl_3.s1.944","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12313"},{"key":"2020050721381611000_68.Suppl_3.s1.945","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2013.12.015"},{"key":"2020050721381611000_68.Suppl_3.s1.946","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2013.01.019"},{"key":"2020050721381611000_68.Suppl_3.s1.947","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jju028"},{"key":"2020050721381611000_68.Suppl_3.s1.948","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000000757"},{"key":"2020050721381611000_68.Suppl_3.s1.949","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12060"},{"key":"2020050721381611000_68.Suppl_3.s1.950","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-006-0168-8"},{"key":"2020050721381611000_68.Suppl_3.s1.951","doi-asserted-by":"publisher","DOI":"10.1097\/DCR.0b013e3182a0e702"},{"key":"2020050721381611000_68.Suppl_3.s1.952","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2015.6"},{"key":"2020050721381611000_68.Suppl_3.s1.953","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2014.07.005"},{"key":"2020050721381611000_68.Suppl_3.s1.954","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/apt.14563","article-title":"Faecal calprotectin effectively excludes inflammatory bowel disease in 789 symptomatic young adults with\/without alarm symptoms: a prospective UK primary care cohort study","volume":"47","author":"Walker","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"2020050721381611000_68.Suppl_3.s1.955","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2013.816771"},{"key":"2020050721381611000_68.Suppl_3.s1.956","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1017\/S1463423616000049","article-title":"Evaluation of a faecal calprotectin care pathway for use in primary care","volume":"17","author":"Turvill","year":"2016","journal-title":"Prim Health Care Res Dev"},{"key":"2020050721381611000_68.Suppl_3.s1.957","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2013.06.028"},{"key":"2020050721381611000_68.Suppl_3.s1.958","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2014.934913"},{"key":"2020050721381611000_68.Suppl_3.s1.959","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2018-100962"},{"key":"2020050721381611000_68.Suppl_3.s1.960","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp16X685645"},{"key":"2020050721381611000_68.Suppl_3.s1.961","doi-asserted-by":"publisher","DOI":"10.1136\/gut.49.3.402"},{"key":"2020050721381611000_68.Suppl_3.s1.962","unstructured":"National Institute for Health and Care Excellence: NICE guideline [NG12] Suspected cancer: recognition and referral. https:\/\/www.nice.org.uk\/guidance\/ng12 [Accessed 16 Dec 2018]."},{"key":"2020050721381611000_68.Suppl_3.s1.963","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp17X690425"},{"key":"2020050721381611000_68.Suppl_3.s1.964","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3109\/00365521.2014.987809","article-title":"Fecal calprotectin in diagnosis and clinical assessment of inflammatory bowel disease","volume":"50","author":"Sipponen","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.965","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20986"},{"key":"2020050721381611000_68.Suppl_3.s1.966","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03835.x"},{"key":"2020050721381611000_68.Suppl_3.s1.967","doi-asserted-by":"crossref","first-page":"299","DOI":"10.15403\/jgld.2014.1121.273.pti","article-title":"Fecal calprotectin in assessing inflammatory bowel disease endoscopic activity: a diagnostic accuracy meta-analysis","volume":"27","author":"Rokkas","year":"2018","journal-title":"J Gastrointestin Liver Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.968","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000057"},{"key":"2020050721381611000_68.Suppl_3.s1.969","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.09.056"},{"key":"2020050721381611000_68.Suppl_3.s1.970","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20927"},{"key":"2020050721381611000_68.Suppl_3.s1.971","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2015.120"},{"key":"2020050721381611000_68.Suppl_3.s1.972","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.13061"},{"key":"2020050721381611000_68.Suppl_3.s1.973","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2014.06.020"},{"key":"2020050721381611000_68.Suppl_3.s1.974","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jju003"},{"key":"2020050721381611000_68.Suppl_3.s1.975","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jju012"},{"key":"2020050721381611000_68.Suppl_3.s1.976","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/apt.13731","article-title":"The prognostic significance of faecal calprotectin in patients with inactive inflammatory bowel disease","volume":"44","author":"Zhulina","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"2020050721381611000_68.Suppl_3.s1.977","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2014.06.002"},{"key":"2020050721381611000_68.Suppl_3.s1.978","doi-asserted-by":"crossref","unstructured":"Haisma SM , van Rheenen PF , Wagenmakers L , et al . Calprotectin instability may lead to undertreatment in children with IBD. Arch Dis Child 2019.\u00a0doi: 10.1136\/archdischild-2018-316584. [Epub ahead of print 17 Jan 2019].doi:10.1136\/archdischild-2018-316584","DOI":"10.1136\/archdischild-2018-316584"},{"key":"2020050721381611000_68.Suppl_3.s1.979","doi-asserted-by":"publisher","DOI":"10.1136\/gut.14.12.990"},{"key":"2020050721381611000_68.Suppl_3.s1.980","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0025-7125(16)30214-0","article-title":"Toxic megacolon","volume":"77","author":"Present","year":"1993","journal-title":"Med Clin North Am"},{"key":"2020050721381611000_68.Suppl_3.s1.981","first-page":"270","article-title":"Complications in colonoscopy","volume":"148","author":"Schwesinger","year":"1979","journal-title":"Surg Gynecol Obstet"},{"key":"2020050721381611000_68.Suppl_3.s1.982","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5107(77)73622-3"},{"key":"2020050721381611000_68.Suppl_3.s1.983","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20049"},{"key":"2020050721381611000_68.Suppl_3.s1.984","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1077445"},{"key":"2020050721381611000_68.Suppl_3.s1.985","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5107(04)02776-2"},{"key":"2020050721381611000_68.Suppl_3.s1.986","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2013.04.011"},{"key":"2020050721381611000_68.Suppl_3.s1.987","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e328361dcd3"},{"key":"2020050721381611000_68.Suppl_3.s1.988","doi-asserted-by":"publisher","DOI":"10.1067\/mge.2002.125361"},{"key":"2020050721381611000_68.Suppl_3.s1.989","doi-asserted-by":"crossref","first-page":"5994","DOI":"10.3748\/wjg.v23.i32.5994","article-title":"Systematic review and meta-analysis of colon cleansing preparations in patients with inflammatory bowel disease","volume":"23","author":"Restellini","year":"2017","journal-title":"World J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.990","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(99)80026-5"},{"key":"2020050721381611000_68.Suppl_3.s1.991","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.685"},{"key":"2020050721381611000_68.Suppl_3.s1.992","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0b013e31829ed8a6"},{"key":"2020050721381611000_68.Suppl_3.s1.993","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/apt.12476","article-title":"Factors associated with thiopurine non-adherence in patients with inflammatory bowel disease","volume":"38","author":"Goodhand","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"2020050721381611000_68.Suppl_3.s1.994","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01212.x"},{"key":"2020050721381611000_68.Suppl_3.s1.995","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0b013e31828132cb"},{"key":"2020050721381611000_68.Suppl_3.s1.996","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(02)01383-9"},{"key":"2020050721381611000_68.Suppl_3.s1.997","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw002"},{"key":"2020050721381611000_68.Suppl_3.s1.998","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-015-0256-7"},{"key":"2020050721381611000_68.Suppl_3.s1.999","doi-asserted-by":"publisher","DOI":"10.1093\/jpepsy\/jsr092"},{"key":"2020050721381611000_68.Suppl_3.s1.1000","doi-asserted-by":"publisher","DOI":"10.1155\/2005\/250504"},{"key":"2020050721381611000_68.Suppl_3.s1.1001","doi-asserted-by":"crossref","unstructured":"Depont F , Berenbaum F , Filippi J , et al . Interventions to improve adherence in patients with immune-mediated inflammatory disorders: a systematic review. PLoS One 2015;10:e0145076.doi:10.1371\/journal.pone.0145076","DOI":"10.1371\/journal.pone.0145076"},{"key":"2020050721381611000_68.Suppl_3.s1.1002","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03698.x"},{"key":"2020050721381611000_68.Suppl_3.s1.1003","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21570"},{"key":"2020050721381611000_68.Suppl_3.s1.1004","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.220160"},{"key":"2020050721381611000_68.Suppl_3.s1.1005","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-014-3471-1"},{"key":"2020050721381611000_68.Suppl_3.s1.1006","unstructured":"National Institute for Health and Care Excellence. Quality standard [QS43] Smoking: supporting people to stop. https:\/\/www.nice.org.uk\/guidance\/qs43 (Accessed 15 Dec 2018)."},{"key":"2020050721381611000_68.Suppl_3.s1.1007","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02424.x"},{"key":"2020050721381611000_68.Suppl_3.s1.1008","first-page":"22","article-title":"Smoking cessation: What should you recommend?","volume":"65","author":"Bornemann","year":"2016","journal-title":"J Fam Pract"},{"key":"2020050721381611000_68.Suppl_3.s1.1009","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13511"},{"key":"2020050721381611000_68.Suppl_3.s1.1010","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200501000-00006"},{"key":"2020050721381611000_68.Suppl_3.s1.1011","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13239"},{"key":"2020050721381611000_68.Suppl_3.s1.1012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjsurg.2014.10.033","article-title":"Smoking as dominant risk factor for anastomotic leak after left colon resection","volume":"210","author":"Baucom","year":"2015","journal-title":"Am J Surg"},{"key":"2020050721381611000_68.Suppl_3.s1.1013","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e3182708cc5"},{"key":"2020050721381611000_68.Suppl_3.s1.1014","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20884"},{"key":"2020050721381611000_68.Suppl_3.s1.1015","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20828"},{"key":"2020050721381611000_68.Suppl_3.s1.1016","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-3565(03)00290-8"},{"key":"2020050721381611000_68.Suppl_3.s1.1017","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2014.300"},{"key":"2020050721381611000_68.Suppl_3.s1.1018","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000000371"},{"key":"2020050721381611000_68.Suppl_3.s1.1019","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13423"},{"key":"2020050721381611000_68.Suppl_3.s1.1020","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjv113"},{"key":"2020050721381611000_68.Suppl_3.s1.1021","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2013.05.007"},{"key":"2020050721381611000_68.Suppl_3.s1.1022","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2012.04.011"},{"key":"2020050721381611000_68.Suppl_3.s1.1023","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1111\/jgh.12616","article-title":"Second peak in the distribution of age at onset of ulcerative colitis in relation to smoking cessation","volume":"29","author":"Takahashi","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"2020050721381611000_68.Suppl_3.s1.1024","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/ajg.2012.190","article-title":"The truth about cigarette smoking and the risk of inflammatory bowel disease","volume":"107","author":"Rosenfeld","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.1025","doi-asserted-by":"publisher","DOI":"10.1007\/BF01648362"},{"key":"2020050721381611000_68.Suppl_3.s1.1026","doi-asserted-by":"publisher","DOI":"10.1007\/BF00299330"},{"key":"2020050721381611000_68.Suppl_3.s1.1027","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.03944.x"},{"key":"2020050721381611000_68.Suppl_3.s1.1028","doi-asserted-by":"publisher","DOI":"10.1080\/00365520500527482"},{"key":"2020050721381611000_68.Suppl_3.s1.1029","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2011.12.010"},{"key":"2020050721381611000_68.Suppl_3.s1.1030","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199403243301202"},{"key":"2020050721381611000_68.Suppl_3.s1.1031","first-page":"769","article-title":"Transdermal nicotine compared with oral prednisolone therapy for active ulcerative colitis","volume":"8","author":"Thomas","year":"1996","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2020050721381611000_68.Suppl_3.s1.1032","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199504133321503"},{"key":"2020050721381611000_68.Suppl_3.s1.1033","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12086"},{"key":"2020050721381611000_68.Suppl_3.s1.1034","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/0954-6111(95)90235-X","article-title":"Ulcerative colitis responsive to smoking and to nicotine chewing gum in a patient with \u03b11 anti-trypsin deficiency","volume":"89","author":"Watson","year":"1995","journal-title":"Respiratory Medicine"},{"key":"2020050721381611000_68.Suppl_3.s1.1035","doi-asserted-by":"publisher","DOI":"10.1007\/BF01536795"},{"key":"2020050721381611000_68.Suppl_3.s1.1036","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/ajg.2013.439","article-title":"Ulcerative colitis and electronic cigarette: what\u2019s the matter?","volume":"109","author":"Camus","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.1037","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-317182"},{"key":"2020050721381611000_68.Suppl_3.s1.1038","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2008.01980.x"},{"key":"2020050721381611000_68.Suppl_3.s1.1039","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.22916"},{"key":"2020050721381611000_68.Suppl_3.s1.1040","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.22850"},{"key":"2020050721381611000_68.Suppl_3.s1.1041","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.cgh.2016.05.012","article-title":"Negative effects on psychological health and quality of life of genuine irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease","volume":"15","author":"Gracie","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2020050721381611000_68.Suppl_3.s1.1042","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/MIB.0000000000001017","article-title":"Prevalence and impact of inflammatory bowel disease-irritable bowel syndrome on patient-reported outcomes in CCFA Partners","volume":"23","author":"Abdalla","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.1043","doi-asserted-by":"publisher","DOI":"10.2174\/156652408784533832"},{"key":"2020050721381611000_68.Suppl_3.s1.1044","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20068"},{"key":"2020050721381611000_68.Suppl_3.s1.1045","doi-asserted-by":"publisher","DOI":"10.1080\/08870446.2012.691169"},{"key":"2020050721381611000_68.Suppl_3.s1.1046","first-page":"CD006913","article-title":"Psychological interventions for treatment of inflammatory bowel disease","volume":"2","author":"Timmer","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"2020050721381611000_68.Suppl_3.s1.1047","doi-asserted-by":"publisher","DOI":"10.1007\/s10880-012-9301-8"},{"key":"2020050721381611000_68.Suppl_3.s1.1048","doi-asserted-by":"publisher","DOI":"10.1097\/01.chi.0000142284.10574.1f"},{"key":"2020050721381611000_68.Suppl_3.s1.1049","doi-asserted-by":"publisher","DOI":"10.1080\/00365520310003110"},{"key":"2020050721381611000_68.Suppl_3.s1.1050","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12529-016-9580-9","article-title":"Cognitive-behavioural therapy for inflammatory bowel disease: 24-month data from a randomised controlled trial","volume":"24","author":"Mikocka-Walus","year":"2017","journal-title":"Int J Behav Med"},{"key":"2020050721381611000_68.Suppl_3.s1.1051","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/MIB.0000000000000629","article-title":"A controlled study of a group mindfulness intervention for individuals living with inflammatory bowel disease","volume":"22","author":"Neilson","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.1052","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2014.01.018"},{"key":"2020050721381611000_68.Suppl_3.s1.1053","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1159\/000356316","article-title":"A randomized controlled trial of mindfulness-based stress reduction to prevent flare-up in patients with inactive ulcerative colitis","volume":"89","author":"Jedel","year":"2014","journal-title":"Digestion"},{"key":"2020050721381611000_68.Suppl_3.s1.1054","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/apt.13202","article-title":"Review article: gut-directed hypnotherapy in the management of irritable bowel syndrome and inflammatory bowel disease","volume":"41","author":"Peters","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"2020050721381611000_68.Suppl_3.s1.1055","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12449"},{"key":"2020050721381611000_68.Suppl_3.s1.1056","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2014.02.011"},{"key":"2020050721381611000_68.Suppl_3.s1.1057","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1097\/MIB.0000000000000207","article-title":"Abdominal pain and the neurotrophic system in ulcerative colitis","volume":"20","author":"Deberry","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.1058","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v16.i25.3168"},{"key":"2020050721381611000_68.Suppl_3.s1.1059","doi-asserted-by":"publisher","DOI":"10.1007\/s10880-008-9132-9"},{"key":"2020050721381611000_68.Suppl_3.s1.1060","doi-asserted-by":"crossref","unstructured":"Zeitz J , Ak M , M\u00fcller-Mottet S , et al . Pain in IBD patients: very frequent and frequently insufficiently taken into account. PLoS One 2016;11:e0156666.doi:10.1371\/journal.pone.0156666","DOI":"10.1371\/journal.pone.0156666"},{"key":"2020050721381611000_68.Suppl_3.s1.1061","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jju027.734"},{"key":"2020050721381611000_68.Suppl_3.s1.1062","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0b013e31829614c6"},{"issue":"Suppl 2","key":"2020050721381611000_68.Suppl_3.s1.1063","doi-asserted-by":"crossref","first-page":"S490","DOI":"10.14309\/00000434-201410002-01650","article-title":"Causes and consequences of chronic abdominal pain in crohn\u2019s disease: A five-year prospective study","volume":"109","author":"Seth","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 1","key":"2020050721381611000_68.Suppl_3.s1.1064","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1097\/01.MIB.0000438730.46835.46","article-title":"P-051 YI\u2003Assessment of pain in IBD patients at a tertiary center","volume":"19","author":"Kinnucan","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.1065","doi-asserted-by":"publisher","DOI":"10.1097\/SGA.0000000000000055"},{"key":"2020050721381611000_68.Suppl_3.s1.1066","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3109\/00365521.2014.898084","article-title":"Prevalence of irritable bowel syndrome-like symptoms in ulcerative colitis patients with clinical and endoscopic evidence of remission: prospective multicenter study","volume":"49","author":"Fukuba","year":"2014","journal-title":"Scand J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.1067","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2011.579156"},{"key":"2020050721381611000_68.Suppl_3.s1.1068","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1002\/ibd.21412","article-title":"Irritable pouch syndrome is characterized by visceral hypersensitivity","volume":"17","author":"Shen","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.1069","first-page":"1167","article-title":"Fibromyalgia in inflammatory bowel disease","volume":"26","author":"Buskila","year":"1999","journal-title":"J Rheumatol"},{"key":"2020050721381611000_68.Suppl_3.s1.1070","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S2468-1253(16)30206-0","article-title":"Effect of psychological therapy on disease activity, psychological comorbidity, and quality of life in inflammatory bowel disease: a systematic review and meta-analysis","volume":"2","author":"Gracie","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2020050721381611000_68.Suppl_3.s1.1071","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(87)90043-1"},{"key":"2020050721381611000_68.Suppl_3.s1.1072","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1097\/01.MIB.0000435442.07237.a4","article-title":"The burden of comedication among patients with inflammatory bowel disease","volume":"19","author":"Buckley","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.1073","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20847"},{"key":"2020050721381611000_68.Suppl_3.s1.1074","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.00256.x"},{"key":"2020050721381611000_68.Suppl_3.s1.1075","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1093\/ibd\/izy040","article-title":"The association between sustained poor quality of life and future opioid use in inflammatory bowel disease","volume":"24","author":"Anderson","year":"2018","journal-title":"Inflamm Bowel Dis"},{"issue":"Suppl","key":"2020050721381611000_68.Suppl_3.s1.1076","doi-asserted-by":"crossref","first-page":"S312","DOI":"10.14309\/00000434-201610001-00688","article-title":"688 Patterns between multi-year steroid use in patients with inflammatory bowel disease and quality of life, disease severity, and healthcare utilization","volume":"111","author":"Cheng","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.1077","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2014.230"},{"issue":"Suppl 1","key":"2020050721381611000_68.Suppl_3.s1.1078","doi-asserted-by":"crossref","first-page":"S296","DOI":"10.14309\/00000434-201610001-00646","article-title":"Narcotic use, psychiatric history, and corticosteroid use are associated with depressive symptoms in patients with IBD","volume":"111","author":"Flath","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.1079","doi-asserted-by":"publisher","DOI":"10.1007\/BF02555345"},{"key":"2020050721381611000_68.Suppl_3.s1.1080","doi-asserted-by":"publisher","DOI":"10.1007\/BF01072276"},{"key":"2020050721381611000_68.Suppl_3.s1.1081","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2010.04347.x"},{"key":"2020050721381611000_68.Suppl_3.s1.1082","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2014.01.004"},{"key":"2020050721381611000_68.Suppl_3.s1.1083","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjv091"},{"key":"2020050721381611000_68.Suppl_3.s1.1084","doi-asserted-by":"publisher","DOI":"10.1097\/01.MIB.0000437614.91258.70"},{"key":"2020050721381611000_68.Suppl_3.s1.1085","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04914.x"},{"key":"2020050721381611000_68.Suppl_3.s1.1086","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2011.02.008"},{"key":"2020050721381611000_68.Suppl_3.s1.1087","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21580"},{"key":"2020050721381611000_68.Suppl_3.s1.1088","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21285"},{"key":"2020050721381611000_68.Suppl_3.s1.1089","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12659"},{"key":"2020050721381611000_68.Suppl_3.s1.1090","doi-asserted-by":"publisher","DOI":"10.1111\/jan.12060"},{"key":"2020050721381611000_68.Suppl_3.s1.1091","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e32835aba83"},{"key":"2020050721381611000_68.Suppl_3.s1.1092","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2010.01502.x"},{"key":"2020050721381611000_68.Suppl_3.s1.1093","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07414.x"},{"key":"2020050721381611000_68.Suppl_3.s1.1094","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1097\/MEG.0000000000000200","article-title":"Anaemia from a patient perspective in inflammatory bowel disease: results from the European Federation of Crohn\u2019s and Ulcerative Colitis Association\u2019s online survey","volume":"26","author":"Danese","year":"2014","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2020050721381611000_68.Suppl_3.s1.1095","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2013.14"},{"key":"2020050721381611000_68.Suppl_3.s1.1096","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.114.103366"},{"key":"2020050721381611000_68.Suppl_3.s1.1097","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2013.07.006"},{"key":"2020050721381611000_68.Suppl_3.s1.1098","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2147\/CEG.S123942","article-title":"Fatigue in patients with inflammatory bowel disease is associated with distinct differences in immune parameters","volume":"10","author":"Vogelaar","year":"2017","journal-title":"Clin Exp Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.1099","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200207000-00001"},{"key":"2020050721381611000_68.Suppl_3.s1.1100","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2008.02175.x"},{"key":"2020050721381611000_68.Suppl_3.s1.1101","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v13.i14.2089"},{"key":"2020050721381611000_68.Suppl_3.s1.1102","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-305191"},{"key":"2020050721381611000_68.Suppl_3.s1.1103","doi-asserted-by":"publisher","DOI":"10.1016\/S0005-7967(03)00146-3"},{"key":"2020050721381611000_68.Suppl_3.s1.1104","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjv213"},{"key":"2020050721381611000_68.Suppl_3.s1.1105","doi-asserted-by":"publisher","DOI":"10.1136\/gut.42.3.387"},{"key":"2020050721381611000_68.Suppl_3.s1.1106","doi-asserted-by":"crossref","first-page":"kev288","DOI":"10.1093\/rheumatology\/kev288","article-title":"Delay to diagnosis in axial spondyloarthritis: are we improving in the UK?","volume":"54","author":"Sykes","year":"2015","journal-title":"Rheumatology"},{"key":"2020050721381611000_68.Suppl_3.s1.1107","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e328342273a"},{"key":"2020050721381611000_68.Suppl_3.s1.1108","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.052878"},{"key":"2020050721381611000_68.Suppl_3.s1.1109","first-page":"S128","article-title":"Use of methotrexate in patients with ankylosing spondylitis","volume":"28","author":"Haibel","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"2020050721381611000_68.Suppl_3.s1.1110","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200411000-00009"},{"key":"2020050721381611000_68.Suppl_3.s1.1111","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21281"},{"key":"2020050721381611000_68.Suppl_3.s1.1112","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2014.966753"},{"key":"2020050721381611000_68.Suppl_3.s1.1113","doi-asserted-by":"crossref","first-page":"599","DOI":"10.36076\/ppj.2015\/18\/599","article-title":"Coxib\u2019s safety in patients with inflammatory bowel diseases: a meta-analysis","volume":"18","author":"Ribaldone","year":"2015","journal-title":"Pain Physician"},{"key":"2020050721381611000_68.Suppl_3.s1.1114","first-page":"CD007744","article-title":"Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease","volume":"10","author":"Miao","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2020050721381611000_68.Suppl_3.s1.1115","doi-asserted-by":"publisher","DOI":"10.2147\/CEG.S27530"},{"key":"2020050721381611000_68.Suppl_3.s1.1116","doi-asserted-by":"crossref","unstructured":"Mallon P , McKay D , Kirk S , et al . Probiotics for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 2007:CD005573.doi:10.1002\/14651858.CD005573.pub2","DOI":"10.1002\/14651858.CD005573.pub2"},{"key":"2020050721381611000_68.Suppl_3.s1.1117","first-page":"CD007443","article-title":"Probiotics for maintenance of remission in ulcerative colitis","volume":"12","author":"Naidoo","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"2020050721381611000_68.Suppl_3.s1.1118","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2008.11.017"},{"key":"2020050721381611000_68.Suppl_3.s1.1119","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1001\/jama.2018.20046","article-title":"Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: a randomized clinical trial","volume":"321","author":"Costello","year":"2019","journal-title":"JAMA"},{"key":"2020050721381611000_68.Suppl_3.s1.1120"},{"key":"2020050721381611000_68.Suppl_3.s1.1121","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.04.001"},{"key":"2020050721381611000_68.Suppl_3.s1.1122","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.03.045"},{"issue":"Suppl 1","key":"2020050721381611000_68.Suppl_3.s1.1123","first-page":"S1008","article-title":"The role of fecal microbiota transplantation in ulcerative colitis and Crohn\u2019s disease: results from a parallel inflammatory bowel disease cohort study","volume":"152","author":"El-Nachef","year":"2017","journal-title":"Gastroenterology"},{"key":"2020050721381611000_68.Suppl_3.s1.1124","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14173"},{"key":"2020050721381611000_68.Suppl_3.s1.1125"},{"key":"2020050721381611000_68.Suppl_3.s1.1126","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/jama.2018.20397","article-title":"Manipulating the microbiome with fecal transplantation to treat ulcerative colitis","volume":"321","author":"Kelly","year":"2019","journal-title":"JAMA"},{"key":"2020050721381611000_68.Suppl_3.s1.1127","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/apt.13868","article-title":"Consensus report: faecal microbiota transfer - clinical applications and procedures","volume":"45","author":"K\u00f6nig","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"2020050721381611000_68.Suppl_3.s1.1128","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-300219"},{"key":"2020050721381611000_68.Suppl_3.s1.1129","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw019.795"},{"key":"2020050721381611000_68.Suppl_3.s1.1130","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2015.02.019"},{"key":"2020050721381611000_68.Suppl_3.s1.1131","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.08.008"},{"key":"2020050721381611000_68.Suppl_3.s1.1132","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.cgh.2007.03.002","article-title":"Curcumin for maintenance therapy in ulcerative colitis","volume":"5","author":"Moss","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2020050721381611000_68.Suppl_3.s1.1133","doi-asserted-by":"publisher","DOI":"10.1001\/jama.299.14.1690"},{"key":"2020050721381611000_68.Suppl_3.s1.1134","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.01.005"},{"key":"2020050721381611000_68.Suppl_3.s1.1135","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70362-2"},{"key":"2020050721381611000_68.Suppl_3.s1.1136","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1053\/j.gastro.2016.10.004","article-title":"Complementary and alternative medicines used by patients with inflammatory bowel diseases","volume":"152","author":"Cheifetz","year":"2017","journal-title":"Gastroenterology"},{"key":"2020050721381611000_68.Suppl_3.s1.1137","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.drugalcdep.2015.08.035","article-title":"Patterns of cannabis use in patients with inflammatory bowel disease: a population based analysis","volume":"156","author":"Weiss","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"2020050721381611000_68.Suppl_3.s1.1138","first-page":"668","article-title":"Therapeutic use of cannabis in inflammatory bowel disease","volume":"12","author":"Ahmed","year":"2016","journal-title":"Gastroenterol Hepatol"},{"key":"2020050721381611000_68.Suppl_3.s1.1139","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e328349bb4c"},{"key":"2020050721381611000_68.Suppl_3.s1.1140","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/ibd\/izy002","article-title":"A randomized, double-blind, placebo-controlled, parallel-group, pilot study of cannabidiol-rich botanical extract in the symptomatic treatment of ulcerative colitis","volume":"24","author":"Irving","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.1141","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2013.04.034"},{"key":"2020050721381611000_68.Suppl_3.s1.1142","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.12.037"},{"key":"2020050721381611000_68.Suppl_3.s1.1143","doi-asserted-by":"publisher","DOI":"10.1136\/gut.48.4.526"},{"key":"2020050721381611000_68.Suppl_3.s1.1144","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199011013231802"},{"key":"2020050721381611000_68.Suppl_3.s1.1145","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-3565(04)00543-9"},{"key":"2020050721381611000_68.Suppl_3.s1.1146","doi-asserted-by":"publisher","DOI":"10.1097\/01.MIB.0000217770.21261.ce"},{"key":"2020050721381611000_68.Suppl_3.s1.1147","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2003.11.010"},{"key":"2020050721381611000_68.Suppl_3.s1.1148","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.08.001"},{"key":"2020050721381611000_68.Suppl_3.s1.1149","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.03.028"},{"key":"2020050721381611000_68.Suppl_3.s1.1150","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2010.428"},{"key":"2020050721381611000_68.Suppl_3.s1.1151","doi-asserted-by":"crossref","unstructured":"Mahmoud R , Shah SC , Ten Hove JR , et al . No association between pseudopolyps and colorectal neoplasia in patients with inflammatory bowel diseases. Gastroenterology 2019;156.doi:10.1053\/j.gastro.2018.11.067","DOI":"10.1053\/j.gastro.2018.11.067"},{"key":"2020050721381611000_68.Suppl_3.s1.1152","doi-asserted-by":"publisher","DOI":"10.1136\/gut.32.2.167"},{"key":"2020050721381611000_68.Suppl_3.s1.1153","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.02854.x"},{"key":"2020050721381611000_68.Suppl_3.s1.1154","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2013.05.017"},{"key":"2020050721381611000_68.Suppl_3.s1.1155","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2013.09.016"},{"key":"2020050721381611000_68.Suppl_3.s1.1156","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2009.179804"},{"key":"2020050721381611000_68.Suppl_3.s1.1157","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.12.037"},{"key":"2020050721381611000_68.Suppl_3.s1.1158","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2012.09.005"},{"key":"2020050721381611000_68.Suppl_3.s1.1159","doi-asserted-by":"crossref","unstructured":"Collins PD , Mpofu C , Watson AJ , et al . Strategies for detecting colon cancer and\/or dysplasia in patients with inflammatory bowel disease. Cochrane Database Syst Rev 2006:CD000279.doi:10.1002\/14651858.CD000279.pub3","DOI":"10.1002\/14651858.CD000279.pub3"},{"key":"2020050721381611000_68.Suppl_3.s1.1160","first-page":"1083","article-title":"Colon cancer surveillance in chronic ulcerative colitis: historical cohort study","volume":"85","author":"Lashner","year":"1990","journal-title":"Am J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.1161","doi-asserted-by":"publisher","DOI":"10.1136\/gut.42.5.711"},{"key":"2020050721381611000_68.Suppl_3.s1.1162","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/0016-5085(93)90715-O","article-title":"Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis","volume":"105","author":"Choi","year":"1993","journal-title":"Gastroenterology"},{"key":"2020050721381611000_68.Suppl_3.s1.1163","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605359"},{"key":"2020050721381611000_68.Suppl_3.s1.1164","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2015.65"},{"key":"2020050721381611000_68.Suppl_3.s1.1165","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.03.044"},{"key":"2020050721381611000_68.Suppl_3.s1.1166","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04753.x"},{"key":"2020050721381611000_68.Suppl_3.s1.1167","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.gie.2014.12.009","article-title":"SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease","volume":"81","author":"Laine","year":"2015","journal-title":"Gastrointest Endosc"},{"key":"2020050721381611000_68.Suppl_3.s1.1168","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1365-2036.2009.04195.x","article-title":"Systematic review: molecular chemoprevention of colorectal malignancy by mesalazine","volume":"31","author":"Lyakhovich","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"2020050721381611000_68.Suppl_3.s1.1169","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1097\/MIB.0000000000000540","article-title":"Mesalamine, but not sulfasalazine, reduces the risk of colorectal neoplasia in patients with inflammatory bowel disease","volume":"21","author":"O\u02bcConnor","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.1170","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.18632\/oncotarget.13715","article-title":"Chemopreventive effects of 5-aminosalicylic acid on inflammatory bowel disease-associated colorectal cancer and dysplasia: a systematic review with meta-analysis","volume":"8","author":"Qiu","year":"2017","journal-title":"Oncotarget"},{"key":"2020050721381611000_68.Suppl_3.s1.1171","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/apt.14023","article-title":"Systematic review with meta-analysis: use of 5-aminosalicylates and risk of colorectal neoplasia in patients with inflammatory bowel disease","volume":"45","author":"Bonovas","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"2020050721381611000_68.Suppl_3.s1.1172","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-317021"},{"key":"2020050721381611000_68.Suppl_3.s1.1173","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-012-0352-6"},{"key":"2020050721381611000_68.Suppl_3.s1.1174","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-3565(05)00738-X"},{"key":"2020050721381611000_68.Suppl_3.s1.1175","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2014.05.019"},{"key":"2020050721381611000_68.Suppl_3.s1.1176","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/apt.14436","article-title":"Systematic review with meta-analysis: thiopurines decrease the risk of colorectal neoplasia in patients with inflammatory bowel disease","volume":"47","author":"Lu","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"2020050721381611000_68.Suppl_3.s1.1177","doi-asserted-by":"publisher","DOI":"10.1007\/BF01686465"},{"key":"2020050721381611000_68.Suppl_3.s1.1178","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(97)70215-4"},{"key":"2020050721381611000_68.Suppl_3.s1.1179","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(89)90058-9"},{"key":"2020050721381611000_68.Suppl_3.s1.1180","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2008.71"},{"key":"2020050721381611000_68.Suppl_3.s1.1181","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2012.11.011"},{"key":"2020050721381611000_68.Suppl_3.s1.1182","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2012.10.024"},{"key":"2020050721381611000_68.Suppl_3.s1.1183","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3109\/00365521.2013.812141","article-title":"Pregnancy and newborn outcome of mothers with inflammatory bowel diseases exposed to anti-TNF-\u03b1 therapy during pregnancy: three-center study","volume":"48","author":"Bortlik","year":"2013","journal-title":"Scand J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.1184","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/j.gastro.2016.04.002","article-title":"Concentrations of adalimumab and infliximab in mothers and\u00a0newborns, and effects on infection","volume":"151","author":"Julsgaard","year":"2016","journal-title":"Gastroenterology"},{"key":"2020050721381611000_68.Suppl_3.s1.1185","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/apt.14040","article-title":"The effects of pregnancy on the pharmacokinetics of infliximab and adalimumab in inflammatory bowel disease","volume":"45","author":"Seow","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"2020050721381611000_68.Suppl_3.s1.1186","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1053\/j.gastro.2018.05.040","article-title":"Exposure concentrations of infants breastfed by women receiving biologic therapies for inflammatory bowel diseases and effects of breastfeeding on infections and development","volume":"155","author":"Matro","year":"2018","journal-title":"Gastroenterology"},{"key":"2020050721381611000_68.Suppl_3.s1.1187","doi-asserted-by":"publisher","DOI":"10.1080\/14767050410001668662"},{"key":"2020050721381611000_68.Suppl_3.s1.1188","first-page":"1595","article-title":"Crohn\u2019s disease as a risk factor for the outcome of pregnancy","volume":"47","author":"Morales","year":"2000","journal-title":"Hepato-Gastroenterology"},{"key":"2020050721381611000_68.Suppl_3.s1.1189","doi-asserted-by":"publisher","DOI":"10.3109\/00365528309182088"},{"key":"2020050721381611000_68.Suppl_3.s1.1190","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1080\/00365521.1984.12005800","article-title":"Pregnancy in Crohn\u2019s disease","volume":"19","author":"Nielsen","year":"1984","journal-title":"Scand J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.1191","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-309321"},{"key":"2020050721381611000_68.Suppl_3.s1.1192","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/MIB.0000000000001102","article-title":"The effect of disease activity on birth outcomes in a nationwide cohort of women with moderate to severe inflammatory bowel disease","volume":"23","author":"Kammerlander","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.1193","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1097\/MIB.0000000000000802","article-title":"Adverse pregnancy outcomes among women with inflammatory bowel disease: a population-based study from England","volume":"22","author":"Abdul Sultan","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.1194","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjv234"},{"key":"2020050721381611000_68.Suppl_3.s1.1195","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12936"},{"key":"2020050721381611000_68.Suppl_3.s1.1196","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1038\/s41395-018-0176-7","article-title":"Continuous anti-TNF\u03b1\u00a0use throughout pregnancy: possible complications for the mother but not for the fetus. A retrospective cohort on the French National Health Insurance Database (EVASION)","volume":"113","author":"Luu","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"Suppl","key":"2020050721381611000_68.Suppl_3.s1.1197","first-page":"A149","article-title":"Long-term health outcomes of 1000 children born to mothers with inflammatory bowel disease in the anti-TNF-\u03b1 era","volume":"5","author":"Kanis","year":"2017","journal-title":"United Eur Gastroenterol J"},{"key":"2020050721381611000_68.Suppl_3.s1.1198","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/ajg.2017.501","article-title":"Long-term safety of in utero exposure to anti-TNF\u03b1 drugs for the treatment of inflammatory bowel disease: results from the multicenter European TEDDY Study","volume":"113","author":"Chaparro","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.1199","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1016\/S0016-5085(16)30422-X","article-title":"Do infant serum levels of biologic agents at birth correlate with risk of adverse outcomes? Results from the PIANO Registry","volume":"150","author":"Mahadevan","year":"2016","journal-title":"Gastroenterology"},{"issue":"Suppl 2","key":"2020050721381611000_68.Suppl_3.s1.1200","doi-asserted-by":"crossref","first-page":"232.2","DOI":"10.1136\/annrheumdis-2014-eular.4415","article-title":"Pregnancy outcomes in women exposed to the tumor necrosis factor gnhibitor, Golimumab","volume":"73","author":"Lau","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.1201","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cgh.2017.08.041","article-title":"Use of biologic therapy by pregnant women with inflammatory bowel disease does not affect infant response to vaccines","volume":"16","author":"Beaulieu","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"2020050721381611000_68.Suppl_3.s1.1202","doi-asserted-by":"crossref","first-page":"S527","DOI":"10.1093\/ecco-jcc\/jjx180.944","article-title":"Live-vaccines and lactation in newborn exposed in utero to anti-TNF: A multi-centre French experience in inflammatory bowel disease","volume":"12","author":"Bendaoud","year":"2018","journal-title":"J Crohn\u2019s Colitis"},{"key":"2020050721381611000_68.Suppl_3.s1.1203","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/ecco-jcc\/jjy053","article-title":"Hepatitis B vaccination effective in children exposed to anti-tumour necrosis factor alpha in utero","volume":"12","author":"de Lima","year":"2018","journal-title":"J Crohns Colitis"},{"key":"2020050721381611000_68.Suppl_3.s1.1204","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/apt.13960","article-title":"Vedolizumab exposure in pregnancy: outcomes from clinical studies in inflammatory bowel disease","volume":"45","author":"Mahadevan","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"2020050721381611000_68.Suppl_3.s1.1205","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-313444"},{"key":"2020050721381611000_68.Suppl_3.s1.1206","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208840"},{"key":"2020050721381611000_68.Suppl_3.s1.1207","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12876-017-0633-6","article-title":"Fetal death in utero and miscarriage in a patient with Crohn\u2019s disease under therapy with ustekinumab: case-report and review of the literature","volume":"17","author":"Venturin","year":"2017","journal-title":"BMC Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.1208","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1093\/ibd\/izy160","article-title":"Outcomes of pregnancies with maternal\/paternal exposure in the Tofacitinib Safety Databases for Ulcerative Colitis","volume":"24","author":"Mahadevan","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.1209","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jju006"},{"key":"2020050721381611000_68.Suppl_3.s1.1210","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.12.003"},{"key":"2020050721381611000_68.Suppl_3.s1.1211","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.07.023"},{"key":"2020050721381611000_68.Suppl_3.s1.1212","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjv064"},{"key":"2020050721381611000_68.Suppl_3.s1.1213","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2014-100548"},{"issue":"Suppl 1","key":"2020050721381611000_68.Suppl_3.s1.1214","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000437066","article-title":"Management of IBD patients with current immunosuppressive therapy and concurrent infections","volume":"33","author":"Rahier","year":"2015","journal-title":"Dig Dis"},{"issue":"Suppl","key":"2020050721381611000_68.Suppl_3.s1.1215","first-page":"A373","article-title":"Prevention of opportunistic infections in patients on biological agents for management of inflammatory bowel disease","volume":"2","author":"Gordon","year":"2014","journal-title":"United Eur Gastroenterol J"},{"key":"2020050721381611000_68.Suppl_3.s1.1216","doi-asserted-by":"publisher","DOI":"10.1086\/378746"},{"key":"2020050721381611000_68.Suppl_3.s1.1217","unstructured":"National Institute for Health and Care Excellence. Quality standard [QS81] Inflammatory bowel disease. February 2015 https:\/\/www.nice.org.uk\/guidance\/qs81 (Accessed 15 Dec 2018)."},{"key":"2020050721381611000_68.Suppl_3.s1.1218","doi-asserted-by":"publisher","DOI":"10.1016\/S1590-8658(08)60539-3"},{"key":"2020050721381611000_68.Suppl_3.s1.1219","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2012-100160"},{"key":"2020050721381611000_68.Suppl_3.s1.1220","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2013.06.004"},{"key":"2020050721381611000_68.Suppl_3.s1.1221","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.3748\/wjg.v21.i4.1182","article-title":"Optimizing perioperative Crohn\u2019s disease management: role of coordinated medical and surgical care","volume":"21","author":"Bennett","year":"2015","journal-title":"World J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.1222","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2014.02.022"},{"key":"2020050721381611000_68.Suppl_3.s1.1223","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1093\/ecco-jcc\/jjx085","article-title":"The 5C concept and 5S principles in inflammatory bowel disease management","volume":"11","author":"Hibi","year":"2017","journal-title":"J Crohns Colitis"},{"key":"2020050721381611000_68.Suppl_3.s1.1224","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjv085"},{"key":"2020050721381611000_68.Suppl_3.s1.1225","doi-asserted-by":"crossref","unstructured":"Kapasi R , Glatter J , Lamb CA , et al . Consensus standards of healthcare for adults and children with inflammatory bowel disease in the United Kingdom. Frontline Gastroenterol 2019. doi: 10.1136\/flgastro-2019-101260. [Epub ahead of print 19 Jul 2019].","DOI":"10.1136\/flgastro-2019-101260"},{"key":"2020050721381611000_68.Suppl_3.s1.1226","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1463-1318.2006.01027.x","article-title":"Results of a survey of the role of multidisciplinary team coordinators for colorectal cancer in England and Wales","volume":"9","author":"Soukop","year":"2007","journal-title":"Colorectal Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.1227","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-011-1675-6"},{"key":"2020050721381611000_68.Suppl_3.s1.1228","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0889-8553(01)00023-1","article-title":"The surgical management of Crohn\u2019s disease","volume":"31","author":"Schraut","year":"2002","journal-title":"Gastroenterol Clin North Am"},{"key":"2020050721381611000_68.Suppl_3.s1.1229","doi-asserted-by":"publisher","DOI":"10.1186\/1478-7547-11-7"},{"key":"2020050721381611000_68.Suppl_3.s1.1230","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2013.10.010"},{"key":"2020050721381611000_68.Suppl_3.s1.1231","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2013-100333"},{"issue":"Suppl 2","key":"2020050721381611000_68.Suppl_3.s1.1232","doi-asserted-by":"crossref","first-page":"A71.1","DOI":"10.1136\/gutjnl-2012-302514a.165","article-title":"OC-165\u2005No increase in surgical complication in patients treated with rescue therapy for acute severe ulcerative colitis: data from the UK IBD audit","volume":"61","author":"Lynch","year":"2012","journal-title":"Gut"},{"issue":"Suppl 2","key":"2020050721381611000_68.Suppl_3.s1.1233","doi-asserted-by":"crossref","first-page":"A397.2","DOI":"10.1136\/gutjnl-2012-302514d.244","article-title":"PWE-244\u2005Does thromboprophylaxis in ulcerative colitis work?: data from the UK IBD audit","volume":"61","author":"Lynch","year":"2012","journal-title":"Gut"},{"issue":"Suppl 1","key":"2020050721381611000_68.Suppl_3.s1.1234","doi-asserted-by":"crossref","first-page":"A231.1","DOI":"10.1136\/gutjnl-2014-307263.497","article-title":"PTH-051\u2005The first year\u2019s outcome data from IBD-SSHAMP; UK\u2019s first remote web-based self management programme for stable inflammatory bowel disease patients","volume":"63","author":"Johnson","year":"2014","journal-title":"Gut"},{"issue":"Suppl 1","key":"2020050721381611000_68.Suppl_3.s1.1235","doi-asserted-by":"crossref","first-page":"A231.2","DOI":"10.1136\/gutjnl-2014-307263.498","article-title":"PTH-052\u2005How the new inflammatory bowel disease registry and patient management system (IBD-R\/PMS) has helped define the future of our district general IBD service","volume":"63","author":"Johnson","year":"2014","journal-title":"Gut"},{"key":"2020050721381611000_68.Suppl_3.s1.1236","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2012.01.021"},{"key":"2020050721381611000_68.Suppl_3.s1.1237","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2010.08.009"},{"key":"2020050721381611000_68.Suppl_3.s1.1238","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2013.09.018"},{"key":"2020050721381611000_68.Suppl_3.s1.1239","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/MIB.0000000000001013","article-title":"Effects of education and information on vaccination behavior in patients with inflammatory bowel disease","volume":"23","author":"Coenen","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.1240","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw019.894"},{"issue":"Suppl 1","key":"2020050721381611000_68.Suppl_3.s1.1241","doi-asserted-by":"crossref","first-page":"A96.1","DOI":"10.1136\/gutjnl-2015-309861.196","article-title":"PTU-081\u00a0The impact of a nurse co-ordinated IBD multidisciplinary team meeting in enhancing safety and reducing cost","volume":"64","author":"Stansfield","year":"2015","journal-title":"Gut"},{"key":"2020050721381611000_68.Suppl_3.s1.1242","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jju027.852"},{"key":"2020050721381611000_68.Suppl_3.s1.1243","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200012090-00001"},{"key":"2020050721381611000_68.Suppl_3.s1.1244","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/imj.12861","article-title":"Changing face of care for patients with moderate to severe inflammatory bowel disease: the role of specialist nurses in the governance of anti-TNF prescribing","volume":"45","author":"Connell","year":"2015","journal-title":"Intern Med J"},{"key":"2020050721381611000_68.Suppl_3.s1.1245","doi-asserted-by":"crossref","first-page":"434","DOI":"10.5217\/ir.2017.15.4.434","article-title":"Medication adherence in inflammatory bowel disease","volume":"15","author":"Chan","year":"2017","journal-title":"Intest Res"},{"key":"2020050721381611000_68.Suppl_3.s1.1246","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.pec.2009.12.010","article-title":"Telephone nurse counseling for medication adherence in ulcerative colitis: a preliminary study","volume":"81","author":"Cook","year":"2010","journal-title":"Patient Educ Couns"},{"key":"2020050721381611000_68.Suppl_3.s1.1247","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw019.885"},{"key":"2020050721381611000_68.Suppl_3.s1.1248","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2015-100630"},{"key":"2020050721381611000_68.Suppl_3.s1.1249","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.enfcli.2013.12.006","article-title":"[Telematic consultations by nursing staff for patients with inflammatory bowel disease: evaluation of its capacity for resolving problems and its costs]","volume":"24","author":"Sanrom\u00e1n Alvarez","year":"2014","journal-title":"Enferm Clin"},{"issue":"Suppl 1","key":"2020050721381611000_68.Suppl_3.s1.1250","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/jcag\/gwy008.007","article-title":"A6 Preferences for care for active symptoms of ibd in a population based sample","volume":"1","author":"Bernstein","year":"2018","journal-title":"J Can Assoc Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.1251","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.cgh.2013.11.015","article-title":"Association between telephone activity and features of patients with inflammatory bowel disease","volume":"12","author":"Ramos-Rivers","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2020050721381611000_68.Suppl_3.s1.1252","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1097\/MIB.0000000000001210","article-title":"Delivering high value inflammatory bowel disease care through telemedicine visits","volume":"23","author":"Li","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.1253","doi-asserted-by":"publisher","DOI":"10.1016\/S1873-9946(14)60806-0"},{"key":"2020050721381611000_68.Suppl_3.s1.1254","doi-asserted-by":"publisher","DOI":"10.1097\/SGA.0b013e318288c8a8"},{"issue":"Suppl","key":"2020050721381611000_68.Suppl_3.s1.1255","first-page":"A256","article-title":"An evaluation of a pharmacist-led telephone clinic with regard to monitoring, safety and quality of service on patients taking thiopurines for the treatment of inflammatory bowel disease (IBD) and autoimmune hepatitis (AIH) at Barnsley Hospital NHS","volume":"3","author":"Fuertes","year":"2015","journal-title":"United Eur Gastroenterol J"},{"issue":"Suppl 1","key":"2020050721381611000_68.Suppl_3.s1.1256","doi-asserted-by":"crossref","first-page":"A238.3","DOI":"10.1136\/gutjnl-2015-309861.511","article-title":"PWE-062\u00a0The outcomes and benefits of moving stable inflammatory bowel disease patients from a paper based self management system to an supported, self help and management programme (IBD-SSHAMP) with specialist overview","volume":"64","author":"Price","year":"2015","journal-title":"Gut"},{"key":"2020050721381611000_68.Suppl_3.s1.1257","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3109\/13814788.2012.761440","article-title":"Implementing transnational telemedicine solutions: a connected health project in rural and remote areas of six Northern Periphery countries Series on European collaborative projects","volume":"19","author":"Casey","year":"2013","journal-title":"Eur J Gen Pract"},{"key":"2020050721381611000_68.Suppl_3.s1.1258","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i3.829"},{"key":"2020050721381611000_68.Suppl_3.s1.1259","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw059"},{"key":"2020050721381611000_68.Suppl_3.s1.1260","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06105-0"},{"key":"2020050721381611000_68.Suppl_3.s1.1261","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.034256"},{"issue":"Suppl 1","key":"2020050721381611000_68.Suppl_3.s1.1262","doi-asserted-by":"crossref","first-page":"A27.1","DOI":"10.1136\/gutjnl-2015-309861.52","article-title":"OC-052\u00a05 year follow up of a nurse led guided self management programme in ibd","volume":"64","author":"Stansfield","year":"2015","journal-title":"Gut"},{"key":"2020050721381611000_68.Suppl_3.s1.1263","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1111\/jocn.12851","article-title":"Structure and content components of self-management interventions that improve health-related quality of life in people with inflammatory bowel disease: a systematic review, meta-analysis and meta-regression","volume":"24","author":"Tu","year":"2015","journal-title":"J Clin Nurs"},{"key":"2020050721381611000_68.Suppl_3.s1.1264","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0140-6736(17)31327-2","article-title":"Telemedicine for management of inflammatory bowel disease (myIBDcoach): a pragmatic, multicentre, randomised controlled trial","volume":"390","author":"de Jong","year":"2017","journal-title":"Lancet"},{"key":"2020050721381611000_68.Suppl_3.s1.1265","unstructured":"National Institute for Health and Care Excellence. Ulcerative colitis: Clinical Knowledge Summaries. July 2015 https:\/\/cks.nice.org.uk\/ulcerative-colitis (Accessed 15 Dec 2018)."},{"key":"2020050721381611000_68.Suppl_3.s1.1266","doi-asserted-by":"publisher","DOI":"10.1177\/1756283X12461395"},{"issue":"Suppl 1","key":"2020050721381611000_68.Suppl_3.s1.1267","doi-asserted-by":"crossref","first-page":"A142.1","DOI":"10.1136\/gutjnl-2016-312388.256","article-title":"PWE-010\u2005Monitoring IBD medications in primary care: audit of practice in South West London","volume":"65","author":"Alexakis","year":"2016","journal-title":"Gut"},{"issue":"Suppl 1","key":"2020050721381611000_68.Suppl_3.s1.1268","doi-asserted-by":"crossref","first-page":"A142.2","DOI":"10.1136\/gutjnl-2016-312388.257","article-title":"PWE-011\u2005Is ulcerative colitis (UC) managed adequately in primary care?","volume":"65","author":"Aldulaimi","year":"2016","journal-title":"Gut"},{"issue":"Suppl 2","key":"2020050721381611000_68.Suppl_3.s1.1269","doi-asserted-by":"crossref","first-page":"S517","DOI":"10.14309\/00000434-201410002-01746","article-title":"Vaccinating patients with IBD: Still to begin, at the beginning","volume":"109","author":"Goel","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"2020050721381611000_68.Suppl_3.s1.1270","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.3748\/wjg.v21.i7.2152","article-title":"Establishing an integrated gastroenterology service between a medical center and the community","volume":"21","author":"Niv","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"Suppl","key":"2020050721381611000_68.Suppl_3.s1.1271","first-page":"A52","article-title":"The UK\u2019s first internet based remote management system for monitoring stable IBD patients in the community, IBD SSHAMP (supported self help and management programme)","volume":"1","author":"Price","year":"2013","journal-title":"United Eur Gastroenterol J"},{"key":"2020050721381611000_68.Suppl_3.s1.1272","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.eii.2016.03.002","article-title":"Colitis ulcerosa en remisi\u00f3n: mejora de la adhesi\u00f3n terap\u00e9utica desde una perspectiva multidisciplinar","volume":"15","author":"Casellas","year":"2016","journal-title":"Enfermedad Inflamatoria Intestinal al D\u00eda"},{"key":"2020050721381611000_68.Suppl_3.s1.1273","first-page":"105","article-title":"Vaccination coverage in immunosuppressed patients: results of a regional health services research study","volume":"108","author":"Teich","year":"2011","journal-title":"Dtsch Arztebl Int"},{"key":"2020050721381611000_68.Suppl_3.s1.1274","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.gastrohep.2015.09.014","article-title":"Adherence to a predefined vaccination program in patients with inflammatory bowel disease","volume":"39","author":"Ruiz-Cuesta","year":"2016","journal-title":"Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"2020050721381611000_68.Suppl_3.s1.1275","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1097\/01.MIB.0000438728.39212.11","article-title":"P-049\u2003Vaccination\u00a0rates in inflammatory bowel disease","volume":"19","author":"Abdallah","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"2020050721381611000_68.Suppl_3.s1.1276","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2015.162"},{"key":"2020050721381611000_68.Suppl_3.s1.1277","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/jhn.12494","article-title":"What are the dietary treatment research priorities for inflammatory bowel disease? A short report based on a priority setting partnership with the James Lind Alliance","volume":"30","author":"Lomer","year":"2017","journal-title":"J Hum Nutr Diet"},{"key":"2020050721381611000_68.Suppl_3.s1.1278","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw144"},{"key":"2020050721381611000_68.Suppl_3.s1.1279","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2012.09.003"},{"key":"2020050721381611000_68.Suppl_3.s1.1280","doi-asserted-by":"publisher","DOI":"10.4137\/HSI.S11093"},{"key":"2020050721381611000_68.Suppl_3.s1.1281","doi-asserted-by":"publisher","DOI":"10.1136\/gut.38.6.905"},{"key":"2020050721381611000_68.Suppl_3.s1.1282","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.01945.x"},{"key":"2020050721381611000_68.Suppl_3.s1.1283","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199810000-00003"},{"key":"2020050721381611000_68.Suppl_3.s1.1284","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(12)61634-6"},{"key":"2020050721381611000_68.Suppl_3.s1.1285","unstructured":"Department of Health. The UK immunisation schedule: The Green Book, Chapter 11. March 2013 https:\/\/www.gov.uk\/government\/publications\/immunisation-schedule-the-green-book-chapter-11 (Accessed 10 Jan 2019)."},{"key":"2020050721381611000_68.Suppl_3.s1.1286","doi-asserted-by":"publisher","DOI":"10.1177\/2040622315579063"},{"key":"2020050721381611000_68.Suppl_3.s1.1287","doi-asserted-by":"publisher","DOI":"10.1097\/DCR.0b013e31827080c1"},{"key":"2020050721381611000_68.Suppl_3.s1.1288","doi-asserted-by":"crossref","first-page":"e524","DOI":"10.1016\/S2352-3026(17)30182-5","article-title":"Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials","volume":"4","author":"Stoffel","year":"2017","journal-title":"Lancet Haematol"},{"key":"2020050721381611000_68.Suppl_3.s1.1289","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2015.12.047"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2019-318484","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T00:58:47Z","timestamp":1721782727000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2019-318484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,27]]},"references-count":1289,"journal-issue":{"issue":"Suppl 3","published-online":{"date-parts":[[2019,11,7]]},"published-print":{"date-parts":[[2019,12]]}},"alternative-id":["10.1136\/gutjnl-2019-318484"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2019-318484","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,27]]}}}